[
    {
        "Thread Title": "Question 1",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/115/View",
        "Question": "<p>Question 1: Describe the drug-receptor complex formation and comment on how down-regulation and up-regulation can impact your calculation of anesthetic drug dosages.</p>",
        "Responses": [
            {
                "Author": "Marjan Nematpour",
                "Content": "Pharmacology Key Question #1",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/7947/ViewAttachment?fileId=496608",
                        "filename": "Pharmacology Key Question #1, Marjan.pdf"
                    }
                ],
                "Timestamp": "2024-12-07T22:56:38.669Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Thanks, Marjan, for your post on up-regulation and down-regulation.\nIn summary, up-regulation increases the availability of drug receptors, and therefore, we could give a lower dose of the drug to achieve the desired pharmacological effect. Down-regulation results in less available receptors. &#160;This causes a rightward shift in the dose-response curve, which means a higher dose of drug is required to produce the effect.\nIn addition to drugs, aging, genetic mutations, and disorders can also up-regulate or down-regulate the number and affinity of receptors. This may lead to an exaggerated response to one drug, but a resistance response to another. &#160;\nFor example, a patient with a muscle denervation injury is associated with a chronic decrease in acetylcholine release. &#160;This will cause an up-regulation in the number of acetylcholine receptors. &#160;On the one hand, this up-regulation will cause an exaggerated response to Succinylcholine, with more receptors being depolarized, as Marjan pointed out. &#160;On the other hand, this up-regulation can develop resistance to Rocuronium or other non-depolarizing muscle relaxants because more receptors need to be blocked. &#160;\nIn contrast, a patient with myasthenia gravis is associated with a down-regulation in the acetylcholine receptors. &#160;This down-regulation will develop resistance to Succinylcholine, but an increased sensitivity to Rocuronium.\nThis discussion on up- and down-regulation demonstrates the importance of conducting a comprehensive pre-anesthetic assessment. &#160;In addition to the airway assessment and physical exam, we need to note the patient\u2019s medical history, comorbidities, allergies, and current medications.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:38.672Z"
            }
        ]
    },
    {
        "Thread Title": "Question 10",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/106/View",
        "Question": "<p>Question 10: What factors affect the alveolar uptake of inhaled anesthetics? Describe how manipulating these factors can alter the speed of induction and emergence.</p>",
        "Responses": [
            {
                "Author": "Dan Chen",
                "Content": "Question 10: What factors affect the alveolar uptake of inhaled anesthetics? Describe how manipulating these factors can alter the speed of induction and emergence.\n**1. Solubility (Blood:gas Partition Coefficient)&#160;**\nThe main factor that affects alveolar uptake of inhalational anesthetic agent is the blood:gas partition coefficient (solubility of the anesthetic in blood). This coefficient determines how quickly an anesthetic equilibrates between the alveoli and the blood. This is defined as the ratio of its concentration in blood to alveolar gas when their partial pressures are in equilibrium (Cook &amp; Hemmings, 2023). Figure 1 illustrates the blood:gas partition coefficient values of various anesthetic agents.&#160;\nAnesthetics with lower blood:gas partition coefficients do not dissolve well in blood. As a result, the partial pressure in the blood rises quickly because the blood is rapidly saturated, leading to faster induction.&#160;These agents also have quicker emergence, as less anesthetic remains dissolved in the blood, speeding up elimination. In contrast, agents with higher blood solubility take longer to equilibrate, resulting in slower induction and recovery (Cook &amp; Hemmings, 2023).&#160;\n**Manipulation:** Choose a poorly soluble anesthetic (e.g., desflurane) for faster induction and emergence, whereas agents that are more soluble (e.g., halothane) will have a slower induction and emergence (Cook &amp; Hemmings, 2023).&#160;\n<img src=\"/d2l/le/7298/discussions/posts/4097/ViewAttachment?fileId=438631\" style=\"max-width: 100%;\"/>\nFigure 1: Comparative Partition Coefficients of Inhaled Anesthetics. Adapted from Miller&#39;s basics of anesthesia (Cook &amp; Hemmings, 2023, p.84)&#160;\n**2. Inspired Concentration of Anesthetic (FI)&#160;**\nThe ratio of alveolar concentration (FA) to inspired concentration (FI), expressed as FA/FI, is used to determine the speed of induction (Clar, Patel, &amp; Richards, 2024). The inspired concentration is essential for facilitating uptake into the alveoli, as it establishes the partial pressure gradient necessary for anesthetic diffusion into the bloodstream. Increasing the inspired concentration enhances the alveolar concentration, leading to a more rapid uptake of the anesthetic and expediting the induction process. This phenomenon reflects the concentration effect, which illustrates that a higher initial concentration not only accelerates the rate of rise in alveolar concentration but also compensates for the uptake of the anesthetic, ultimately facilitating quicker induction (Berger, 2022). &#160;\n**Manipulation:**&#160;Increasing the inspired concentration by increasing the output concentration of the anesthetic vaporizer and increasing the flow of the flowmeter to improve fresh gas flow raises the anesthetic&#39;s partial pressure in the alveoli, thereby accelerating induction. Conversely, reducing the inspired concentration promotes faster emergence (Berger, 2022).&#160;\n**3. Alveolar Ventilation&#160;**\nAlveolar ventilation influences how effectively gases are exchanged between the lungs and blood, impacting the rate of induction. Higher alveolar ventilation leads to a quicker rise in the partial pressure of the anesthetic in the alveoli, facilitating faster induction and recovery. The effect is more pronounced with soluble agents, which are subject to greater uptake, whereas it is less significant with insoluble agents. (Cook &amp; Hemmings, 2023).&#160;\n**Manipulation:** Increasing tidal volume or respiratory rate on the Anesthetic Gas Machine (AGM) can enhance alveolar ventilation, speeding up both induction and elimination of anesthetic gases during emergence (Cook &amp; Hemmings, 2023).&#160;\n**4. Cardiac Output (Pulmonary Alveolar Blood Flow)&#160;**\nIt is important to note that cardiac output (CO) significantly affects the uptake of soluble anesthetics, slowing their rate of increase with higher CO, while poorly soluble anesthetics are largely unaffected by changes in CO (Cook &amp; Hemmings, 2023).&#160;\nIn the absence of a shunt, pulmonary blood flow equals CO (Trinkmann et al., 2009). CO affects the rate at which anesthetic is distributed throughout the body. Higher CO removes anesthetic from the alveoli more rapidly during induction, slowing the rise of FA/FI and delaying induction. Conversely, a lower CO will speed up induction. In the case of emergence, a higher CO results in prolonged emergence due to increased anesthetic uptake and lower alveolar concentration, while lower CO leads to faster emergence because of reduced anesthetic uptake and higher alveolar concentration. (Cook &amp; Hemmings, 2023).&#160;\n**Manipulation**: Hypothetically, using drugs to decrease the CO will speed up induction and emergence.\n**5. Partial Pressure Gradient Between Alveoli and Venous Blood &#160;**\nA large partial pressure gradient between the alveoli and venous blood drives the rapid uptake of anesthetic into the bloodstream, which can slow the rise in alveolar concentration and prolong induction. As the gradient diminishes, uptake decreases, allowing the alveolar concentration to increase more rapidly, resulting in a faster induction. During emergence, a smaller gradient facilitates quicker washout of the anesthetic from the blood (Berger, 2022).&#160;\n**Manipulation: **A larger gradient slows induction and emergence, while a smaller gradient accelerates induction and emergence (Berger, 2022).&#160;****\n**6. Second Gas Effect&#160;**\nThe second-gas effect occurs when the high uptake of one anesthetic gas (the first gas) accelerates the increase of a concurrently administered companion gas (the second gas). This increases the rate of rise of FA/Fi, thereby speeding up the rate of induction (Berger, 2022).&#160;\nThe second-gas effect is usually associated with nitrous oxide since it is used in high concentrations. When nitrous oxide is administered in high concentrations, it is rapidly absorbed into the blood, reducing alveolar volume and concentrating co-administered volatile anesthetics in the alveoli. This increased concentration speeds up the uptake of volatile anesthetics into the bloodstream, leading to faster induction of anesthesia. While these effects significantly influence induction, their impact on emergence is less pronounced (Cook &amp; Hemmings, 2023).&#160;\n**Manipulation:** Administering a first gas, such as nitrous oxide, accelerates the uptake of the second gas, resulting in faster induction of anesthesia (Berger, 2022).&#160;\n&#160;\nReferences:&#160;\n<div>\n<div>\n<p lang=\"EN-US\"><span lang=\"EN-US\">Berger, A. S. (2022). Inhaled anesthetics. In P. Flood, J. P. Rathmell, &amp; R. D. Urman (Eds.), </span>_<span lang=\"EN-US\">Stoelting&#39;s pharmacology and physiology in anesthetic practice</span>_<span lang=\"EN-US\">_ _(6th ed., pp. </span><span lang=\"EN-US\">485-</span> <span></span><span lang=\"EN-US\">523</span><span lang=\"EN-US\">). Wolters Kluwer.</span><span>&#160;</span>\n</div>\n<div>\n<p lang=\"EN-US\"><span lang=\"EN-US\">Clar, D. T., Patel, S., &amp; Richards, J. R. (2024). Anesthetic gases. In </span>_<span lang=\"EN-US\">StatPearls</span>_<span lang=\"EN-US\">. StatPearls Publishing. </span><a rel=\"noopener\" target=\"_blank\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK537013/\"><span lang=\"EN-US\"><span>https://www.ncbi.nlm.nih.gov/books/NBK537013/</span></span></a><span lang=\"EN-US\"></span><span>&#160;</span>\n</div>\n<div>\n<p lang=\"EN-US\"><span lang=\"EN-US\">Cook, D. C., &amp; Hemmings, H. C. Jr. (2023). Inhaled anesthetics. In M. C. Pardo Jr. (Ed.), </span>_<span lang=\"EN-US\">Miller&#39;s basics of anesthesia </span>_<span lang=\"EN-US\">(8th ed., pp. 84-88). Elsevier.</span><span>&#160;</span>\n</div>\n<div>\n<p lang=\"EN-US\"><span lang=\"EN-US\">Trinkmann, F., Papavassiliu, T., Kraus, F., Leweling, H., Schoenberg, S. O., Borggrefe, M., ... &amp; Saur, J. (2009). Inert gas rebreathing: the effect of haemoglobin based pulmonary </span> <span></span><span lang=\"EN-US\">shunt flow correction on the accuracy of cardiac output measurements in clinical practice. </span><span lang=\"EN-US\">_Clinical physiology and functional imaging,_ _29_(</span><span lang=\"EN-US\">4), 255-262.</span><span>&#160;</span>\n</div>\n</div>",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4097/ViewAttachment?fileId=438631",
                        "filename": "Screen Shot 2024-10-01 at 11.29.01 PM.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:56:44.664Z"
            },
            {
                "Author": "Ryan Christopher Floro",
                "Content": "<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Hi Dan,\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Your summary of all these factors was excellent and the way you organized it made it easy to navigate and understand. I did have a question about the second gas effect though. Like you mentioned, when an inhaled anesthetic is given with nitrous oxide, the uptake of the inhaled anesthetic into the bloodstream is faster and leads to a quicker induction. However, increased cardiac output also increases uptake into the bloodstream but instead delays induction. Why is induction faster in the scenario with nitrous oxide? If it\u2019s because of the higher concentration caused by nitrous oxide, would giving the inhaled anesthetic alone at a higher concentration lead to a faster induction in the second scenario?\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">On the topic of nitrous oxide, I would also like to share another interesting interaction. When nitrous oxide is discontinued during emergence, the partial pressure in the alveoli decreases while the partial pressure remains high in the blood, leading to its diffusion into the alveoli and a rapid emergence (Cook &amp; Hemmings, 2023). Because of this diffusion into the alveoli, other alveolar gases like oxygen would become diluted leading to a lower partial pressure and diffusion hypoxia (Cook &amp; Hemmings, 2023). Perhaps during emergence, a temporarily higher FiO2 would counteract this effect and reduce the chances of desaturation and hypoxemia.\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">References\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Cook, D. C., &amp; Hemmings Jr., H. C. (2023). 7 \u2013 Inhaled Anesthetics. In M. C. Pardo Jr. (Ed.).&#160; <i>Miller\u2019s Basics of Anesthesia (8<sup>th</sup> ed.)</i> (pp. 88-91). Elsevier.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:44.664Z"
            },
            {
                "Author": "Dan Chen",
                "Content": "Hi Ryan,\nThank you for bring to my attention the importance of increasing O2 to prevent diffusion hypoxia during emergence. You raise a good point about cardiac output. While increased cardiac output can enhance the uptake of anesthetics into the bloodstream, it also results in a higher volume of blood being distributed to various tissues. This can lead to a slower rise of anesthetic concentration in the alveoli, thereby delaying induction.\nIn contrast, when nitrous oxide is administered at high concentrations, the partial pressure in the alveoli is significantly higher than in the blood. This steep gradient drives the gas quickly from the alveoli to the blood, facilitating fast induction of anesthesia. This significant uptake reduces the volume of gas in the alveoli, leading to an overall decrease in alveolar volume. Consequently, this reduction in volume increases the relative concentration of coadministered inhaled anesthetics (second gas), facilitating their uptake and enhancing the induction of anesthesia. Simply increasing the concentration of the inhaled anesthetic alone wouldn&#39;t provide the same dynamic benefit in terms of alveolar volume reduction, which is key to the second gas effect (Cook &amp; Hemmings, 2023).\nReference\nCook, D. C., &amp; Hemmings, H. C. Jr. (2023). Inhaled anesthetics. In M. C. Pardo Jr. (Ed.),&#160;_Miller&#39;s basics of anesthesia&#160;_(8th ed., pp. 84-88). Elsevier.&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:44.664Z"
            },
            {
                "Author": "Gregori Kuran",
                "Content": "Hi Dan, thanks for providing this clear and concise breakdown on factors<br/>affecting alveolar uptake of inhaled anesthetics, I really enjoyed how you<br/>effectively explained how to manipulate these factors to change the speed<br/>of induction and emergence.<br/>While nitrous oxide is commonly used to achieve this second gas effect it is<br/>important to be aware of situations and contraindications where the use of<br/>nitrous oxide should be questioned. These contraindications are as follows(1)<br/>\u2022 Pneumothorax<br/>\u2022 Bowel obstruction<br/>\u2022 Certain types of middle ear and eye surgeries<br/>o Especially where the expansion of nitrous gas can lead to<br/>increased pressure in these closed spaces\n\u2022 First trimester of pregnancy<br/>\u2022 Severe psychiatric disorders<br/>o May promote hallucicnatrions<br/>\u2022 Pulmonary hypertension<br/>\u2022 Head and neck surgeries where cautery is used<br/>o May increase the risk of combustion<br/>\u2022 Severe cardiac disease<br/>\u2022 Critically ill patients<br/>o May lead to megaloblastic anemia\nAll these points lead back to the importance of doing a thorough assesment<br/>of a patient\u2019s medical history and current condition inorder to ensure you<br/>can provide a safe and effective anesthetic.\n<div>\n<div>\n<div>1.&#160;Knuf K, Maani CV. Nitrous Oxide. In Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Oct 10]. Available from: <a rel=\"noopener\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK532922/\">http://www.ncbi.nlm.nih.gov/books/NBK532922/</a></div>\n</div>\n</div>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:44.665Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Great discussion on the factors that affect uptake!\nThe uptake of inhaled anesthetics is from the alveoli to the systemic circulation, and then it is distributed to the rest of the body, including the brain, the site of action. &#160;The partial pressures in the alveolar (PA), arterial (Pa), and brain (Pbr) equilibrate with each other. &#160;The partial pressure determines the magnitude of the effects. &#160;Many factors affect the speed of induction, and these same factors alter the speed of emergence in the reverse direction. A simple way to remember is \u201cfast in, fast out; slow in, slow out.\u201d&#160;\nAn easy way to look at the factors that affect the speed of induction is to divide them into two types: (1) input factors that affect the delivery of inhaled anesthetics into the alveoli, and (2) removal factors that affect the uptake of anesthetics from the alveoli into pulmonary arterial blood.\nThe speed of induction depends on the rate of rise of the alveolar concentration (FA) towards inspiratory gas concentration (FI). The rate of rise of the alveolar concentration roughly equals the input factors minus the removal factors. The quicker the rate of rise of the alveolar concentration, the shorter the induction will be. &#160;\nFor the input factors, we can give a higher inspired anesthetic concentration (FI), which will increase FA faster. &#160;This is called the concentration effect, analogous to an intravenous bolus. To increase inspired anesthetic concentration, we can turn up the vaporizer and increase the fresh gas flow to minimize dilution from exhaled gases. In addition to the input factor of increasing alveolar ventilation, we can, in theory, increase the speed of induction using the second gas effect. Administering a volatile agent with a high concentration of nitrous oxide simultaneously, will allow a large-volume uptake of nitrous oxide, which will rapidly increase the volatile agent&#39;s FA.&#160;\nIn contrast, the three removal factors are solubility, cardiac output, and the alveolar-venous partial pressure gradient. The easiest way to understand this is that the blood acts as an inactive reservoir for inhaled anesthetics. The more insoluble it is, the less the blood takes it up, the faster the equilibration of partial pressures between the alveoli and blood, the quicker the rate of rise of FA, and therefore, the faster the induction. &#160;Likewise, if the cardiac output is low, less is taken away from the lungs, equilibrium is reached more quickly, and therefore, the induction is faster. Similarly, as tissues uptake more inhaled anesthetics, the alveolar-venous partial pressure gradient decreases, thus decreasing the uptake by blood, leading to a more rapid rate of rise of FA.\nAs Dan mentioned, of all the factors discussed, solubility is the most critical factor in determining the speed of induction and emergence. &#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:44.665Z"
            }
        ]
    },
    {
        "Thread Title": "Question 11",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/105/View",
        "Question": "<p>Question 11: Describe how the anesthesiologist uses MAC to predict the patient&#39;s optimal dose of inhaled anesthetics.</p>",
        "Responses": [
            {
                "Author": "Ryan Christopher Floro",
                "Content": "<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Minimum alveolar concentration (MAC) is defined, at a MAC value of 1.0, as the concentration of an inhaled anesthetic required to prevent movement in response to a surgical incision within 50% of the population (Cook &amp; Hemmings, 2023). Plotted on a normal distribution, +/- 1 standard deviation (SD) of MAC represents roughly a 10% change in dose. This means that +2 SD, or a MAC value of 1.2, would prevent movement in 95% of the population (Aranake et al., 2013). &#160;Monitoring intra-operatively is done using end-tidal readings of the inhaled anesthetic as it is proportional to the alveolar partial pressure, which itself is reflective of the cerebral and spinal partial pressures (Cook &amp; Hemmings, 2023).</span>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">&#160;</span>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">The MAC concentrations of various inhaled anesthetics are shown in Table 1 below (Cook &amp; Hemmings, 2023). With lower values, less of the anesthetic is required to reach a MAC of 1.0. The anesthesiologist will use these known values as a starting point and adjust the dose according to the patient\u2019s age, history, current state, and other anesthetics to be administered. In general, when a factor increases MAC, potency is decreased and more inhaled anesthetic is required, while conversely, when a factor decreases MAC, potency is increased and less is required (Lobo et al., 2022) \u2013 see Table 2 below for examples. Commonly used medications in anesthesia such as propofol, barbiturates, benzodiazepines, and local anesthetics will decrease MAC, allowing for drug combinations that will optimize the patient with less inhaled anesthetic (Lobo et al., 2022).</span>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">&#160;</span>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">More specific MAC values can be used to define concentrations correlating with certain states or guide management:</span>\n<ul>\n<li style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">MAC-awake, about 1/3 of MAC, is the concentration that prevents voluntary responses (Cook &amp; Hemmings, 2023; Lobo et al., 2022)</span></li>\n<li style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">MAC-amnesia, about 1/4 of MAC, is the concentration that prevents explicit recall (Lobo et al., 2022)</span></li>\n<li style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">For guiding management, MAC blunted autonomic response (MAC-BAR), about 1.5 to 1.6 of MAC, is the concentration that will suppress adrenergic responses including tachycardia and hypertension (Cook &amp; Hemmings, 2023).</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">As an example calculation, taken from a video by Bentley (2014), consider isoflurane being administered at 0.8%, nitrous oxide (N2O) at 2 LPM, and oxygen (O2) at 1 LPM. </span>\n<ul>\n<li style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Isoflurane is given at 0.8% when its MAC value is 1.15%. In this case, the MAC delivered is 0.8% / 1.15% = 0.70 MAC. </span></li>\n<li style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">2 LPM N2O + 1 LPM O2 results in a total gas flow of 3 LPM. In this case, the volume % of N2O delivered is&#160;</span><span style=\"font-family: arial, helvetica, sans-serif;\">roughly 67% (2 LPM N2O / 3 LPM total gas flow = 0.67)</span>\n<ul>\n<li style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Since the MAC value for N2O is 104%, MAC delivered is 67% / 104% = 0.64 MAC.&#160;</span></li>\n</ul>\n</li>\n<li style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Since MAC values are additive (Cook &amp; Hemmings, 2023), the total MAC is 0.70 + 0.64 = 1.34 MAC. </span></li>\n<li style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Considering this is roughly +3 SD, this combination can be expected to prevent movement in 99.7% of the population (Aranake et al., 2013).</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Table 1: Inhaled anesthetics and associated vol% for MAC</span>\n<table border=\"1\" style=\"border-collapse: collapse;width: 28.3755%;height: 251.25px;\"><colgroup><col style=\"width: 35.655%;\"/><col style=\"width: 64.3643%;\"/></colgroup>\n<tbody>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\">**<span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Agent</span>**</td>\n<td style=\"text-align: center;height: 27.9167px;\">**<span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">MAC (vol%)</span>**</td>\n</tr>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">Halothane</span></td>\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">0.75</span></td>\n</tr>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">Enflurane</span></td>\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">1.68</span></td>\n</tr>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">Isoflurane</span></td>\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">1.15</span></td>\n</tr>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">Methoxyflurane</span></td>\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">0.16</span></td>\n</tr>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">Sevoflurane</span></td>\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">2.10</span></td>\n</tr>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">Desflurane</span></td>\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">7.25</span></td>\n</tr>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">Nitrous oxide</span></td>\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">104</span></td>\n</tr>\n<tr style=\"height: 27.9167px;\">\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">Xenon</span></td>\n<td style=\"text-align: center;height: 27.9167px;\"><span style=\"font-size: 14px;font-family: arial, helvetica, sans-serif;\">71</span></td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Adapted from Cook &amp; Hemmings (2023)</span>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">.\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Table 2: Factors that affect MAC\n<table border=\"1\" style=\"border-collapse: collapse;width: 72.6793%;\"><colgroup><col style=\"width: 45.5577%;\"/><col style=\"width: 54.4536%;\"/></colgroup>\n<tbody>\n<tr>\n<td style=\"text-align: center;\"><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">**Increase MAC (need more anesthetic)**</span></td>\n<td style=\"text-align: center;\"><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">**Decrease MAC (need less anesthetic)**</span></td>\n</tr>\n<tr>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Natural red hair</span></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Age - decreases ~6% per decade of life</span></td>\n</tr>\n<tr>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Stimulants - cocaine, ephedrine</span></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Anemia, hypoxia, hypercarbia</span></td>\n</tr>\n<tr>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Chronic alcohol use</span></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Acute alcohol use</span></td>\n</tr>\n<tr>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Acute amphetamine use&#160;</span></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Chronic amphetamine use&#160;</span></td>\n</tr>\n<tr>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Temp - 4% to 5% increase with every +1C</span></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Temp -&#160; 4% to 5% decrease with every -1C</span></td>\n</tr>\n<tr>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Hypernatremia</span></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Hyponatremia</span></td>\n</tr>\n<tr>\n<td></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Pregnancy</span></td>\n</tr>\n<tr>\n<td></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Decreased LOC or neurodegenerative disease</span></td>\n</tr>\n<tr>\n<td></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Barbiturates, benzodiazepines, ketamine</span></td>\n</tr>\n<tr>\n<td></td>\n<td><span style=\"font-family: arial, helvetica, sans-serif;font-size: 14px;\">Propofol, etomidate, dexmedetomidine</span></td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">(Cook &amp; Hemmings, 2023; Lobo et al., 2022)\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">.\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"text-decoration: underline;font-family: arial, helvetica, sans-serif;\">**References**</span>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Aranake, A., Mashour, G. A., &amp; Avidan, M. S. (2013). Minimum alveolar concentration: ongoing relevance and clinical utility. <i>Anesthesia, 68</i>(5), 512-522. <a rel=\"noopener\" href=\"https://doi.org/10.1111/anae.12168\">https://doi.org/10.1111/anae.12168</a></span>\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Bentley, M. (2014, August 5). <i>MAC Calculation</i>. [Video]. YouTube. <a rel=\"noopener\" href=\"https://www.youtube.com/watch?v=MGstMQ_AGeI\">https://www.youtube.com/watch?v=MGstMQ_AGeI</a></span>\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Cook, D. C., &amp; Hemmings Jr., H. C. (2023). 7 \u2013 Inhaled Anesthetics. In M. C. Pardo Jr. (Ed.).&#160; <i>Miller\u2019s Basics of Anesthesia (8<sup>th</sup> ed.)</i> (pp. 88-91). Elsevier.</span>\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Lobo, S. A., Ojeda, J., Dua., A., Singh, K., &amp; Lopez, J. (2022). Minimum alveolar concentration. In <i>StatsPearl</i>. StatsPearl Publishing. <a rel=\"noopener\" href=\"https://pubmed.ncbi.nlm.nih.gov/23414556/\">https://pubmed.ncbi.nlm.nih.gov/23414556/</a></span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:48.800Z"
            },
            {
                "Author": "Deena Kurilsky",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Your material on minimum alveolar concentration was very informative. I appreciated the clear breakdown of MAC values as well as the correlation between potency and MAC and the real-world application.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">An additional class of drugs to consider with effects on minimum alveolar concentration (MAC) are opioids. Opioids are commonly used during induction and maintenance of a general anesthesia. Opioids result in a decrease of MAC resulting in an increased potency.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Initially the interaction between fentanyl and volatile anesthetics is quite profound, however there is limited benefit from additional fentanyl. The key take away is that even a small dose of opioid can significantly lower the concentration of volatile anesthetic needed to prevent movement in the patient.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Reference:<br/><br/>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Flood, P., &amp; Shafer, S. L. (Eds.). (2022). Basic Principles of Pharmacology. In P. Flood, J. P. Rathmell (Eds.),&#160;<i>Stoelting\u2019s pharmacology &amp; physiology in anesthetic</i>&#160;practice (6<sup>th</sup>&#160;ed., pp 220). Wolters Kluwer\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:48.800Z"
            },
            {
                "Author": "Janet Rozek",
                "Content": "<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">Thank you, Ryan, for a great overview of how anesthesia uses MAC to predict the dosing of inhaled gases for patients.&#160; You did a great job showing us an example of a what concentrations of gases are needed to reach an optimal mac.&#160; I just wanted to review the term and highlight a few things regarding this topic.&#160; As you discussed above, MAC value of 1.0, is the concentration of an inhaled anesthetic required to prevent movement in response to a surgical incision within 50% of the population <a rel=\"noopener\" name=\"_Hlk178724970\">(Cook &amp; Hemmings, 2023). </a>The topic I would like to review is the second gas effect. The effect is important in induction of anesthesia with inhaled anesthetics because it speeds induction of anesthesia. The second gas effect is the phenomenon where the ability of high-volume uptake of one gas (the first gas), accelerates the rate of increase of a second gas.&#160; This increased uptake of the second drug allows higher concentrations of the second gas in the lungs resulting in the increased rate of induction using the second gas effect. Nitrous is used for this effect in induction of anesthesia and emergence. Nitrous oxide is insoluble in blood and other tissues which results in rapid absorption through alveoli and is often co-administered with oxygen and other halogenated anesthetics like sevoflurane (Cook &amp; Hemmings, 2023; Flood &amp; Shafer 2018).\n<p style=\"text-align: center;line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">References\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">Cook, D. C., &amp; Hemmings Jr., H. C. (2023). 7 \u2013 Inhaled Anesthetics. In M. C. Pardo Jr. (Ed.).&#160;&#160;<i>Miller\u2019s </i>\n<p style=\"text-indent: 36pt;line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\"><i>Basics of Anesthesia (8<sup>th</sup>&#160;ed.)</i>&#160;(pp. 88-91). Elsevier.\n<p style=\"margin: 5pt 0cm 0cm;line-height: 200%;font-size: 12pt;font-family: Calibri, sans-serif;color: black;\"><span style=\"font-size: 11.0pt;line-height: 200%;font-family: Aptos, sans-serif;color: windowtext;\">Flood, P., &amp; Shafer, S. (2018).&#160;Inhaled Anesthetics. In P. Flood, J. P. Rathmell, &amp; R. D. Urman (Eds.) <i>&#160;</i></span>\n<p style=\"margin: 5pt 0cm 0cm 36pt;line-height: 200%;font-size: 12pt;font-family: Calibri, sans-serif;color: black;\"><i><span style=\"font-size: 11.0pt;line-height: 200%;font-family: Aptos, sans-serif;color: windowtext;\">Stoelting&#39;s pharmacology and physiology in anesthetic practice</span></i><span style=\"font-size: 11.0pt;line-height: 200%;font-family: Aptos, sans-serif;color: windowtext;\">&#160;(5th ed., pp 72-77). Wolters Kluwer Health.</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:48.800Z"
            },
            {
                "Author": "Dan Chen",
                "Content": "Great summary Ryan! The example calculation really helped me understand the concept of MAC better. Definitely will be using this for the exam prep. Hi Janet, thank you for highlighting the importance of the second gas effect in accelerating the induction of anesthesia. Additionally, it\u2019s worth noting the **concentration effect**, which occurs when high concentrations of nitrous oxide (60-70% vol%) reduce alveolar volume as it is absorbed. This reduction helps concentrate other inhaled anesthetics in the remaining alveolar space, further enhancing their delivery. In summary, the concentration effect focuses on nitrous oxide&#39;s impact on alveolar volume, while the second gas effect emphasizes its facilitation of the uptake of other anesthetics.&#160;Both effects play a critical role in optimizing anesthesia induction, with nitrous oxide being a key player in this process (Cook &amp; Hemmings, 2023).\nCook, D. C., &amp; Hemmings, H. C. Jr. (2023). Inhaled anesthetics. In M. C. Pardo Jr. (Ed.), Miller&#39;s basics of anesthesia (8th ed., pp. 84-88). Elsevier.&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:48.801Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Ryan, what an excellent summary on MAC!</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">One interesting thing in Ryan\u2019s table that lists the factors that affect MAC is that alcohol can both increase and decrease MAC. &#160;The difference lies in the fact that whether it is a chronic or acute abuse. &#160;Patients who have chronic alcohol abuse will create some tolerance and, hence, require a higher concentration of inhaled anesthetics for the same effects. &#160;In this case, chronic alcoholism increases MAC. &#160;On the other hand, patients who are acutely intoxicated by alcohol require a lower concentration of inhalation anesthetics. &#160;In this case, the alcohol behaves like other central nervous system depressants and, hence, decreases MAC.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">We often express inhaled anesthetics concentration as multiples of MAC. As Ryan suggested, we can use multiples of MAC as a guideline to titrate the level of inhaled anesthetics to achieve the desired effects. In addition to the specific MAC endpoints already mentioned, we often start at a 3 MAC to 4 MAC value during a pure inhalation induction to speed up the rate of rise of the alveolar concentration and, thus, a quicker induction. &#160;For example, since Sevoflurane has a MAC of ~ 2%, I will start at 6-8% for an inhalation induction. I will then titrate down as the patient becomes drowsier. &#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">One last thing I want to mention about MAC is that it is only a guideline. &#160;We would still need to titrate to effect on an individual basis. The different factors that affect MAC would give us a general direction on whether to increase or reduce our anesthetics. &#160;The best way to ensure we give the appropriate amount of anesthetics is through vigilant monitoring,&#160;our topic to review in weeks 6 and 7.&#160;</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:48.801Z"
            },
            {
                "Author": "Paula Watkis",
                "Content": "Hello Ryan,&#160;\nYour summary on MAC allows me to have a better appreciation of the subject. The table clearly outlines the correlation between the inhaled agents and the MAC values. There are various factors as you have mentioned that affects MAC and those will help to guide the dosing of the anesthetics, as each anesthetic has its own MAC value. The MAC value basically gives the anaesthesist a reference point&#160; for dosing.\nSee table below depicting different MAC Levels and Effects on the patient\n<div>\n<table cellspacing=\"0\" border=\"1\" style=\"width: 651px;border-collapse: collapse;height: 303.2px;border-spacing: 0px;border-style: solid;\"><colgroup width=\"20%\"></colgroup><colgroup width=\"80%\"></colgroup>\n<tbody>\n<tr style=\"height: 30.4625px;\">\n<td style=\"width: 113.238px;height: 30.4625px;\">**&#160;MAC level**</td>\n<td style=\"width: 503.362px;height: 30.4625px;\">**Effect**</td>\n</tr>\n<tr style=\"height: 63.3px;\">\n<td style=\"width: 113.238px;height: 63.3px;\">**0.3 MAC**</td>\n<td style=\"width: 503.362px;height: 63.3px;\">MAC<sub>awake</sub>&#160;(MAC value below this will allow the patient to become conscious)</td>\n</tr>\n<tr style=\"height: 89.475px;\">\n<td style=\"width: 113.238px;height: 89.475px;\">**1 MAC**</td>\n<td style=\"width: 503.362px;height: 89.475px;\">End-tidal concentration of anesthetic agent necessary to prevent movement in response to a surgical stimulus in 50% of patients</td>\n</tr>\n<tr style=\"height: 59.9625px;\">\n<td style=\"width: 113.238px;height: 59.9625px;\">**1.5 MAC**</td>\n<td style=\"width: 503.362px;height: 59.9625px;\">MAC value where 90% of patients will not move in response to a surgical stimulus</td>\n</tr>\n<tr style=\"height: 60px;\">\n<td style=\"width: 113.238px;height: 60px;\">**2.0 MAC**</td>\n<td style=\"width: 503.362px;height: 60px;\">MAC-BAR&#160;(MAC value required to block autonomic responses to a surgical stimulus in 50% of patients)</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div></div>\n<div>**MAC**: minimum alveolar concentration; a value of 1.0 MAC is the concentration of an inhaled anesthetic agent in the alveoli that is required to prevent movement to a surgical stimulus in 50% of patients.</div>\n**MAC-awake value** \u2013 The MAC-awake (also termed MAC-aware) value is the concentration of that inhaled agent in the alveoli at which 50 percent of patients will not respond to a verbal or non-noxious tactile stimulus. Therefore\nMAC-awake is the ED<sub>50</sub>&#160;(or effective concentration EC<sub>50</sub>) for response to voice or light touch and is thought to approximate the ED<sub>50</sub>&#160;(or effective concentration EC<sub>50</sub>) required for perceptive awareness and anesthetic recall.&#160;\nFor each inhalation agent, MAC-awake values are generally approximately 40 percent of the standard MAC value required to tolerate surgical stimuli without movement.\n**MAC-BAR value**&#160;\u2013 The MAC-BAR (blunt adrenergic response) value is the concentration of an inhalation agent in the alveoli required to prevent an adrenergic response to a noxious stimulus in 50 percent of subjects [<a rel=\"noopener\" href=\"https://www.uptodate.com/contents/inhalation-anesthetic-agents-clinical-effects-and-uses/abstract/5-7\">5-7</a>]. As with the MAC value, the tested noxious stimulus is typically a skin incision in human studies. Thus, MAC-BAR is the effective dose ED<sub>50</sub>&#160;(or effective concentration EC<sub>50</sub>) for absence of adrenergic response in response to surgical pain. MAC-BAR values are generally approximately 150 percent of the standard MAC value required to tolerate surgical stimuli without movement.\nIn conjunction with the various factors you mentioned it may be noted that an older patient may require a lower dose of anesthetic to achieve a lower MAC. However, if that individual has chronic alcohol misuse, which requires more drug to achieve the MAC, how would we be able to balance the drug to&#160; prevent under or over dosing to achieve the desired MAC?\nReferences:\nCook, D. C., &amp; Hemmings, H. C. Jr. (2023). Inhaled anesthetics. In M. C. Pardo Jr. (Ed.), Miller&#39;s basics of anesthesia (8th ed., pp. 88-91). Elsevier.&#160;\nHays, S. R. (September, 2024). Inhalation anesthetic agents: Clinical effects and uses. <a rel=\"noopener\" href=\"https://www.uptodate.com/contents/inhalation-anesthetic-agents-clinical-effects-and-uses?search=MEAN%20ALVELOAR%20CONCENTRATION%20%20IN%20THE%20LUNG%20AND%20OPTIMAL%20DOSE%20OF%20INHALED%20ANESTHETIC&amp;source=search_result&amp;selectedTitle=2%7E150&amp;usage_type=default&amp;display_rank=2#H2769569626\">Inhalation anesthetic agents: Clinical effects and uses - UpToDate</a>&#160;&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:48.801Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Hi Paula,\nGreat question for a segue to our next topic, monitoring in anesthesia. As you said, MAC values are a reference point, and we have other monitors that can help us monitor the anesthetic depth of our patients.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:48.801Z"
            },
            {
                "Author": "Shawn Page",
                "Content": "Hello Ryan,\nI learned about MAC back in RT school, and for some reason I could never wrap my head around it.&#160; Honestly, I still can&#39;t, but your explanation has made the topic less murky for me, so thank you.&#160; But for some reason, it just isn&#39;t a topic that &quot;makes sense&quot; to me, and that obstructs my mastering it. What would an indication be for altering MAC be? Would we increase it if the pt started to wake or move?&#160; I know it can be adjusted if the BP increases, but it&#39;s effects are slow to occur.\nSome anesthetists will use entropy monitoring to gage depth of anesthesia and adjust MAC based on that.&#160; I am sure there will be a learning activity on entropy in our near future, so perhaps that will help me understand MAC more.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:48.802Z"
            }
        ]
    },
    {
        "Thread Title": "Question 12",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/104/View",
        "Question": "<p>Question 12: Given the four stages of induction for general anesthesia, predict the outcome of anesthetic agents in terms of their ability to provide full or partial anesthesia.</p>",
        "Responses": [
            {
                "Author": "Mary Johnsy Joseph",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">General anesthesia is a medically induced loss of consciousness with concurrent loss of protective reflexes due to anesthetic agents. (Siddiqui &amp; Kim, 2023). &#160;Various medications may be prescribed to induce unconsciousness, amnesia, analgesia, skeletal muscle relaxation, and the loss of autonomic system reflexes (Siddiqui &amp; Kim, 2023).</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"><img alt=\"A table with text on itDescription automatically generated\" height=\"376\" width=\"624\" src=\"/d2l/le/7298/discussions/posts/4615/ViewAttachment?fileId=444952\"/></span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Table 1: Clinical assessment of the stages of anesthesia. (Gagliardi &amp; Perci, 2023)<br/><br/></span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><b><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Stages of Anesthesia Based on Guedel&#39;s Classification</span></b>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160; Guedel&#39;s classification for the stages of general anesthesia was initially established to deliver diethyl ether, the single available volatile anesthetic&#160;at the time (Siddiqui &amp; Kim, 2023). &#160;&#160;While Guedel&#39;s patients were usually pre-medicated with sedative agents such as morphine and atropine, ether was the drug of choice for induction.&#160;It offered analgesia, amnesia, and relaxation of muscles (Siddiqui &amp; Kim, 2023). &#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160; Siddiqui &amp; Kim (2023) stated that today, the &quot;balanced anesthesia&quot; approach uses several types of medications for induction (such as intravenous anesthetics, analgesics, neuromuscular blockers, and benzodiazepines), which can disguise the characteristic clinical markers of each&#160;defined anesthesia stage. These agents also have a higher safety profile than diethyl ether. Lastly, advances in awareness, breathing, and circulation monitoring due to technology have greatly augmented the clinical data obtained from the patient&#39;s physical examination. Therefore, some anesthesiologists view Guedel&#39;s work as antiquated. Yet others still employ his classification to describe developments in general anesthesia and clinical practice for inhalation inductions across various surgical procedures.&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><b><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;</span></b>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><b><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Intravenous Anesthetics</span></b>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160; General anesthesia is most achieved&#160;via IV sedatives and analgesics induction, followed by volatile anesthetics maintenance (D\u2019Cruz et al., 2023).&#160; Patients better tolerate intravenous (IV) induction, but inhalational induction is often used in children or where IV access is problematic (D\u2019Cruz et al., 2023).&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160; &#160;In their study, D\u2019Cruz et al. (2023) stated that all IV anesthetics can produce rapid unconsciousness depending on dosage and rate of administration.&#160; Redistribution from the brain to muscle and adipose tissue and metabolism leads to awakening.&#160; Propofol is a phenol agent with rapid onset and a short duration of action and can be used for induction and maintenance of anesthesia.&#160; An induction dose can cause profound respiratory depression. However, Propofol offers the advantage of effortless awakening with minimal residual sedation, even with a prolonged infusion.</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160; D\u2019Cruz et al. (2023) also included some other examples of intravenous anesthetics commonly used in general anesthesia. Ketamine is a dissociative anesthetic that distorts the perception of sight and sounds and produces feelings of detachment from the environment and self.&#160; Unique among IV anesthetics, ketamine produces intense analgesia. Significant side effects of ketamine include increased secretions, the risk of laryngospasm, and hallucinations.&#160; Dexmedetomidine is a selective alpha-2 receptor agonist with sedative, sympatholytic, and analgesic properties.&#160; The advantages of dexmedetomidine include better patient tolerance, hemodynamic stability, and preservation of the patent airway.&#160; These qualities make it a preferred agent for conscious fiberoptic intubation.</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160; While observing induction of general anesthesia in operating room, the anesthetist used an approach called balanced anesthesia such as use of two drugs to maintain anesthesia. The procedure was a bowel resection. Most commonly, an opioid is added to propofol or an inhaled anesthetic to provide control of ANS nociceptive responses to surgical stimulation (Brown et al., 2019)</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"><img alt=\"A chart with green textDescription automatically generated\" height=\"396\" width=\"624\" src=\"/d2l/le/7298/discussions/posts/4615/ViewAttachment?fileId=444951\"/></span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">(Brown et al., 2019)</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\">&#160;\n<p style=\"text-align: center;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">References</span>\n<p style=\"text-align: center;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\">&#160;\n<p style=\"margin-left: 1cm;text-indent: -1cm;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">Gagliardi, G. A., &amp; Percy, S. (2023). Stages of anesthesia. <i>IARS: International anesthesia &#160;&#160;&#160;&#160;</i>\n<p style=\"margin-left: 1cm;text-indent: -1cm;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><i>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;research society</i>, 3-9. &#160;https://www.openanesthesia.org/keywords/\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Siddiqui, A. B., &amp; Kim, Y. P. (2023). Anesthesia stages. In <i>StatPearls</i>, StatPearls Publishing. </span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/\">https://www.ncbi.nlm.nih.gov/</a> </span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Smith, G., D\u2019Cruz, R. J., &amp; Rondeau, G. B. (2023). General anesthesia for surgeons. In </span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <i>StatPearls, </i>StatPearls Publishing. <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK493199/\">https://www.ncbi.nlm.nih.gov/books/NBK493199/</a></span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Brown, N. E., Santa, A. L., &amp; Subramanian, S. (2019). Multimodal general anesthesia in </span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; practice. In <i>McMahon</i>, McMahon publishing. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;line-height: 115%;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a rel=\"noopener\" href=\"https://www.anesthesiologynews.com/Commentary/Article/08-24/If-Looks-Could-Kill-Anesthetic-Implications-of-Cosmetic-Enhancements/74503\">https://www.anesthesiologynews.com/Commentary/Article/08-24/If-Looks-Could-Kill-Anesthetic-Implications-of-Cosmetic-Enhancements/74503</a></span>",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4615/ViewAttachment?fileId=444949",
                        "filename": "image_16676616521728089152739.png"
                    },
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4615/ViewAttachment?fileId=444950",
                        "filename": "image_67523742831728089152740.jpg"
                    },
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4615/ViewAttachment?fileId=444951",
                        "filename": "image_31695722351728089274755.jpg"
                    },
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4615/ViewAttachment?fileId=444952",
                        "filename": "image_47757942441728089274753.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:56:52.673Z"
            },
            {
                "Author": "Ryan Christopher Floro",
                "Content": "<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Hi Mary,\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Your discussion on the various anesthetic agents was thorough and I appreciate how you included information about the different stages of anesthesia. The table was quite helpful, and I will be referencing that later on.\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">I also wanted to highlight a few other anesthetic agents we may come across. Midazolam is a benzodiazepine that can be used to supplement partial anesthesia as it sedates and produces a strong anterograde amnesic effect. It can be given IV for regional anesthesia, brief procedures, or, when provided with propofol, for colonoscopies. In terms of induction, however, it is seldom used due to delayed unconsciousness (Bokoch &amp; Su, 2023). Etomidate, on the other hand, can be used for induction with similar onset to propofol and minimal effects to hemodynamics unlike other anesthetic agents for full anesthesia. Its use is not routine due to the suppression of the adrenocortical system, lasting up to 48 hours (Bokoch &amp; Su, 2023).\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">References\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Bokoch, M. P. &amp; Su, P., P. (2023). 8 \u2013 Intravenous Anesthetics. In M. C. Pardo Jr. (Ed.).&#160; <i>Miller\u2019s Basics of Anesthesia (8<sup>th</sup> ed.)</i> (pp. 88-91). Elsevier.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:52.673Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Mary, thanks for your lovely table on the four stages of anesthesia.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Based on Guedel\u2019s stages of anesthesia, partial anesthesia would be classified as Stages 1 or 2. &#160;It includes minimal sedation, moderate sedation, and deep sedation, since patients are still able to respond to painful stimuli. &#160;In contrast, full anesthesia is general anesthesia due to the loss of consciousness and the fact that patients are not responding to painful stimuli. &#160;It would be classified as Stage 3.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">One difference between intravenous and inhaled anesthetics is that the stages of anesthesia progress much quicker with intravenous than inhalational inductions. &#160;The faster a patient can pass through Stage 2, the safer it is because of the potential risks of laryngospasm, airway obstruction, regurgitation, vomiting, and aspiration in Stage 2, as shown in Mary\u2019s table of stages of anesthesia. &#160;Because of the ability to rapidly go from Stage 1 to Stage 3 and thus reduce the risks of Stage 2, intravenous induction is the preferred method of administering a general anesthetic in adults.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">As Mary has pointed out, the balanced anesthesia approach can mask clinical signs of the anesthesia stage. The class of drugs that revolutionized entirely the concept of stages of anesthesia is the neuromuscular blocking agents. &#160;We now could produce temporary paralysis without deep anesthesia. Most of the signs of Guedel\u2019s classification depend upon muscular movements, but with muscle paralysis, patients\u2019 traditional clinical signs are less detectable, and landmarks between stages are less noticeable. &#160;Moreover, we no longer need to increase our dosage of anesthetics to reach muscle relaxation for intubation and surgery (Stage 3). &#160;We just need enough anesthetics to cover unconsciousness and analgesia, and then let the neuromuscular blocking agents complete the triad of anesthesia.&#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">As Mary has shared, the common practice nowadays is to use a balanced anesthesia approach to induction and maintenance of anesthesia. &#160;We use a combination of different classes of drugs to satisfy the different anesthesia properties. &#160;This allows for lower doses of each drug and, therefore, minimizes the dose-dependent side effects.</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:52.673Z"
            }
        ]
    },
    {
        "Thread Title": "Question 13",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/103/View",
        "Question": "<p>Question 13: Compare the use of inhalational agents to intravenous agents in the speed and depth of induction, uptake and distribution, and reversal.</p>",
        "Responses": [
            {
                "Author": "Junia Isaac",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;\">The two primary methods of anesthesia are inhalational and intravenous (IV) of which both are used in induction and maintenance of anesthesia but differ in their pharmacokinetic properties.&#160;</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;\">Inhalational or volatile agents such as sevoflurane, isoflurane, desflurane, and nitrous oxide (N\u2082O), are commonly clinically used in the induction and maintenance of anesthesia (</span><span style=\"font-size: 11pt;\">Hays, 2024)</span><span style=\"font-size: 11pt;\">. Inhalation agents are complete general anesthetic agents in that they provide hypnosis (loss of consciousness), amnesia (lack of recall), analgesia (pain relief), akinesia (immobility) and autonomic and somatic block (suppression of autonomic reflexes and motor function) at clinically relevant concentrations (</span><span style=\"font-size: 11pt;\">Campagna et al., 2003; Hays, 2024)</span><span style=\"font-size: 11pt;\">. All these effects, however, persist only so long as the inhalational agent is administered at sufficient concentration. Discontinuation of the inhalational agent results in cessation of its clinical effects. Compared to IV agents, the induction speed of inhalational agents is generally slower, largely determined by their blood-gas partition coefficient (Cook &amp; Hemmings Jr, 2023). Agents with lower coefficients, like sevoflurane, equilibrate more rapidly between alveoli and arterial blood, allowing for faster onset, while agents with higher coefficients, such as isoflurane, have a slower onset.&#160;</span><span style=\"font-size: 11pt;color: black;background-color: white;\">Sevoflurane, the most commonly used inhaled anesthetic has an onset time of 2 minutes, isoflurane in 7-10 minutes, 5 minutes for desflurane, while nitrous oxide begins to work in 30 seconds&#160;</span><span style=\"font-size: 11pt;\">(</span><span style=\"font-size: 11pt;\">Hays, 2024).</span><span style=\"font-size: 11pt;\"> Depth of induction is more easily adjustable with inhalational agents, making them highly useful for the maintenance of anesthesia. Fine-tuning the inspired concentration in conjunction with fresh gas flow allows clinicians to alter anesthetic depth in real-time, which is particularly advantageous during lengthy procedures. However, the slower onset compared to IV agents may make them less ideal for initial induction (Cook &amp; Hemmings Jr, 2023).</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;\">Uptake and distribution of these agents depend on several factors, including solubility in blood (reflected in the blood-gas partition coefficient), alveolar ventilation, extent of tissue perfusion, cardiac output, metabolism and age. The s</span><span style=\"font-size: 11pt;color: black;background-color: white;\">olubility of these agents in the blood is low which causes a faster equilibration between alveoli and blood leading to rapid induction (Wissing et al., 2000). </span><span style=\"font-size: 11pt;\">For instance, sevoflurane, with its lower solubility, reaches equilibrium faster between the alveoli and bloodstream, allowing for quicker onset and distribution to the brain and other tissues. The v</span><span style=\"font-size: 11pt;color: black;background-color: white;\">olume of distribution is<sub>&#160;</sub>as follows: desflurane: 612mL/kg, isoflurane: 4112 mL/kg, sevoflurane: 1634 mL/kg (Wissing et al., 2000).</span><span style=\"font-size: 11pt;\">&#160;Reversal of inhalational agents occurs primarily through exhalation.</span><span style=\"font-size: 11pt;color: black;background-color: white;\">&#160;There are no direct reversal agents for sevoflurane, isoflurane, desflurane or nitrous oxide.</span><span style=\"font-size: 11pt;\">&#160;After discontinuing the agent, it moves from the blood into the lungs and is eliminated through the respiratory system. Agents like desflurane and sevoflurane, which have lower blood solubility, are eliminated faster, offering quicker recovery times. While the overall reversal of inhalational agents tends to be slower than that of IV agents, newer agents like sevoflurane provide relatively swift recovery compared to older agents like halothane (Cook &amp; Hemmings Jr, 2023).</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;color: black;\">Intravenous agents such as propofol, etomidate and ketamine are commonly used for the induction and maintenance of anesthesia (</span><span style=\"font-size: 11pt;\">Bravenec, 2022)</span><span style=\"font-size: 11pt;color: black;\">. These fast-acting&#160;&#160;</span><span style=\"font-size: 11pt;color: black;background-color: white;\">drugs produce effects ranging from a state of impaired awareness to deep sedation. While the properties and side effects of intravenous&#160;</span><span style=\"font-size: 11pt;color: black;\">anesthetics vary&#160;<span style=\"background-color: white;\">depending on the specific agent, they all are effective in inducing hypnosis&#160;</span></span><span style=\"font-size: 11pt;\">(\u201cIV Sedation: Definition &amp; Effects\u201d, 2022)<span style=\"color: black;background-color: white;\">.&#160;</span><span style=\"color: black;background-color: white;\">These agents are particularly valued for their rapid onset times&#160;</span></span><span style=\"font-size: 11pt;\">allowing for rapid induction</span><span style=\"font-size: 11pt;color: black;background-color: white;\">&#160;and smooth transitions in anesthetic depth.&#160;</span><span style=\"font-size: 11pt;\">Propofol has the fastest onset within 30 seconds, while&#160;</span><span style=\"font-size: 11pt;color: black;background-color: white;\">etomidate takes about 1 minute and ketamine between 1 to 5 minutes (</span><span style=\"font-size: 11pt;\">Bokoch &amp; Su, 2023)</span><span style=\"font-size: 11pt;color: black;background-color: white;\">. Their</span><span style=\"font-size: 11pt;\">&#160;high lipid solubility allows them to rapidly cross the blood-brain barrier, bypassing pulmonary absorption and producing swift anesthetic effects, unlike inhalational anesthetics.&#160;</span><span style=\"font-size: 11pt;\">The duration of action for these agents also varies: propofol and etomidate last for 3 to 8 minutes, while ketamine lasts for around 10 minutes <span style=\"color: black;background-color: white;\">(</span></span><span style=\"font-size: 11pt;\">Bokoch &amp; Su, 2023)</span><span style=\"font-size: 11pt;\">.<span style=\"color: black;background-color: white;\">&#160;Intravenous&#160;</span></span><span style=\"font-size: 11pt;\">agents can induce a deep, rapid state of anesthesia, though it can be challenging to adjust the depth immediately after a bolus dose. Continuous infusion, however, provides better control over the anesthetic depth, making it easier to maintain the desired level of anesthesia during procedures. Intravenous anesthetic agents are often used in total intravenous anesthesia (TIVA) and are administered via continuous infusion, allowing for precise control over the depth of anesthesia. This approach provides stable anesthesia, making these agents particularly useful for longer surgeries. One meta-analysis suggests that the use of propofol-based TIVA may be associated with improved recurrence-free survival and overall survival in patients undergoing cancer surgery (Yap et al., 2019).</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;color: black;background-color: white;\">Once administered, these drugs are rapidly distributed to vessel-rich organs like the brain, heart, and liver. The volume of distribution for these agents is as follows: propofol (3.5-4.5 L/kg), etomidate (2.2-4.5 L/kg), and ketamine (2.5-3.5 L/kg) (</span><span style=\"font-size: 11pt;\">Bokoch &amp; Su, 2023)</span><span style=\"font-size: 11pt;color: black;background-color: white;\">. After this initial distribution, they are redistributed to peripheral tissues such as fat and muscle.</span><span style=\"font-size: 11pt;\">&#160;H</span><span style=\"font-size: 11pt;color: black;background-color: white;\">owever, their effects are terminated primarily due to redistribution to peripheral tissues, facilitating faster emergence and recovery; most IV anesthetic agents are eventually metabolized by the liver (</span><span style=\"font-size: 11pt;\">Bokoch &amp; Su, 2023)</span><span style=\"font-size: 11pt;color: black;background-color: white;\">.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;color: black;background-color: white;\">Both propofol and etomidate can suppress respiratory drive while providing deep sedation. Unlike propofol, which can decrease blood pressure, etomidate generally does not have negative cardiovascular effects. Ketamine, on the other hand, maintains the patient\u2019s respiratory drive while providing sedation. The effects of these medications may be influenced by patient characteristics, as well as adjunct medications such as benzodiazepines, narcotics, and analgesics. It is important to note that none of these intravenous agents have specific reversal drugs, so adequate time must be allowed for recovery (Rathmell &amp; Roscow, 2014).</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;color: black;background-color: white;\">In summary, both inhalational and intravenous anesthetic agents are effective in providing adequate depth of induction, either independently or in combination. While intravenous agents, typically offer faster induction, inhalational agents provide more precise control over the depth of anesthesia, particularly during maintenance. Uptake also varies, with intravenous agents being rapidly distributed systemically, whereas inhalational agents depend on lung absorption, solubility, and ventilation. Though neither class has a direct reversal agent, the effects of intravenous agents diminish quickly due to redistribution and metabolism, while inhalational agents are primarily eliminated via the lungs, with faster recovery linked to agents with low solubility. Ultimately, the choice between these two approaches depends on patient-specific factors, including demographics, comorbidities, medications, the nature of the surgical procedure, and the patient\u2019s medical history.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\"><b><span style=\"font-size: 11pt;\">References</span></b>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\"><span style=\"font-size: 11pt;\">Bokoch, M. P., &amp; Su, P. P. (2023). Intravenous anesthetics. In M. C. Pardo (Ed.),&#160;<i>Miller\u2019s basics of anesthesia</i>&#160;(8th ed., pp. 107-124). Elsevier.&#160;</span>\n<p style=\"margin: 0cm;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\"><span style=\"font-size: 11pt;font-family: Aptos, sans-serif;\">Bravenec, B. (2022).&#160;<i>General anesthesia: Intravenous induction agents</i>. UpToDate.&#160;</span><span style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><a rel=\"noopener\" target=\"_blank\" href=\"https://www.uptodate.com/contents/general-anesthesia-intravenous-induction-agents?search=intravenous%20anesthetics&amp;source=search_result&amp;selectedTitle=1%7E150&amp;usage_type=default&amp;display_rank=1\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://www.uptodate.com/contents/general-anesthesia-intravenous-induction-agents?search=intravenous%20anesthetics&amp;source=search_result&amp;selectedTitle=1%7E150&amp;usage_type=default&amp;display_rank=1</a></span><span style=\"font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -36pt;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -36pt;\"><span style=\"font-size: 11pt;font-family: Aptos, sans-serif;\">Campagna, J. A., Miller, K. W., &amp; Forman, S. A. (2003). Mechanisms of Actions of Inhaled Anesthetics.&#160;<i>New England Journal of Medicine</i>,&#160;<i>348</i>(21), 2110\u20132124.&#160;</span><span style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><a rel=\"noopener\" href=\"https://doi.org/10.1056/nejmra021261\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi.org/10.1056/nejmra021261</a></span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -36pt;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\"><span style=\"font-size: 11pt;\">Cook, D. C., &amp; Hemmings Jr, H. C. (2023). Inhaled anesthetics. In M. C. Pardo (Ed.),&#160;<i>Miller\u2019s basics of anesthesia</i>(8th ed., pp. 82-106). Elsevier.&#160;</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\"><span style=\"font-size: 11pt;\">Hays, S.R. (2024).&#160;<i>Inhalational anesthetic agents: Clinical effects and uses</i>. UpToDate.&#160;</span><span style=\"font-size: 11pt;\"><a rel=\"noopener\" target=\"_blank\" href=\"https://www.uptodate.com/contents/inhalation-anesthetic-agents-clinical-effects-and-uses?search=speed%20and%20depth%20of%20induction%20with%20IV%20agents&amp;source=search_result&amp;selectedTitle=9%7E150&amp;usage_type=default&amp;display_rank=9\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://www.uptodate.com/contents/inhalation-anesthetic-agents-clinical-effects-and-uses?search=speed%20and%20depth%20of%20induction%20with%20IV%20agents&amp;source=search_result&amp;selectedTitle=9%7E150&amp;usage_type=default&amp;display_rank=9</a></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\"><span style=\"font-size: 11pt;\">IV sedation: Definition &amp; effects - made for this moment. (2022).&#160;<a rel=\"noopener\" href=\"https://www.asahq.org/madeforthismoment/anesthesia-101/types-of-anesthesia/ivmonitored-sedation/\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://www.asahq.org/madeforthismoment/anesthesia-101/types-of-anesthesia/ivmonitored-sedation/</a></span>\n<p style=\"margin: 0cm;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\"><span style=\"font-size: 11pt;\">Rathmell, J. P., &amp; Rosow, C. E. (2014). Intravenous sedatives and hypnotics. In P. Flood, J. P. Rathmell, &amp; R. D. Urman (Eds.),&#160;<i>Stoelting&#39;s pharmacology and physiology in anesthetic practice&#160;</i>(5th ed., pp. 160-203). Wolters Kluwer.&#160;</span>\n<p style=\"margin: 0cm;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -36pt;\"><span style=\"font-size: 11pt;font-family: Aptos, sans-serif;\">Wissing, H., Kuhn, I., Rietbrock, S., &amp; Fuhr, U. (2000). Pharmacokinetics of inhaled anesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. <i>British Journal of Anaesthesia</i>,&#160;<i>84</i>(4), 443\u2013449.&#160;</span><span style=\"font-size: 11pt;font-family: Aptos, sans-serif;\"><a rel=\"noopener\" href=\"https://doi.org/10.1093/oxfordjournals.bja.a013467\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi.org/10.1093/oxfordjournals.bja.a013467</a></span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -36pt;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: &#39;Times New Roman&#39;, serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -36pt;\"><span style=\"font-size: 11pt;font-family: Aptos, sans-serif;\">Yap, A., Lopez-Olivo, M. A., Dubowitz, J., Hiller, J., Riedel, B., &amp; Global Onco-Anesthesia Research Collaboration Group. (2019). Anesthetic technique and cancer outcomes: A meta-analysis of total intravenous versus volatile anesthesia.&#160;<i>Canadian Journal of Anaesthesia/Journal Canadien D&#39;anesthesie</i>,&#160;<i>66</i>(5), 546\u2013561.&#160;<a rel=\"noopener\" href=\"https://doi-org.uhn.idm.oclc.org/10.1007/s12630-019-01330-x\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi-org.uhn.idm.oclc.org/10.1007/s12630-019-01330-x</a></span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:56.665Z"
            },
            {
                "Author": "Laryssa Hartmann",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Hi Junia,\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">I think you did a great job at exploring the differences between inhalation and intravenous agents. I was wondering what scenarios would warrant a combination of these two types of agents. From what I have observed in the OR, the anesthetist uses a combination of inhalation and intravenous agents. Especially for longer surgeries, the anesthetist will start with an intravenous agent then transition to an inhalation agent allowing for better management of sedation over an extended period. What are your thoughts on this? Have you come across similar situations?\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:56.665Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Thanks, Junia, for a great comparison between inhalational and intravenous agents. &#160;\nThere is quite a bit of contrast in terms of their pharmacokinetics properties. &#160;When comparing the speed of induction between the two types of agents, intravenous agents induce faster than inhalation agents. &#160;However, because inhalational agents are mostly eliminated unchanged through ventilation, their elimination can be faster than that of intravenous agents. &#160;\nAs Junia has nicely pointed out, the speed of induction with inhalational agents is determined by the anesthetic equilibration between the alveoli and arterial blood, followed by the equilibration between the arterial blood and brain tissues. The partial pressure gradient causes the diffusion of inhalational agents across the compartments. Equilibration is achieved when the partial pressures are equal in both compartments. &#160;The many factors that affect alveolar uptake and, thus, the speed of induction are discussed in Question 10. Many of the factors that speed up induction also speed up recovery.\nOn the other hand, the speed of induction with the intravenous agents depends on the level of protein binding, lipid solubility, and degree of ionization. &#160;Intravenous agents that are unbound, highly lipid soluble, and unionized will cross the blood-brain barrier the quickest and, therefore, will result in a faster induction. Their duration of action depends on the intravenous agents\u2019 redistribution from the brain to other tissues. &#160;\nIt is also interesting to note the influence of different organs on the uptake, distribution, and reversal of the two types of agents. &#160;\nJunia reminded us that intravenous agents directly enter the bloodstream and travel to the central nervous system (CNS), whereas inhalational agents need to enter the lungs first before reaching the CNS. &#160;Therefore, severe lung diseases could greatly affect the uptake and elimination of inhalational agents, but could cause minimal changes to the intravenous agents. &#160;Similarly, severe liver and kidney diseases could greatly affect the metabolism and elimination of intravenous agents, resulting in a prolonged effect. However, they could cause insignificant changes to inhalational agents because most agents are eliminated unchanged through the lungs. &#160;\nAnother point is regarding overdose. Although we do not have a confirmed reversal agent for inhalational agents, an inhalation overdose could be recovered by washing out inhalational agents with air or oxygen. &#160;On the other hand, we have no means of withdrawing an intravenous overdose except by administering a reversal agent (if there is one) or other drugs that will treat the adverse effects of the overdose.&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:56.665Z"
            },
            {
                "Author": "Shawn Page",
                "Content": "Junia, that was nice and thorough and cleared a few things up for myself.\nLaryssa, in the OR if we have an malignant hyperthermia (MH) or suspected MH pt, we will use IV anesthesia only.&#160;&#160;\nI also have seen inhaled used in peads, or in a pt who is afraid of needled, or is a difficult poke.&#160; We will &quot;Breath the pt down&quot; manually with an inhaled anesthetic, to&#160; have the pt sedated.&#160; Once sedated we will intubated the pt, and then start an IV, and run one or the other, or both types of anesthesia.&#160; Last spring we did this for a younger pt (maybe around 12) with ADHD who could not tolerate needles.&#160; We &quot;breathed him down&quot; and did exactly what I described above and it was a very smooth procedure.&#160; It&#39;s really interesting ti be a part of, so I hope you get to do so when we are all at practicum.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:56:56.666Z"
            }
        ]
    },
    {
        "Thread Title": "Question 14",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/102/View",
        "Question": "<p>Question 14: Compare the rationales for a pure inhalational induction with a pure intravenous induction.</p>",
        "Responses": [
            {
                "Author": "Kelly Gram",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">With over 300 million surgeries occurring world wide each year, general anesthesia is common practice, yet the debate over intravenous vs. inhalational induction is ongoing with evidence supporting both methods(1). Comparing the rationales for pure inhalational induction and pure intravenous induction involves considering various clinical factors, patient characteristics, and procedural contexts. Each anesthesia provider brings unique experience with them and combined with patient specific considerations, a decision on induction method is made.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Historically, inhalational induction was more commonly used in children to forgo the need for an IV while the child is awake(2). Some factors to ponder include a patients ability to cooperate, whether due to age, cognitive ability, mental health factors combined with patient risk factors, whether they\u2019re medically complex, have cardiovascular concerns or respiratory disease(1\u20133). Other important factors include type and length of surgery, resources, prior history of anesthetic or airway complications and provider experience(3). Finally, considerations must be made of the side effect profiles for each method and a plan tailored to your patient specific needs should be devised in advance of delivering the anesthetic. Below is a table outlining the pros and cons of each method.\n<table align=\"left\" cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\" style=\"width: 488.8pt;border-collapse: collapse;border: none;margin-left: 6.75pt;margin-right: 6.75pt;\">\n<tbody>\n<tr>\n<td valign=\"top\" colspan=\"2\" style=\"width: 233.65pt;border: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;text-align: center;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Inhalational Induction\n</td>\n<td valign=\"top\" colspan=\"2\" style=\"width: 9.0cm;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;text-align: center;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Intravenous Induction\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Pros\n</td>\n<td valign=\"top\" style=\"width: 106.3pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Cons\n</td>\n<td valign=\"top\" style=\"width: 4.0cm;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Pros\n</td>\n<td valign=\"top\" style=\"width: 5.0cm;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Cons\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<ul style=\"margin-top: 0cm;margin-bottom: 0cm;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Cost effective</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Easy administration</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Beneficial for anxious, uncooperative patients</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Rapid adjustment of depth of anesthesia</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Quick emergence</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">More cardioprotective</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Single agent often achieves state of anesthesia</li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 106.3pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<ul style=\"margin-top: 0cm;margin-bottom: 0cm;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">More PONV</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Emergence delerium</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Pollution, contribution to global warming</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Risk of Malignant Hyperthermia</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Claustrophobic patients</li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 4.0cm;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<ul style=\"margin-top: 0cm;margin-bottom: 0cm;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Rapid onset</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Good for rapid sequence induction</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Significantly less PONV (especially with propofol)</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Predictable dose response</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Elderly patients less cognitive decline post op</li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 5.0cm;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<ul style=\"margin-top: 0cm;margin-bottom: 0cm;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Requires multiple agents to achieve anesthesia state</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Often requires reversal agents</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Longer time to clear</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Requires IV placement while awake</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Costly</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">Risk of propofol infusion syndrome in small children</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Table 1: A comparison of pros and cons of intravenous vs. inhalational induction of anesthesia (1-7)\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">As outlined in Table 1, there are many benefits to an inhalational induction including the simplicity of needing only a single agent to provide complete anesthesia, lack of invasive lines required for induction and the ability to rapidly adjust depth of anesthesia including a very quick emergence and recovery(4). &#160;Additionally inhalational inductions have been found to be more cardioprotective with no risk of propofol related infusion syndrome, particularly of concern in small children (5,6). Conversely, despite the low cost of the volatile agents, the need for antiemetics and other delirium correcting medications may nullify the initial low cost of the intervention(2,3). Alternatively, intravenous induction provides many benefits including a more predictable dose response, rapid onset and loss of airway reflexes and less incidence of emergence delirium (1,2). Arguably the most significant benefit to IV induction is the marked reduction in post operative nausea and vomiting (PONV), some studies have shown up to a 40% reduction(1,7). A recent meta-analysis found both inhalation and intravenous anesthetics to be equally efficacious and safe, however two main areas of secondary outcomes were significantly better in the intravenous inductions and those were PONV and post operative delirium in older patients(1).&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">When balancing the pros and cons, cost is balanced due to the need for antiemetics in the inhalational induction group(2). IV induction offers less risk of respiratory events in children, and no risk of malignant hyperthermia (MH), while cardiovascular risk is higher compared to the use of volatile anesthetics(5,7). Studies have shown that onset of anesthesia is not significantly different between two induction methods but emergence is definitely slower in the IV group(2). Cognitively across all ages, there is benefit to intravenous sedation, however, in terms of patient preference and anxiety reduction, there is slight partiality for inhalational induction(4). Clear indicators that an inhalational induction would be beneficial would be lack of patient cooperation/difficult IV access or airway compromise where it is crucial to maintain airway tone and breathing during induction.&#160; Similarly, a strong history of PONV or cognitive impairment would yield a strong preference for an IV induction.&#160; In summary, there is no one size fits all approach to induction of anesthesia, so it is up to providers to be up to date with the latest research and recommendations so an evidence based, patient tailored approach can be confidently and safely carried out.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><u>REFERENCES</u>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Kampman JM, Hermanides J, Hollmann MW, Gilhuis CN, Bloem WA, Schraag S, et al. Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and meta-analysis. eClinicalMedicine [Internet]. 2024 Jun 1 [cited 2024 Oct 1];72. Available from: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00215-3/fulltext#fig1\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Fleischmann E, Akca O, Wallner T, Arkilic CF, Kurz A, Hickle RS, et al. Onset Time, Recovery Duration, and Drug Cost with Four Different Methods of Inducing General Anesthesia. Anesth Analg. 1999 Apr;88(4):930.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Herling SF, Dreijer B, Wrist Lam G, Thomsen T, M&#248;ller AM. Total intravenous anaesthesia versus inhalational anaesthesia for adults undergoing transabdominal robotic assisted laparoscopic surgery. Cochrane Database Syst Rev. 2017 Apr 4;2017(4):CD011387.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; van den Berg AA, Chitty DA, Jones RD, Sohel MS, Shahen A. Intravenous or inhaled induction of anesthesia in adults? An audit of preoperative patient preferences. Anesth Analg. 2005 May;100(5):1422\u20134.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology. 2002 Jul;97(1):42\u20139.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Inhalational versus Intravenous Induction of Anesthesia in Children with a High Risk of Perioperative Respiratory Adverse Events: A Randomized Controlled Trial. Anesthesiology. 2018 Jun 1;128(6):1065\u201374.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Scheiermann P, Herzog F, Siebenhofer A, Strametz R, Weberschock T. Intravenous versus inhalational anesthesia for pediatric inpatient surgery \u2013 A systematic review and meta-analysis. J Clin Anesth. 2018 Sep 1;49:19\u201325.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:00.672Z"
            },
            {
                "Author": "Teresa Nguyen",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Hi Kelly,</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">This was an amazing read. Thanks for summarizing the advantages, disadvantages and rationale for both inhalational and intravenous induction. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Another con I would like to add to the list for inhalational induction is that it requires specialized equipment to administer the inhalant to the patient with accurate concentration in comparison to IV induction (Pardo, Miller, &amp; Stoelting, 2023). The <i>variable-bypass vaporizer</i> dilutes gas saturated with anesthetic with fresh gas in order to reach the prescribed concentration (Pardo et al., 2023). </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">I want to further inquire the tailored approaches to induction. For more specialized patient populations, for example, oncology patients \u2013 are there more specialized approaches of induction if these patients were to undergo a procedure? Several oncology patients may undergo chemotherapy. The side effects of chemotherapy would include nausea, vomiting, and acute pain (Batra, Kalyani, &amp; Rohilla, 2020). As you stated, there is significantly less post-operative nausea and vomiting (PONV) with the use of IV induction compared to inhalational induction. To add to this question, what if this oncology patient had a mastectomy and difficult vascular access? IVs should be placed in the arm opposite of the mastectomy (Packel, Kepics, &amp; Zheng, 2019).</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Additionally, what factors should be prioritized more than others when determining which induction method to use? </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">References</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Batra, A., Kalyani, C.V., &amp; Rohilla, K. (2020). Incidence and severity of self-reported </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;padding-left: 40px;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">chemotherapy side-effects in patients with hematolymphoid malignancies.&#160;<i>Cancer Research, Statistics, and Treatment, 3(</i>4), 736-741. https://doi.org/10.4103/crst.crst_87_20</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Packel, L., Kepics, J., &amp; Zheng, J. (2019). Blood pressures and IVs after mastectomy. OncoLink. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;padding-left: 40px;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">https://www.oncolink.org/frequently-asked-questions/cancers/blood-pressures-and-ivs-after-mastectomy</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;\">Pardo, M., Miller, R. D., &amp; Stoelting, R. K. (2023). <i>Miller\u2019s Basics of Anesthesia</i>. Elsevier. </span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:00.673Z"
            },
            {
                "Author": "Kurt Protacio",
                "Content": "<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">Great review Kelly!\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">To help answer Theresa&#39;s questions regarding prioritization of induction choice/route, I think it depends on the patient and their age, medical history, and whether it is an elective or emergent case. I also believe that by surveying any contraindications for the patient should help in deciding the proper technique to use. For example, patients who are severely hypovolemic or have intracranial hypertension should avoid using inhaled anesthetics in order to avoid cerebral hypoperfusion as it can cause a drop in systemic vascular resistance (Miller, Theodore &amp; Widrich, 2023). In addition, another reason to avoid inhaled anesthetics is bronchospasm, particularly those with severe asthma. Gases like desflurane and isoflurane should be avoided in these patients. However, sevoflurane is favorable in pediatric populations as their gases have been known to have a pleasant smell upon induction (Miller et al., 2023).\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">Generally, pediatric populations do better with inhaled induction as it can be difficult to secure an IV, and that their hepatic and renal organs have not fully developed. On the other hand, another reason of not using pure inhaled anesthetics over intravenous anesthetics in adult populations is that the minimum alveolar concentration (MAC) in adults over 40 years have a decrease in MAC by 6% each decade (Miller et al., 2023). The higher the MAC, the lower the potency of gas needed to achieve sedation. Therefore, more concentration is needed to keep adults sedated while using inhaled anesthetics, which could lead to toxicity, post operative nausea and vomiting (PONV), and/or in rarer cases, malignant hyperthermia (MH).\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">With regards to oncology patients, there are some studies that show both positive and negative impacts in using inhaled anesthetics. Gases like sevoflurane have immunosuppressive characteristics by inhibiting the production of tumor-associated macrophages (TAMs) but further studies are needed to understand their molecular pathway and influence on tumor metastasis (Jing et al., 2022). Due to costs, small sample sizes, and singular tumor type studies, it is warranted to pursue further research in understanding the effects of inhaled anesthetics in oncology patients.\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">References:\n<p style=\"margin-left: 36pt;text-indent: -36pt;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">Liu, Q., Li, R., &amp; Lin, J. (2022). No difference among inhaled anesthetics on the growth and metastasis of murine 4T1 breast cancers in a mouse model of spontaneous metastasis.&#160;_Frontiers in Pharmacology_,&#160;_13_.&#160;<a rel=\"noopener\" href=\"https://doi.org/10.3389/fphar.2022.794109\"><span style=\"color: windowtext;\">https://doi.org/10.3389/fphar.2022.794109</span></a>\n<p style=\"margin-left: 36pt;text-indent: -36pt;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">Miller, A. L., Theodore, D., &amp; Widrich, J. (2023, May 1). _Inhalational anesthetic_. StatPearls - NCBI Bookshelf.&#160;<a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK554540/\"><span style=\"color: windowtext;\">https://www.ncbi.nlm.nih.gov/books/NBK554540/</span></a>\n<div></div>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:00.673Z"
            },
            {
                "Author": "Reneerose Ong",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Great discussion post Kelly!</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">I agree that the decision between intravenous vs inhalation induction changes based on a wide variety of patient and procedural factors. From my experience in pediatrics, inhalational induction is often preferred due to the ease of administering anesthesia without the need for an IV, especially for younger or more anxious patients (&#216;stgaard &amp; Ulvik, 2010). However, if the patient has IV access, it is preferred. In older patients, if they are cooperative and it is developmentally appropriate, anesthesiologists will often offer an awake IV insertion for IV induction. &#160;As you mentioned, patient cooperation, medical history, and the type of procedure plays a significant role in deciding the most appropriate method (<span style=\"color: #212121;background: white;\">Herling et al., 1997; Kampman et al., 2024</span>). </span>\n<p style=\"line-height: 107%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">I also appreciate your emphasis on considering side effects, particularly post-operative nausea and vomiting (PONV). The reduction in PONV using intravenous induction, especially with agents like propofol, makes it a compelling choice in patients at high risk for nausea and vomiting </span><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">(</span><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Lundstr&#246;m</span><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\"> et al., 2010; Sahinovic et al., 2018)</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Ultimately, as you mentioned, there\u2019s no one-size-fits-all approach, and adapting anesthesia based on the unique needs of each patient is key. Your table provides a clear comparison of the benefits and drawbacks of each method. I\u2019m curious to explore more about how these choices play out in older or more medically complex patients, as they often present added challenges in induction (<span style=\"color: #212121;background: white;\">Kampman et al., 2024; </span>Scheiermann et al., 2018).</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"></span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">References:&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Herling, S. F., Dreijer, B., Wrist Lam, G., Thomsen, T., &amp; M&#248;ller, A. M. (2017). Total </span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">intravenous anaesthesia versus inhalational anaesthesia for adults undergoing </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">transabdominal robotic assisted laparoscopic surgery. _The Cochrane database of_&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><i><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">systematic reviews</span></i><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"><span style=\"text-align: start;float: none;\">,&#160;</span><i style=\"text-align: start;\">4</i><span style=\"text-align: start;float: none;\">(4), CD011387. </span></span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"><a rel=\"noopener\" href=\"https://doi.org/10.1002/14651858.CD011387.pub2\">https://doi.org/10.1002/14651858.CD011387.pub2</a> </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Kampman, J. M., Hermanides, J., Hollmann, M. W., Gilhuis, C. N., Bloem, W. A., Schraag, </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">S., Pradelli, L., Repping, S., &amp; Sperna Weiland, N. H. (2024). Mortality and </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">systematic review and meta-analysis. _EClinicalMedicine, 72, 102636_.&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"><a rel=\"noopener\" href=\"https://doi.org/10.1016/j.eclinm.2024.102636\">https://doi.org/10.1016/j.eclinm.2024.102636</a> </span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;line-height: 200%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Lundstr&#246;m, S., Twycross, R., Mihalyo, M., &amp; Wilcock, A. (2010). Propofol.&#160;<i>Journal of pain and symptom management</i>,&#160;<i>40</i>(3), 466\u2013470. </span><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\"><a rel=\"noopener\" href=\"https://doi.org/10.1016/j.jpainsymman.2010.07.001\"><span style=\"background: white;\">https://doi.org/10.1016/j.jpainsymman.2010.07.001</span></a></span><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"> </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">&#216;stgaard, G., &amp; Ulvik, A. (2010). Anestesi til barn [Paediatric anaesthesia].&#160;<i>Tidsskrift for den </i></span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><i><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Norske laegeforening : tidsskrift for praktisk medicin, ny raekke</span></i><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">,&#160;<i>130</i>(7), 752\u2013755. </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\"><a rel=\"noopener\" href=\"https://doi.org/10.4045/tidsskr.08.0529\">https://doi.org/10.4045/tidsskr.08.0529</a> </span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;line-height: 200%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Sahinovic, M. M., Struys, M. M. R. F., &amp; Absalom, A. R. (2018). Clinical Pharmacokinetics and Pharmacodynamics of Propofol.&#160;<i>Clinical pharmacokinetics</i>,&#160;<i>57</i>(12), 1539\u20131558. </span><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\"><a rel=\"noopener\" href=\"https://doi.org/10.1007/s40262-018-0672-3\"><span style=\"background: white;\">https://doi.org/10.1007/s40262-018-0672-3</span></a></span><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"> </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Scheiermann, P., Herzog, F., Siebenhofer, A., Strametz, R., &amp; Weberschock, T. (2018). </span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Intravenous versus inhalational anesthesia for pediatric inpatient surgery - A </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">systematic review and meta-analysis.&#160;<i>Journal of clinical anesthesia</i>,&#160;<i>49</i>, 19\u201325. </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\"><a rel=\"noopener\" href=\"https://doi.org/10.1016/j.jclinane.2018.05.014\">https://doi.org/10.1016/j.jclinane.2018.05.014</a> </span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:00.674Z"
            },
            {
                "Author": "Minna Jin",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Great discussions everyone,&#160;</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">I agree with everyone that factors such as patient cooperation, medical conditions, hemodynamic stability, and the type of surgery all play important roles in deciding which induction technique to use.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">It is also interesting to note that some medical conditions have contraindications for both intravenous (IV) and inhalation induction agents. For example, both the IV agent succinylcholine and inhaled agents like halogenated anesthetic gases are potent triggers of malignant hyperthermia (Watt &amp; McAllister, 2023). Therefore, patients with a history of MH should avoid these agents, and alternative induction agents such as propofol (an IV induction agent) or nitrous oxide (a non-halogenated inhalation induction agent) should be used.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Another example is patients with bronchospasm, who should avoid using thiopental (an IV induction agent) and desflurane (an inhalation induction agent), as both can trigger bronchoconstriction, particularly in patients with airway compromise (Shukla, 2010; Cortese et al., 2020). Alternatively, ketamine (an IV induction agent) and isoflurane (an inhalation induction agent) should be used, as they are both bronchodilators and can reverse bronchospasm (Agrawal &amp; Shrivastava, 2014; Pimentel et al., 2020).</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">A profound knowledge of medical conditions and anesthetic agents is essential for the anesthesia care team, as various perioperative drugs can potentially trigger certain medical conditions. Sometimes, it is not about one induction route being preferred over another; it can depend on the disease and, more specifically, the individual induction agent.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Agrawal, A., &amp; Shrivastava, J. (2014). Intravenous ketamine for refractory bronchospasm precipitated by H1N1 infection.&#160;<i>Frontiers in Pediatrics, 2(</i>24).&#160;https://doi.org/10.3389/fped.2014.00024</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Cortese, G., Carron, M., Montrucchio, G., &amp; Brazzi, L. (2020). Sugammadex-induced bronchospasm during desflurane anaesthesia: An open question.&#160;<i>British Journal of Anesthesia, 124</i>(2), E17\u2013E18.&#160;https://doi.org/10.1016/j.cmi.2020.02.006</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Pimentel, M., Castillo-Rodriguez, M., &amp; Minear, S. (2020). The role of isoflurane in the management of severe bronchospasm in the intensive care unit.&#160;<i>Critical Care Medicine, 48</i>(1), 516.&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1097/01.ccm.0000643228.57666.0f\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi.org/10.1097/01.ccm.0000643228.57666.0f</a></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Shukla, A. (2010). Intraoperative bronchospasm with thiopental.&#160;<i>Indian Journal of Anaesthesia, 54</i>(2), 181\u2013182.&#160;https://doi.org/10.4103/0019-5049.63646</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Watt, S., &amp; McAllister, R. (2023).&#160;</span><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Malignant hyperthermia. In&#160;<i>StatPearls</i>. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430828/</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:00.674Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Hi Kurt,&#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Thanks for sharing about the immunosuppressive characteristics of Sevoflurane. This is new to me &#128522;.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">I want to clarify the use of MAC as the index of inhaled anesthetic potency. MAC is the alveolar concentration of an inhaled anesthetic that prevents movement in 50% of patients in response to a standard surgical stimulus. We can compare the potency between different inhaled anesthetics by looking at their MAC values. For example, 1MAC of Sevoflurane is ~2%, and 1MAC of nitrous oxide is 104%. Sevoflurane, with the lower MAC, is more potent than nitrous oxide. Sevoflurane only needs 2%, while nitrous oxide needs 104% to provide the same MAC effect.&#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Different factors will increase or decrease the inhaled anesthetic concentration required to achieve MAC (see Ryan\u2019s post in Question 11). For example, increasing age is a factor that decreases MAC. 1MAC of Sevoflurane is 2%, but if we administer it to an older patient, we may achieve the same MAC effect with only 1.5%. Therefore, it is not more when comparing adults with pediatrics, but less inhaled anesthetics are needed to maintain adults.</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:00.675Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Very Interesting discussion on the advantages and disadvantages of inhalation and intravenous inductions!\nTypically, we reserve pure inhalation induction for the pediatric population and developmentally delayed patients because it is painless and does not require starting an intravenous first, as Kelly, Kurt, and Renee suggested. Another option for these patient groups is to perform an intramuscular Ketamine induction. Nevertheless, we would need to insert an IV post-induction. &#160;It shouldn\u2019t be a problem because veins literally just pop up due to peripheral vasodilation post-induction.\nRegarding pure inhalational induction, Sevoflurane has replaced Halothane and has become the only agent we use nowadays. To shorten the induction time so that it matches closer to an intravenous induction, in addition to using a high concentration, we can prime our breathing circuits first before applying it to the patient. This technique can produce a loss of consciousness within a minute using only inhaled anesthetics. Although Sevoflurane is known for its low pungency, personally, I still find its smell quite unpleasant. &#160;I have tried scenting the mask before performing an inhalation induction. It is a very good distraction technique, and I was surprised at its effectiveness the first time I was exposed to it. A trick I learned from an anesthesiologist is to use different flavored lip balms. She always comes with her bag of lip balms for the little kids to pick and apply to the mask themselves. &#160;&#160;\nFor adult patients, the gold standard is an intravenous induction because of its rapid onset. Other rationales include performing a rapid sequence induction for patients with a high risk of aspiration (as listed in Kelly\u2019s table), and minimizing the generation of aerosols (during the COVID era), personal or familial history of malignant hyperthermia (MH), decreased postoperative nausea and vomiting (PONV), minimizing the environmental impact of inhaled anesthetics, and other reasons mentioned in the above posts.&#160;\nLastly, I want to clarify that after a pure intravenous induction, we usually still maintain the patient with inhaled anesthetics. As PONV came up in many of the posts, if the patient has a history of very severe PONV, we may consider a total intravenous anesthesia (TIVA) approach where only intravenous agents are used during the induction and maintenance phases. TIVA is also indicated for patients with MH history or where an anesthesia gas machine is not available.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:00.675Z"
            }
        ]
    },
    {
        "Thread Title": "Question 15",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/101/View",
        "Question": "<p>Question 15: Which muscles are most sensitive to neuromuscular blocking agents? What is the importance of this during the induction and emergence phases of anesthesia?</p>",
        "Responses": [
            {
                "Author": "Minna Jin",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: 36pt;\">Neuromuscular blocking agents are usually used in anesthesia to facilitate endotracheal intubation or mechanical ventilation. Different muscle groups have different sensitivities to neuromuscular blocking agents. Particularly, the&#160;<b>pharyngeal muscles</b>,&#160;<b>masseter muscle</b>&#160;and&#160;<b>genioglossus muscles</b>&#160;are the most sensitive muscles to neuromuscular blocking agents (Rodney et al., 2024). These muscles are important composition of the upper airway. The pharyngeal muscles, from a respiratory perspective, play an important role in keeping pharyngeal airway open (Edwards &amp; White, 2011). The Masseter muscle is the muscle of mastication and is important for the chewing motion (Corcoran &amp; Goldman, 2023). Lastly, the genioglossus muscle (tongue muscle) is a pharyngeal dilator muscle, its major function is to keep the tongue protruded and maintain open airway (McCausland &amp; Bordoni, 2023).&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: 36pt;\">During the induction phase of anesthesia, it is important to relax these muscles to facilitate endotracheal intubation, optimize surgical condition and prevent injury (Rodney et al., 2024). Specifically, relaxing the masseter muscle (jaw muscle) helps with jaw/mouth opening prior to intubation or airway management. Relaxing the genioglossus and pharyngeal muscles prevents unwanted muscle movement in response to laryngoscopy and intubation, thus minimizing the risk of corresponding muscle injury. (Plaud et al., 2020). On the other hand, since these muscles play an important role in maintaining airway patency, relaxing/paralysing these muscles with neuromuscular blocking agents might lead to airway compromise. Prompt airway management with endotracheal intubation is key to prevent respiratory distress during induction of anesthesia (Hillman et al., 2003).&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: 36pt;\">Although these three muscles are the most sensitive muscles to neuromuscular blocking agents, they are also the slowest muscles to recover (Rodney et al., 2024). During emergence phase of anesthesia, incomplete neuromuscular recovery from pharyngeal muscles can result in upper airway muscle weakness, impaired pharyngeal function and potentially pulmonary aspiration (Rodney et al., 2024). Incomplete neuromuscular recovery of genioglossus muscle can result in airway constriction and loss of motor control of tongue muscle and cause tongue to fall back and obstruct upper airway (Rodney et al., 2024). Therefore, it is critical to monitor for any signs of residual neuromuscular block both perioperatively and postoperatively and provide neuromuscular antagonists as needed.&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: 36pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><img alt=\"A diagram of muscle sensitivityDescription automatically generated\" src=\"/d2l/le/7298/discussions/posts/4284/ViewAttachment?fileId=439915\" height=\"256\" width=\"631\"/>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Onset, recovery and sensitivity of different muscle groups to neuromuscular blocking agents (Rodney et al., 2024).\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: center;\"><b>Reference</b>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Corcoran, N. M., &amp; Goldman, E. M. (2023). Anatomy, head and neck, masseter muscle. In&#160;<i>StatPearls</i>. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK539869/#:~:text=The%20masseter%20is%20one%20of,some%20protraction%20of%20the%20mandible.\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Edwards, B. A., &amp; White, D. P. (2011). Control of the pharyngeal musculature during wakefulness and sleep: Implications in normal controls and sleep apnea.&#160;_Head and&#160;Neck, 33_(1), 37-45. 10.1002/hed.21841\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Hillman, D. R., Platt, P. R., &amp; Eastwood, P. R. (2003). The upper airway during anaesthesia.&#160;<i>BJA: British Journal of Anaesthesia, 91</i>(1), 31\u201339.&#160;<span style=\"color: black;\"><a rel=\"noopener\" target=\"_new\" href=\"https://doi.org/10.1093/bja/aeg126\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\"><span style=\"color: black;\">https://doi.org/10.1093/bja/aeg126</span></a></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">McCausland, T., &amp; Bordoni, B. (2023). Anatomy, head and neck: Genioglossus muscle. In&#160;<i>StatPearls</i>. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK545141/\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Plaud, B., Baillard, C., Bourgain, J.-L., Bouroche, G., Desplanque, L., Devys, J.-M., Fletcher, D., Fuchs-Buder, T., Lebuffe, G., Meistelman, C., Motamed, C., Raft, J., Servin, F., Sirieix, D., Slim, K., Velly, L., Verdonk, F., &amp; Debaene, B. (2020). Guidelines on muscle relaxants and reversal in anaesthesia.&#160;<i>Anaesthesia Critical Care &amp; Pain Medicine,&#160;39</i>(1), 125\u2013142.&#160;https://doi.org/10.1016/j.accpm.2020.01.001\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: normal;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Rodney, G., Raju, P., &amp; Brull, S. J. (2024). Neuromuscular block management: Evidence-based principles and practice.&#160;<i>BJA: British Journal of Anesthesia, 24</i>(1), 13-22. 10.1016/j.bjae.2023.10.005",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4284/ViewAttachment?fileId=439915",
                        "filename": "image_22757324921727914734793.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:04.713Z"
            },
            {
                "Author": "Junia Isaac",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Hi Minna, great job on breaking down the sensitivity of different muscles to neuromuscular blocking agents and their implications during induction and emergence! I appreciate how you connected muscle relaxation to both intubation and airway management. To further explore this topic, I think it\u2019s worth diving into the differential sensitivity between fast-twitch and slow-twitch muscle fibres. As you mentioned, the pharyngeal and genioglossus muscles are particularly sensitive, but it\u2019s also interesting to note how different fibre types recover at varying rates post-anesthesia. Studies have shown that fast-twitch muscles, like those controlling fine motor functions, tend to recover faster compared to slow-twitch, postural muscles, which may contribute to the delay in recovery you pointed out during the emergence phase (Plaud et al., 2020). I wonder if this delay might be influenced by patient-specific factors such as age, comorbidities, or even the type of neuromuscular blocking agent used. For example, agents like rocuronium and vecuronium have different recovery profiles, which could be critical in clinical decision-making, particularly in vulnerable patients (Naguib, 2014). Additionally, I\u2019d like to hear your thoughts on the role of quantitative neuromuscular monitoring in ensuring complete recovery before extubation. In some cases, clinical signs of muscle recovery may not be sufficient, and tools like acceleromyography or train-of-four (TOF) ratios help reduce the risk of residual block, especially in muscles like the pharyngeal muscles that are slow to recover (Plaud et al., 2020).\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Plaud, B., Baillard, C., Bourgain, J.-L., Bouroche, G., Desplanque, L., Devys, J.-M., Fletcher, D., Fuchs-Buder, T., Lebuffe, G., Meistelman, C., Motamed, C., Raft, J., Servin, F., Sirieix, D., Slim, K., Velly, L., Verdonk, F., &amp; Debaene, B. (2020). Guidelines on muscle relaxants and reversal in anaesthesia.&#160;<i>Anaesthesia Critical Care &amp; Pain Medicine,&#160;39</i>(1), 125\u2013142.&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1016/j.accpm.2020.01.001\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi.org/10.1016/j.accpm.2020.01.001</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 30.05pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -30.05pt;\">Naguib, M. A. (2014). Neuromuscular blocking drugs and reversal agents. In P. Flood, J. P. Rathmell, &amp; R. D. Urman (Eds.),&#160;<i>Stoelting&#39;s pharmacology and physiology in anesthetic practice&#160;</i>(5th ed., pp. 323-344). Wolters Kluwer.&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:04.713Z"
            },
            {
                "Author": "Laryssa Hartmann",
                "Content": "<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-family: Calibri, sans-serif;color: black;background: white;\">Hi Minna and Junia, </span>\n<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-family: Calibri, sans-serif;color: black;background: white;\">Minna you did a really good job at explaining how different muscle groups have different sensitivities to neuromuscular blocking agents. I really liked how you distinguished the importance between the induction phase and emergence phase. </span>\n<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-family: Calibri, sans-serif;color: black;background: white;\">Junia you raise excellent points about the differential recovery rates of muscle fibers and how that impacts clinical outcomes. I agree that factors like patient age and comorbidities can significantly influence recovery times. &#160;It\u2019s also fascinating to consider how the choice of neuromuscular blocking agents can change the approach for monitoring and recovery. </span>\n<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-family: Calibri, sans-serif;color: black;background: white;\">In regards to quantitative neuromuscular monitoring I believe it is extremely important in ensuring complete recovery before extubation and helps reduce the risk of residual block. There have been numerous publications that illustrate how adequate neuromuscular recovery cannot be guaranteed without neuromuscular monitoring. In one study, succinylcholine was administered to patients with a variant (BChE) which increases the risk of anesthesia emergence prior to recovery from NMB </span><span style=\"font-family: Calibri, sans-serif;color: #333333;background: white;\">(Harris et al., 2024</span><span style=\"font-family: Calibri, sans-serif;color: black;background: white;\">). The application of adductor pollicis train of four (TOF) was used in both cases. However, in the first case, neuromuscular monitoring was applied too late to prevent awareness while the patient was in the OR. In the second case, neuromuscular monitoring was applied prior to administration of succinylcholine, which enabled clinicians to prevent premature awakening from anesthesia. These cases illustrated the importance of quantitative neuromuscular monitoring in short cases and with short acting depolarizing agents such as succinylcholine</span><span style=\"font-family: Calibri, sans-serif;color: #333333;background: white;\"> (Harris et al., 2024).</span><span style=\"font-family: Calibri, sans-serif;color: black;background: white;\"> Without quantitative monitoring, clinical signs such as head lift, hand grip or tidal volume are not a reliable indicator for adequate recovery</span><span style=\"font-family: Calibri, sans-serif;color: #333333;background: white;\"> (Harris et al., 2024).</span><span style=\"font-family: Calibri, sans-serif;color: black;background: white;\"> I believe that incorporating neuromuscular monitoring into cases will enhance patient safety and overall experiences in the OR. &#160;&#160;</span>\n<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-family: Calibri, sans-serif;color: black;background: white;\">Has anyone come across studies that highlight the use of different quantitative neuromuscular monitoring techniques available? Do you think certain methods are preferred over others? </span>\n<p style=\"margin: 0in 0in 8pt;line-height: 106%;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;\n<p style=\"margin: 0in 0in 0.0001pt;line-height: 18.75pt;background: white;word-break: break-all;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;\n<p style=\"margin: 0in 0in 0.0001pt;line-height: 18.75pt;background: white;word-break: break-all;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;\n<p style=\"margin: 0in 0in 0.0001pt;line-height: 18.75pt;background: white;word-break: break-all;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-family: Calibri, sans-serif;color: black;\">References:</span>\n<span style=\"font-size: 12.0pt;line-height: 107%;font-family: Calibri, sans-serif;color: black;\">Harris, E. M., Funk, E. M., Plezia, D., Elliott, J., Elliott, R., Pitman, J., &amp; Grant, S. A. (2024). Quantitative Neuromuscular Monitoring Permits Early Diagnosis of Abnormal Butyrylcholinestrase: Two Case Studies Demonstrating Prevention of Awareness from Premature Awakening. In <i>EBSCO</i>. Retrieved October 3, 2024, from https://web.p.ebscohost.com/nup/pdfviewer/pdfviewer?vid=2&amp;sid=9cf3a7db-e27d-4c19-b987-77761dce6312%40redis </span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:04.713Z"
            },
            {
                "Author": "Minna Jin",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hi Junia and Laryssa,</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Thank you for diving into the different recovery rates between fast-twitch and slow-twitch muscle fibres and bringing up the importance of quantitative monitors in muscle recovery from neuromuscular blocking agents. To further elaborate this topic, I have included a comparison between two common quantitative monitors: acceleromyography (AMG) and electromyography (EMG).</span>\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\" style=\"color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;border-collapse: collapse;border: medium;\">\n<tbody>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border: 1pt solid windowtext;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n<td valign=\"top\" style=\"width: 177.2pt;border-width: 1pt 1pt 1pt medium;border-style: solid solid solid none;border-color: windowtext windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">AMG</span>\n</td>\n<td valign=\"top\" style=\"width: 162.95pt;border-width: 1pt 1pt 1pt medium;border-style: solid solid solid none;border-color: windowtext windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">EMG</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border-width: medium 1pt 1pt;border-style: none solid solid;border-color: currentcolor windowtext windowtext;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Measurement&#160;</span>\n</td>\n<td valign=\"top\" style=\"width: 177.2pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Measures the acceleration and muscle contraction in response to nerve stimulation to determine train-of-four (TOF) ratio</span>\n</td>\n<td valign=\"top\" style=\"width: 162.95pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Measures the electrical activity of muscles in response to nerve stimulation to determine TOF ratio</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border-width: medium 1pt 1pt;border-style: none solid solid;border-color: currentcolor windowtext windowtext;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Placement of sensors</span>\n</td>\n<td valign=\"top\" style=\"width: 177.2pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">most commonly on adductor pollicis muscle of the thumb</span>\n</td>\n<td valign=\"top\" style=\"width: 162.95pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">most commonly on adductor pollicis muscle of the thumb</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border-width: medium 1pt 1pt;border-style: none solid solid;border-color: currentcolor windowtext windowtext;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Data interpretation&#160;</span>\n</td>\n<td valign=\"top\" style=\"width: 177.2pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Focuses on contraction strength and speed for functional recovery</span>\n</td>\n<td valign=\"top\" style=\"width: 162.95pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Analyzes electrical signals to determine neuromuscular recovery</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border-width: medium 1pt 1pt;border-style: none solid solid;border-color: currentcolor windowtext windowtext;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Sensitivity of position</span>\n</td>\n<td valign=\"top\" style=\"width: 177.2pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Sensitive to patient positioning; requires free movement of the thumb to get an accurate reading</span>\n</td>\n<td valign=\"top\" style=\"width: 162.95pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Less sensitive to patient positioning as it directly measures muscle electrical activity</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border-width: medium 1pt 1pt;border-style: none solid solid;border-color: currentcolor windowtext windowtext;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Cost</span>\n</td>\n<td valign=\"top\" style=\"width: 177.2pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Lower in cost compared to EMG</span>\n</td>\n<td valign=\"top\" style=\"width: 162.95pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Higher cost due to more sophisticated equipment&#160;</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border-width: medium 1pt 1pt;border-style: none solid solid;border-color: currentcolor windowtext windowtext;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Accuracy&#160;</span>\n</td>\n<td valign=\"top\" style=\"width: 177.2pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Tend to overestimate TOF ratio, need normalization to ensure accuracy</span>\n</td>\n<td valign=\"top\" style=\"width: 162.95pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Less variability in TOF ratio, higher accuracy&#160;</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 127.35pt;border-width: medium 1pt 1pt;border-style: none solid solid;border-color: currentcolor windowtext windowtext;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Clinical application</span>\n</td>\n<td valign=\"top\" style=\"width: 177.2pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Used for routine clinical monitoring in the operating room</span>\n</td>\n<td valign=\"top\" style=\"width: 162.95pt;border-width: medium 1pt 1pt medium;border-style: none solid solid none;border-color: currentcolor windowtext windowtext currentcolor;padding: 0cm 5.4pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;line-height: normal;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Used in research settings</span>\n</td>\n</tr>\n</tbody>\n</table>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Liang et al., 2013; Renew, 2021; Wedemeyer et al., 2024)</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">In summary, AMG is more commonly used in anesthesia practice due to its cost-effectiveness and simplicity. While EMG offers higher accuracy and is more commonly used for research-focused monitoring. In both cases, a TOF ratio of greater than 0.9 is required before extubation to ensure optimal patient safety (Murphy &amp; Brull, 2010).&#160;</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: center;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Reference</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Liang, S. S., Stewart, P. A., &amp; Phillips, S. B. (2013). An ipsilateral comparison of acceleromyography and electromyography during recovery from nondepolarizing neuromuscular block under general anesthesia in humans.&#160;<i>Anesthesia &amp; Analgesia, 117</i>(2), 373\u2013379.&#160;10.1213/ANE.0b013e3182937fc4</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Murphy, G. S., &amp; Brull, S. J. (2010). Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block.&#160;<i>Anesthesia &amp; Analgesia, 111</i>(1), 120\u2013128.&#160;10.1213/ANE.0b013e3181da832d</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Renew, J. R. (2021). Advancements in quantitative neuromuscular monitoring.&#160;<i>Anesthesia Patient Safety Foundation, 36</i>(3). https://www.apsf.org/article/advancements-in-quantitative-neuromuscular-monitoring/</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Wedemeyer, Z., Michaelsen, K. E., Jelacic, S., Silliman, W., Lopez, A., Togashi, K., &amp; Bowdle, A. (2024). Accuracy and precision of three acceleromyographs, three electromyographs, and a mechanomyograph measuring the train-of-four ratio in the absence of neuromuscular blocking drugs.&#160;<i>Anesthesiology, 141</i>, 262\u2013271.&#160;<span style=\"color: black;\"><a rel=\"noopener\" target=\"_new\" href=\"https://doi.org/10.1097/ALN.0000000000005051\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\"><span style=\"color: black;\">10.1097/ALN.0000000000005051</span></a></span></span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:04.713Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Great overview on the effects of neuromuscular blocking agents on different muscles!\nBecause of the differences in nerve fibers and stimulation rates, different muscle groups respond differently to neuromuscular blocking agents (NMBAs), as illustrated in the figure in Minna\u2019s post. Blockade occurs faster in central muscles (i.e., diaphragm, larynx, orbicularis oculi) than peripheral muscles because of the greater blood flow and, thus, increased drug delivery to the site of action. Similarly, the central muscles recover faster from NMBAs for the same reasons.&#160;\nIn addition to the speed of onset and recovery (pharmacokinetics), the blockade (pharmacodynamics) also differs between muscle groups. The central muscles are more resistant to NMBAs than the peripheral muscles. Therefore, the degree of blockade assessed at one site does not equal the degree of blockade at another site. For example, the blockade at the adductor pollicis occurs later but more intensely than at the diaphragm or orbicularis oculi. This is why surgeons may note that patients are \u201ctight\u201d while it shows 0 of 4 twitches of the train-of-four at the adductor pollicis. Similarly, recovery of the adductor pollicis occurs more slowly than the diaphragm or orbicularis oculi. This is important because if we base the NMBA dosage according to the result at the orbicularis oculi, we may overdose our patients. Similarly, if we base the reversal agent dosing on the result at the orbicularis oculi, we can underestimate the reversal needed and increase the incidence of residual blockade postoperatively.\nLastly, I want to point out that it is lucky that our NMBAs affect only striated, voluntary muscles and not the myocardium and the smooth muscles under autonomic control.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:04.714Z"
            }
        ]
    },
    {
        "Thread Title": "Question 16",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/100/View",
        "Question": "<p>Question 16: Comment on the choice of vasopressors used to control blood pressure intraoperatively.</p>",
        "Responses": [
            {
                "Author": "Meera Sathananthan",
                "Content": "<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"color: rgb(0, 0, 0);font-family: Arial, sans-serif;font-size: 11pt;letter-spacing: 0.02rem;\">When managing hypotension perioperatively, it is important to determine whether it is an acute onset that can be resolved with a short-acting pressor or if prolonged vasoactive support is required (1). Therefore, it is important to identify the underlying cause of hypotension, as well as consider the clinical context. Perioperative hypotension may be a result of the patient profile (age, fluid status, past medical history, current medications, reason for surgery etc), anesthesia or the surgery itself (2).&#160;</span><span style=\"color: rgb(0, 0, 0);font-family: Arial, sans-serif;font-size: 11pt;letter-spacing: 0.02rem;\"></span><span style=\"color: rgb(0, 0, 0);font-family: Arial, sans-serif;font-size: 11pt;letter-spacing: 0.02rem;\"></span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"color: rgb(0, 0, 0);font-family: Arial, sans-serif;font-size: 11pt;letter-spacing: 0.02rem;\"></span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Understanding the mechanism of vasopressors helps determine their appropriate use . So we will very quickly review the downstream effects of adrenergic receptors. Other receptors, dopamine and vasopressin, are also important in vasopressor therapy but will be discussed when we compare the 6 vasopressors we commonly see in the operating room (OR). This will be followed by an analysis of when and how each pressor serves us best.&#160;</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"></span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">The pressors we will explore are: Phenylephrine, Ephedrine, Norepinephrine, Epinephrine, Vasopressin and Dopamine.</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"></span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">I am a visual learner, so brace yourselves for some/a lot of figures throughout the discussion.</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);text-decoration: underline;\"></span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);text-decoration: underline;\">Effects of Adrenergic Receptors</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"></span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Figure 1:</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"> The effects of adrenergic receptors \u03b1-1, \u03b2-1 and \u03b2-2, stimulation on different organs (3).</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"><span style=\"border: none;\"><img src=\"/d2l/le/7298/discussions/posts/4792/ViewAttachment?fileId=445445\" width=\"702\" height=\"398\"/></span></span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);text-decoration: underline;\">Meet the Vasopressors</span>**\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">We are looking at a few heroes here: Phenylephrine, Ephedrine, Norepinephrine, Epinephrine, Vasopressin and Dopamine. For the Marvel fans, get excited - a few of these have been characterised as Avengers. Not all have had the honour, but they\u2019re all equally important. A few infographics for you:</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Phenylephrine</span>**\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Figure 2: </span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Phenylephrine and its main effects (4)</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"><span style=\"border: none;\"><img height=\"601\" width=\"602\" src=\"https://lh7-rt.googleusercontent.com/docsz/AD_4nXeLeSXtrwVHXko4aspstlaoSc-AvFbE3cqGLOZk97-B1PS6oERSj15iedX5Fobl4f88Rq-iiR68RT62uIw_ulFQODC27Kr7x0hNzvUQE0F2Lq7GbDT05UTCvs7C_MhZGTLWDWdzzuiM-d0BW3jVclKnrtA?key=2AFmz41P5gQPX_82EVrT8A\"/></span></span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Main points:&#160;</span>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 12pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Used for peripheral vasoconstriction when cardiac output (CO) is adequate; causes a compensatory decrease in CO (5; 6)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Rapid onset within 1-3 minutes - makes it very ideal as a push dose for acute hypotension (7)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Short duration of action (5-10 minutes) (5)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Ideally as a bolus: 40-100mcg (5)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Can be delivered as an infusion: 10-20mcg/min (5)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;\">Should be avoided in septic shock as it reduces splanchnic blood flow and oxygen delivery (6)</span>\n</li>\n</ul>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Ephedrine (5):</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"> Unfortunately has not yet been characterised as an avenger.&#160;</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Main points:</span>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 12pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Like phenylephrine, it is also delivered as a push dose.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Completely bioavailable within 3-5 minutes (8)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Duration of action is 10-15 minutes (8)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Main mechanism: inhibits reuptake of norepinephrine (NE) leading to longer time in synapses and prolonged NE effects (9)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Causes vasoconstriction, inotropy and chronotropy (5)</span>\n<ul>\n<li style=\"list-style-type: disc;font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Would not want to use it for patients with tachycardia or who are prone to arrhythmias.&#160;</span>\n</li>\n<li style=\"list-style-type: disc;font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;\">Ideal for hypotension with bradycardia; i.e. patients receiving a high spinal anesthetic, patients in neurogenic shock or patients who experience a vasovagal reflex intraoperatively.&#160;&#160;</span>\n</li>\n</ul>\n</li>\n</ul>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Norepinephrine:</span>**\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Figure 3: </span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Norepinephrine (Levophed) and its main effects (10)</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"><span style=\"border: none;\"><img height=\"601\" width=\"602\" src=\"https://lh7-rt.googleusercontent.com/docsz/AD_4nXfrD9uQLDL4w1Nr7hAHqeOXTHaDhUGezX3J6wnOa-YHO45T11xK-_LQv7XglI2lq9_GswywhFCodTIAZp-Q9En_dmIzfaONec2pkuwKExNnMVwmiEdQj0W0b8YgeovJ4VA_tLZDgugmXJKzYA4kdUHerYQG?key=2AFmz41P5gQPX_82EVrT8A\"/></span></span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Main points (11):</span>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 12pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Administered via continuous infusion; Short half-life of 2.5 min</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Short onset of action; achieves steady-state concentrations within 5 min</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Crosses the placenta, but not blood-brain barrier</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;\">Use cautiously in patients with poor cardiac function or pulmonary hypertension</span>\n</li>\n</ul>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Epinephrine:&#160;</span>**\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">**Figure 4:** Epinephrine and its effects (12)</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"><span style=\"border: none;\"><img height=\"601\" width=\"602\" src=\"https://lh7-rt.googleusercontent.com/docsz/AD_4nXeUhv8vcrWHYdvcJxPsfC41bNoO4xn4Q9TCbF5v_2bk8WLLmbk2WQmC-9wPmUJaEb7yjyzhCAfpdPpjfUOuzG-h9Xi7WL9jPiOUVKfCk1pQSVKg0SQsNXS2MFEDNRnC2a11_8YsDldjNJ_Fjzn810GjmgmI?key=2AFmz41P5gQPX_82EVrT8A\"/></span></span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Main points (5):</span>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 12pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Typically used as a continuous infusion when treating hypotension as an adjunct to other pressors (3)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Low-dose - promotes bronchodilation and decreases vascular tone</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Intermediate dose (2-10mcg/min) - increases HR, contractility, AV node conduction.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">High dose (&gt;10mcg/min) - generalized vasoconstriction and potential reflex bradycardia</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Most effective in anaphylactic shock (13)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;\">Can be used in conjunction with other pressors in presence of profound hypotension or severe septic shock. Also used for ACLS (12)</span>\n</li>\n</ul>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Vasopressin:</span>**\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">**Figure 5:** Vasopressin and its effects (14)</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);text-decoration: underline;\"><span style=\"border: none;\"><img height=\"601\" width=\"602\" src=\"https://lh7-rt.googleusercontent.com/docsz/AD_4nXdRAEQ2Pbm6oL_h3peSGlc0CJMdrOaMpqCNHGU7r9KDEx157GczOBZd0xpOY52YP0LrS4yxpv788RSM-JW2s8CHKScaY3UFryvjOGYZpEEZA2KD908XMieTGPkFZoDlctV7SCEnvK6AtLdR_2WFn7JnEfeF?key=2AFmz41P5gQPX_82EVrT8A\"/></span></span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Main points (15):</span>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 12pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Does not exert effects through adrenergic receptors; instead it uses vasopressin receptors. Effects depicted in Figure 6 (15).&#160;</span>\n<ul>\n<li style=\"list-style-type: disc;font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">V1a receptors are found on vascular smooth muscles - causes contraction</span>\n</li>\n<li style=\"list-style-type: disc;font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">V2 receptors are found on renal tubular cells (mainly on the collecting ducts) - stimulation leads to aquaporin-2 recruitment - causes water reabsorption</span>\n</li>\n<li style=\"list-style-type: disc;font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">V1b receptors are found in anterior pituitary and pancreas - increases cortisol and insulin secretion</span>\n</li>\n</ul>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Half-life is 5-15 min (16)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Does not constrict pulmonary vasculature (therefore beneficial in cases involving right heart failure, pulmonary hypertension and PEs) (16)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Especially helpful in vasodilatory shock that is resistant to catecholamine treatment and fluids, septic shock, uncontrolled hemorrhagic shock, portal venous hypertension and CPR (17)</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;\">Often used with norepinephrine (14)</span>\n</li>\n</ul>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Figure 6: </span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">A closer look at the effects of vasopressin in the body (15)</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"><span style=\"border: none;\"><img height=\"347\" width=\"602\" src=\"https://lh7-rt.googleusercontent.com/docsz/AD_4nXdQN1jKHT8OTYGewOll2cKzhvXTsdeFoIKnPprNCwv451CmFq1m0PjQFyv8BxffXRMHWylcZrmdTb5HJ6_AzdUwggMpO5k2ot8uM8EFS_6tC8jPhge8s2AEEMTAVGWV98-cI336MfFppi0CdFgQX17qC9w5?key=2AFmz41P5gQPX_82EVrT8A\"/></span></span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">_<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Legend: ACTH - Adrenocorticotropic hormone; AVP - Arginine vasopressin; AQP2 - Aquaporin 2</span>_\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dopamine:</span>**\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dopamine is a real Jekyll/Hyde type of drug, as its effects vary depending on the dose.&#160;</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Main points:</span>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 12pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Low-dose: stimulates dopaminergic and beta-1 receptors (18)</span>\n<ul>\n<li style=\"list-style-type: disc;font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Acts as an inotrope, chronotrope and mild vasodilator (18).&#160;</span>\n</li>\n<li style=\"list-style-type: disc;font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Known to cause renal vasodilation</span>\n</li>\n</ul>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">High-dose: pure vasoconstrictor by exerting its effects mostly on alpha-1 receptors (18)&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;\">Half-life is 2 minutes, which is why it must be administered as a continuous infusion (19)</span>\n</li>\n</ul>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Figure 7: </span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">The effects of dopamine administration at 7(a) low and 7(b) high doses akin to the transformation of Bruce Banner to the Hulk (20)</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">**Figure 7a:** Low-dose dopamine as Bruc</span><span style=\"color: rgb(0, 0, 0);font-family: Arial, sans-serif;font-size: 11pt;letter-spacing: 0.02rem;\">e Banner (20)</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"color: rgb(0, 0, 0);font-family: Arial, sans-serif;font-size: 11pt;letter-spacing: 0.02rem;\"><img height=\"601\" width=\"602\" src=\"https://lh7-rt.googleusercontent.com/docsz/AD_4nXcG5hHqwPpBpl4GpHjt1bSqB-oar6pAyDpLYipJDO6SbmkAxPUhNJFYL7aMRa3qlG4NqVMl08oc3jkuyzWvWDT5Fcw0NJ9W8jlHMCYa5KJQYTlUBNrpIbpwm6wHthJOkocjihanjL3foy8bivEfKNsoGEI?key=2AFmz41P5gQPX_82EVrT8A\" style=\"letter-spacing: 0.4px;color: rgb(0, 0, 0);font-family: Arial, sans-serif;font-size: 14.6667px;\"/></span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">_<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Legend: HR - Heart Rate; CO - Cardiac Output; D1- Dopamine-1 Receptor; D2 - Dopamine-2 Receptor</span>_\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">**Figure 7b:** High-dose dopamine as the Hulk. As you can see, no dopaminergic effects at high doses. Instead, dopamine acts as a pure alpha-1 agonist here (20)</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"><span style=\"border: none;\"><img height=\"601\" width=\"602\" src=\"https://lh7-rt.googleusercontent.com/docsz/AD_4nXdiZkdqIXNCrM4W0ZNe9lB-5Z8KfSHmZ0rgHfpiyq33_HdmsTzNp0C92vuOjTtpxUn37gGli63eUoHoSTkUfBv-ksyasnyYb6gmP6x19YDI8cwThoomzzW-zXVG0AWCn5RVH2d_aUig2C1YEemWbubjkoc0?key=2AFmz41P5gQPX_82EVrT8A\"/></span></span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">&#160;</span>_<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Legend: BP - Blood Pressure; SVR - Systemic Vascular Resistance</span>_\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Now that we have explored all of the vasopressors, we can directly compare their effects (Table 1).</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Table 1:</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"> Vasoactive agents, their receptors and effects, modified excerpt from (9)</span>\n<div align=\"left\">\n<table style=\"border: none;\"><colgroup><col style=\"width: 124px;\"/><col style=\"width: 61px;\"/><col style=\"width: 52px;\"/><col style=\"width: 71px;\"/><col style=\"width: 48px;\"/><col style=\"width: 35px;\"/><col style=\"width: 35px;\"/><col style=\"width: 247px;\"/></colgroup>\n<thead>\n<tr style=\"height: 38.5pt;\">\n<th scope=\"col\" style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Vasoactive Agent</span>**\n</th>\n<th scope=\"col\" style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u03b11</span>**\n</th>\n<th scope=\"col\" style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u03b12</span>**\n</th>\n<th scope=\"col\" style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u03b21</span>**\n</th>\n<th scope=\"col\" style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u03b22</span>**\n</th>\n<th scope=\"col\" style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">D</span>**\n</th>\n<th scope=\"col\" style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">V</span>**\n</th>\n<th scope=\"col\" style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Clinical Effect</span>**\n</th>\n</tr>\n</thead>\n<tbody>\n<tr style=\"height: 54.75pt;\">\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Epinephrine</span>**\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+++(+)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0(+)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\"></td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u25b2 in SVR predominates, vasodilator in low dose. \u25b2 CO by \u25b2 inotrope and \u25b2 HR.</span>\n</td>\n</tr>\n<tr style=\"height: 25.5pt;\">\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Ephedrine</span>**\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+++(+)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\"></td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u25b2 in SVR predominates. Mild \u25b2 CO by \u25b2 inotrope.</span>\n</td>\n</tr>\n<tr style=\"height: 75pt;\">\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Norepinephrine</span>**\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0(+)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\"></td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u25b2 \u25b2 in SVR predominates because of alpha effects. \u25bc CO s/t \u25b2 in SVR offset by inotrope. \u25b2 HR at higher doses may limit clinical effectiveness.</span>\n</td>\n</tr>\n<tr style=\"height: 73.5pt;\">\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Phenylephrine</span>**\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\"></td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u25b2 \u25b2 in SVR predominates. CO neutral at low doses s/t \u25b2 venous return offsets the \u25b2 SVR effect on CO. At high doses, \u25b2 in SVR predominates with \u25bc CO.</span>\n</td>\n</tr>\n<tr style=\"height: 21pt;\">\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Vasopressin</span>**\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\u25b2 \u25b2 in SVR predominates.</span>\n</td>\n</tr>\n<tr style=\"height: 45.25pt;\">\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dopamine (0.5-2 &#181;g/kg/min)</span>**\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">0</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">(+)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\"></td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dose 1: \u25b2 CO by \u25b2 inotrope</span>\n</td>\n</tr>\n<tr style=\"height: 48.75pt;\">\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dopamine (3.0-10 &#181;g/kg/min)</span>**\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">(+)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\"></td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dose 2: \u25b2 SVR and \u25b2 CO by \u25b2 inotrope and \u25b2 HR.</span>\n</td>\n</tr>\n<tr style=\"height: 48pt;\">\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dopamine (10-20 &#181;g/kg/min)</span>**\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+(+++)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">(+)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++(+++)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">+(+)</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">++</span>\n</td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\"></td>\n<td style=\"vertical-align: top;border: 1pt solid rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dose 3: \u25b2 in SVR predominates. \u25b2 HR at higher doses may limit clinical effectiveness.</span>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">_<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Legend: 0 - no effect; + - minimal receptor stimulation; ++ - mild receptor stimulation; +++ - moderate receptor stimulation; ++++ - strong receptor stimulation; - - debated activity; () - variable effects; \u25b2 - increase; \u25bc - decrease; \u03b1 - alpha receptor; \u03b2 - beta receptor; D - dopaminergic receptor; V - vasopressin receptor; CO - cardiac output; HR - heart rate; SVR - systemic vascular resistance</span>__<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"><br/><br/></span>_\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Choosing the Right Vasopressor</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Given all of the information we\u2019ve gone over for these vasopressors, we can now try to distinguish when each vasoactive agent would be most ideally used.</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<ol style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);font-weight: bold;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;\">Determine Hemodynamic Profile</span>**\n</li>\n</ol>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Normal/High Heart Rate with Hypotension:&#160;</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"> </span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Phenylephrine</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"> </span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">for vasoconstriction, particularly when cardiac output (CO) is adequate, as it causes peripheral vasoconstriction without significantly increasing heart rate. Avoid in cases where reduction in splanchnic blood flow is a concern (e.g., septic shock) (5, 6).</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Hypotension with Bradycardia:&#160;</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use Ephedrine for its combined vasoconstrictive, inotropic, and chronotropic effects. Ideal for patients with bradycardia, such as those receiving a high spinal anesthetic, in neurogenic shock, or experiencing a vasovagal reflex intraoperatively (5, 8, 9).</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<ol start=\"2\" style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);font-weight: bold;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;\">Severity of Hypotension</span>**\n</li>\n</ol>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Mild to Moderate Hypotension:</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">For acute episodes, use Phenylephrine as a push dose due to its rapid onset (1-3 minutes) and short duration of action (5-10 minutes). This is effective when CO is adequate and a rapid response is needed (5, 7).</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Severe Hypotension or Septic Shock:&#160;</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use Norepinephrine to increase systemic vascular resistance (SVR) and maintain perfusion. Typically used as a continuous infusion, norepinephrine is effective in maintaining blood pressure during severe hypotensive states and is considered first-line in septic shock (11).</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Refractory Hypotension (Unresponsive to Catecholamines):&#160;</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use Vasopressin as an adjunct to norepinephrine. Vasopressin acts through non-adrenergic pathways, which makes it valuable in vasodilatory shock that is resistant to catecholamines (14, 15).</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<ol start=\"3\" style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);font-weight: bold;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;\">Presence of Cardiac Dysfunction</span>**\n</li>\n</ol>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Poor Cardiac Function:&#160;</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use Norepinephrine cautiously to avoid overloading the heart, especially at higher doses. It helps maintain blood pressure without significantly increasing myocardial oxygen demand compared to other agents (11).</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Right Heart Failure, Pulmonary Hypertension:&#160;</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use Vasopressin due to its ability to increase SVR without constricting the pulmonary vasculature. This makes it particularly useful in managing patients with right heart failure, pulmonary hypertension, or pulmonary embolism (16, 17).</span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<ol start=\"4\" style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);font-weight: bold;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;\">Requirement for Cardiac Output Augmentation</span>**\n</li>\n</ol>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Need to Increase Both Cardiac Output and Blood Pressure:&#160;</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use Dopamine when both CO and BP need augmentation. Dopamine has dose-dependent effects, acting as an inotrope at low doses and as a vasoconstrictor at higher doses. It is particularly useful for patients who need increased CO with mild to moderate hypotension (18).</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Dose Considerations</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">:&#160;</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use low-dose dopamine (1-5 mcg/kg/min) for its dopaminergic and beta-1 effects, improving renal perfusion and CO. At higher doses (&gt;10 mcg/kg/min), dopamine stimulates alpha-1 receptors, leading to vasoconstriction and increased SVR (18, 19).</span>\n<ol start=\"5\" style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;\">Specific Clinical Situations</span>**\n</li>\n</ol>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Pregnancy and Epidurals</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">:&#160;</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">For pregnant patients undergoing epidural anesthesia, Ephedrine is often preferred for treating hypotension due to its favorable effects on uteroplacental blood flow. Phenylephrine can also be used, particularly if the patient has tachycardia, but careful monitoring is required to avoid excessive vasoconstriction, which may reduce uteroplacental perfusion (5).</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Anaphylactic Shock</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">:&#160;</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use Epinephrine for its combined alpha and beta receptor effects. Low doses promote bronchodilation and decrease vascular tone, while higher doses (&gt;10 mcg/min) provide generalized vasoconstriction (13).</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Cardiac Arrest</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">:&#160;</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Use Epinephrine for its potent vasoconstrictive and inotropic effects, crucial in advanced cardiovascular life support (ACLS) protocols. Epinephrine remains the pressor of choice during CPR due to its ability to increase coronary perfusion pressure (3, 12).</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Hypotension during Anesthesia</span>**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">:&#160;</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">For anesthesia-induced hypotension, use Phenylephrine or Ephedrine depending on heart rate. Phenylephrine is preferred in patients with tachycardia, while ephedrine is useful for hypotension with associated bradycardia (5).</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"></span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">Conclusion</span>**\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">The optimal vasopressor for intraoperative blood pressure control should be selected based on the patient&#39;s hemodynamic profile and the specific clinical scenario:</span>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 12pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Phenylephrine is ideal for hypotension due to vasodilation in patients with normal or high heart rates.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Ephedrine is preferred when hypotension is accompanied by bradycardia.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Norepinephrine is effective in severe hypotension, especially in septic shock, to increase SVR and maintain perfusion.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Dopamine can be used when both cardiac output and blood pressure need augmentation.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><span style=\"font-size: 11pt;\">Vasopressin is useful in cases of refractory hypotension unresponsive to catecholamines.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;\">Epinephrine is reserved for severe cases like anaphylaxis and cardiac arrest due to its potent effects.</span>\n</li>\n</ul>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">We must carefully consider individual patient factors, including comorbidities and the potential for side effects, to choose the most appropriate vasopressor agent. Continuous monitoring and dose adjustments are essential to achieve the desired hemodynamic goals while minimising adverse effects.</span>\n<p style=\"margin-top: 12pt;margin-bottom: 12pt;\"><span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\"></span>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">**<span style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">References</span>**\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\">\n<ol style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Lonjaret L, Lairez O, Minville V, Geeraerts T. Optimal perioperative management of arterial blood pressure. Integr Blood Press Control. 2014 Sep 12;7:49\u201359.&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Guarracino F, Bertini P. Perioperative hypotension: causes and remedies. J Anesth Analg Crit Care. 2022 Apr 14;2:17.&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Manson DK, Dzierba AL, Seitz KM, Brodie D. Running from a bear: how we teach vasopressors, adrenoreceptors, and shock. ATS Scholar. 2023 Jun;4(2):216\u201329.&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Cichon, C. Avengers as pressors, part 5/7: phenylephrine, or \u201cHawkeye,\u201d hangs at the periphery as the go-to push-dose pressor. Watch out or one of those arrows will neo-stick you. Available from: <a rel=\"noopener\" href=\"https://x.com/DocScribbles/status/1158371254128087040\">https://x.com/DocScribbles/status/1158371254128087040</a>&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Stein EJ, Glick DB. Autonomic nervous system. In: Pardo MC Jr, Miller RD, editors. Basics of anesthesia. 7th ed. Philadelphia (USA): Elsevier; 2018. p. 73-77.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Sessler DI [Internet]. Rochester (USA): Anesthesia Patient Safety Foundation; c2021. Perioperative hypotension; 2024 [cited 2024 Oct 3].&#160; Available from: <a rel=\"noopener\" href=\"https://www.apsf.org/article/perioperative-hypotension/\">https://www.apsf.org/article/perioperative-hypotension/</a></span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Richards E, Lopez MJ, Maani CV. Phenylephrine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Oct 1]. Available from: <a rel=\"noopener\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK534801/\">http://www.ncbi.nlm.nih.gov/books/NBK534801/</a></span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Therapeutic Goods Administration (TGA). AusPAR: Ephedrine hydrochloride MYX - mayne pharma international pty ltd. PM-2015-01131-1-3. Canberra (AUS): Department of Health; 2017 Jun 22 [cited 2024 Oct 3]</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Ellender TJ, Skinner JC. The use of vasopressors and inotropes in the emergency medical treatment of shock. Emergency Medicine Clinics of North America. 2008 Aug 1;26(3):759\u201386.&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Cichon, C. Avengers as pressors, part 1/7: norepinephrine makes a great \u201cCaptain America\u201d as the typical first line pressor. Available from: <a rel=\"noopener\" href=\"https://x.com/DocScribbles/status/1156377634651033601\">https://x.com/DocScribbles/status/1156377634651033601</a>&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Smith MD, Maani CV. Norepinephrine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Oct 5]. Available from: <a rel=\"noopener\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK537259/\">http://www.ncbi.nlm.nih.gov/books/NBK537259/</a></span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Cichon, C. Avengers as pressors part 2/7: Epinephrine as \u201cIron Man,\u201d ready to swoop in during a crisis...and also a little bit of a show-off. Available from: <a rel=\"noopener\" href=\"https://x.com/DocScribbles/status/1157691332892061696\">https://x.com/DocScribbles/status/1157691332892061696</a>&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Panchal AR, Bartos JA, Caba&#241;as JG, Donnino MW, Drennan IR, Hirsch KG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020 Oct 20;142(16_suppl_2):S366\u2013468.&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Cichon, C. Avengers as pressors, part 4/7 (the real part 4): vasopressin as \u201cBucky Barnes,\u201d aka the winter soldier, aka cap\u2019s iconic sidekick. Typically 2nd line in septic shock, used as an adjunct to norepinephrine. Available from: <a rel=\"noopener\" href=\"https://x.com/DocScribbles/status/1158197148967555073\">https://x.com/DocScribbles/status/1158197148967555073</a></span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Demiselle J, Fage N, Radermacher P, Asfar P. Vasopressin and its analogues in shock states: a review. Annals of Intensive Care. 2020 Jan 22;10(1):9.&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Weingart S. EMCrit 382 \u2013 a deep dive on vasopressin: timing, push dose vaso and the vasopressin load test. In: EMCrit Blog [Internet]. ; August 23, 2024 [cited 2024 Oct 3]. Available from: <a rel=\"noopener\" href=\"https://emcrit.org/emcrit/vasopressin-deep-dive/\">https://emcrit.org/emcrit/vasopressin-deep-dive/</a></span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Park KS, Yoo KY. Role of vasopressin in current anesthetic practice. Korean J Anesthesiol. 2017;70(3):245.&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Kislitsina ON, Rich JD, Wilcox JE, Pham DT, Churyla A, Vorovich EB, et al. Shock \u2013 classification and pathophysiological principles of therapeutics. CCR. 2019 Mar 12;15(2):102\u201313.</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Ankravs M, Kowalski M, Fyfe R, Ingram R, Jones A, Trevillian S, et al. Safer Care Victoria. 2018 [cited 2024 Sep 29]. Dopamine | Safer Care Victoria. Available from: <a rel=\"noopener\" href=\"https://www.safercare.vic.gov.au/best-practice-improvement/clinical-guidance/critical/dopamine\">https://www.safercare.vic.gov.au/best-practice-improvement/clinical-guidance/critical/dopamine</a>&#160;</span>\n</li>\n<li style=\"font-size: 11pt;font-family: Arial, sans-serif;color: rgb(0, 0, 0);\">\n<p style=\"margin-top: 0pt;margin-bottom: 10pt;\"><span style=\"font-size: 11pt;\">Cichon, C. Low-dose dopamine as Bruce Banner and high-dose dopamine as the Hulk. Different effects at different strengths! Available from: <a rel=\"noopener\" href=\"https://x.com/DocScribbles/status/1158777210578202624\">https://x.com/DocScribbles/status/1158777210578202624</a>&#160;</span>\n</li>\n</ol>\n<p style=\"margin-top: 0pt;margin-bottom: 0pt;\"><br/><br/><br/>",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4792/ViewAttachment?fileId=445445",
                        "filename": "image_405090378111728183887426.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:09.668Z"
            },
            {
                "Author": "Ryan Smith",
                "Content": "This isn&#39;t an official reply, I just wanted to tip my cap to you in this textbook quality addition to our class.&#160; Kudos.&#160; Also I&#39;d like to order poster size glossy prints of your superheroes our block room, is that a thing?&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:09.668Z"
            },
            {
                "Author": "Meera Sathananthan",
                "Content": "Thanks Ryan, I really appreciate that! I definitely went overboard, hoping it\u2019s helpful for learning!<br/><br/>\nAs for the superhero prints, I found them on Twitter: <a rel=\"noopener\" href=\"https://x.com/docscribbles?s=21&amp;t=MaSlMutUpq95jBYjYqJmGQ\">https://x.com/docscribbles?s=21&amp;t=MaSlMutUpq95jBYjYqJmGQ</a>\nThis doc makes a lot of medical illustrations, they\u2019re definitely a fun way to cement some ideas. I feel like they would be perfect for a block room or a study or break room.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:09.669Z"
            },
            {
                "Author": "Adrian Harris",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Hi Meera! I also want to echo Ryan\u2019s sentiments and thank you for providing such amazing Avenger infographics on vasopressor choices for managing intraoperative blood pressure.&#160; Wow! I\u2019m a very visual learner and a huge Avengers fan as well so I really appreciate your post \u2013 it\u2019s certainly contributed to my learning! </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">I wanted to also add onto your fantastic information of intraoperative vasopressors, based a comment made by one of the AAs in the OR a few days ago.&#160; She commented on the ability, or sometimes the lack thereof, of vasopressors to reasonably control blood pressure in the absence of fluid management.&#160; </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Some of the data on intraoperative hypotension suggests that depending on the patient\u2019s condition preoperatively or the current condition intraoperatively, hypotension could be challenging to manage with vasopressors alone as a strategy (1).&#160; In cases of intraoperative hypotension, especially in post-spinal/neuraxial anesthesia patients, vasopressors may need to be supported with fluid administration prior to their use (2,3). </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">As you posted with the Avenger Hawkeye, the intraoperative administration of phenylephrine increases systemic vascular resistance (SVR) to help improve afterload and blood pressure but causes a reflex bradycardia with a minimal decrease in cardiac output (4). &#160;A very recent study of term, pregnant women undergoing elective caesarian section using spinal anesthesia suggests that those who were preloaded with a fluid bolus had a less of a drop in cardiac output which led to a lower overall amount of phenylephrine administration, compared to patients who only received maintenance fluids (3). &#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Without getting too off-topic into a whole other discussion on intraoperative hypotension management, there are some interesting suggestions in the literature around current pre-operative fluid restriction guidelines, one even potentially encouraging unrestricted fluid intake until 2hrs prior to surgery (5). This study proposed that along with liberally administered fluid bolus top-ups prior to surgery, intraoperatively hypotensive patients could be fluid-optimized and then subsequently managed with vasopressors (5).&#160; </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">While intraoperative hypotension has a multitude of causes and remedies, the evidence exists that use of both vasopressors and fluids could be considered as part of a multi-modal approach (5). &#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><img style=\"width: 163pt;height: 88pt;visibility: visible;\" src=\"/d2l/le/7298/discussions/posts/5810/ViewAttachment?fileId=470921\"/>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 8.0pt;font-family: Calibri, sans-serif;\">Figure 1. Management of perioperative hypotension (5)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Thanks again for the Avengers and their respective vasopressors!</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">1. Guarracino F, Bertini P. Perioperative hypotension: causes and remedies. J Anesth Analg Crit Care</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160;&#160;&#160;&#160;[Internet]. 2022 Apr [cited 2024 Oct 10];14:2-17. Available from:</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160;&#160; &#160;https://janesthanalgcritcare.biomedcentral.com/articles/10.1186/s44158-022-00045-8</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">2. Hofhuizen C, Lemson J, Snoeck M, Scheffer GJ. Spinal anesthesia-induced hypotension is caused</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160; &#160; by a </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">decrease in stroke volume in elderly patients. Local Reg Anesth [Internet]. 2019 Mar 4 [cited</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160; &#160; 2024 Oct </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">10];12:19-26. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404676</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">3. Buddeberg BS, Seeburger E, Blasi C, Bandschapp O, Palanisamy A, Girard T, et al. Is crystalloid</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160; &#160; co- </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">loading necessary to prevent spinal hypotension during elective cesarean delivery? a&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; randomized </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">double-blind trial. Intl J Obs Anesth [Internet]. 2023 Dec 13 [cited 2024 Oct 10] 58;&#160; &#160;</span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160; &#160; &#160; &#160; open access. </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Available from: https://www.obstetanesthesia.com/article/S0959-289X(23)00322-</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160; &#160; 9/fulltext</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">4. Lorenzo J. Sympathomimetics. In: Flood P, Rathmell JP, Urman RD, editors. Stoelting\u2019s</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160; &#160; pharmacology &amp; </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">physiology in anesthetic practice. 6th ed. Philadelphia: Wolters Kluwer; c2021. p.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160; &#160; 450-470.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">5. Miller TE, Myles PS. Perioperative fluid therapy for major surgery. Anesthesiology [Internet]. 2019</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160; &#160; May </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">[cited 2024 Oct 10];130:825-832. Available from:</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160;&#160; &#160;https://pubs.asahq.org/anesthesiology/article/130/5/825/18881/Perioperative-Fluid-Therapy-for-</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160;&#160;&#160; Major-Surgery</span>",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/5810/ViewAttachment?fileId=470921",
                        "filename": "image_32597302221728587155905.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:09.669Z"
            },
            {
                "Author": "Tenzing Choedar",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hi Meera, </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Thank you for this wonderful post on the choice of vasopressors for the management of intraoperative hypotension. The beautiful illustrations you chose to represent each pressors will definitely help many of us remember as I can see that most of us are visual learners here. You provided an exceptional foundational framework elucidating the distinct pharmacodynamic mechanisms of various vasopressors and their corresponding physiological ramifications, while also facilitating a nuanced understanding of the clinical contexts in which their administration is most appropriate. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">In conjunction with your preceding discussion, I fully concur with Adrian\u2019s insights regarding the administration of vasopressors in the absence of adequate fluid resuscitation. It is imperative to ensure that the circulatory &#39;reservoir&#39; is sufficiently replenished before deploying our beloved Avengers. As we have learned, the majority of anesthetic agents employed during general anesthesia induce vasodilation, either through direct action on vascular smooth muscle or by attenuating sympathetic nervous system activity. In addition, patients are fasting for more or at least 8 hours which could exacerbate our hemodynamics further with the use of GA. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">I also wanted to add on to this wonderful topic, the use of Methlylene Blue (MB) in the state of vasoplegia when all vasopressors have been maxed out intraoperatively or postoperatively. The reason why I wanted to talk about this medication is because I have only seen it used once in my ICU in three years and I thought this patient was going to die. He was a post liver transplant patient in my coronary ICU who was bed spaced during the covid pandemic. He was maxed out on norepinephrine, epinephrine and vasopressin and was still hypotensive. One of my CICU fellow recommended the use of MB and it worked. Even our staff attending at that time was baffled and had no idea about the use of MB. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">MB is primarily used to treat methemoglobinemia (FDA approved), a condition where Fe2+ of hemoglobin gets oxidized to Fe3+, reducing the oxygen-carrying capacity of hemoglobin leading to cyanosis and hypoxemia. However, it also has an off label use of vasopressor mainly due to its </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">capacity to inhibit the body&#39;s inflammatory response by reducing nitric oxide (NO) production via selective inhibition of the enzyme inducible nitric oxide synthase and endothelial nitric oxide synthase. It also prevents NO from activating soluble guanylate cyclase, a key enzyme in the pathway that leads to smooth muscle relaxation, thereby helping restore vascular tone (Bistas &amp; Sanghavi, 2023). Based on the current literature, MB is mainly used as a last resort to septic shock and vasoplegia refractory to catecholamines in liver transplant or cardiac surgeries.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">A case study reported by Fischer et al. (2010) used a loading dose of MB at 2mg/kg over 30 minutes followed by continuous infusion over 6 hours at 0.5mg/kg/h for a patient during liver transplant surgery after graft reperfusion because the patient became profoundly hypotensive and after having difficulty maintaining a MAP above 65mmhg with epinephrine, norepinephrine and vasopressin plus fluid resuscitation. Shortly after the administration of MB, there was a significant improvement in hemodynamics, enabling the gradual tapering and eventual discontinuation of all pressors. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Furthermore, in the same case report, they point out multiple studies that have shown therapeutic benefit with low side effect profile, whether given prophylactically or with refractory shock, including \u2013 fewer dependencies on the pressors, quicker wean off pressors and reduction in mortality rate. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Dosage guideline as per Uptodate Lexidrug (2024) for refractory distributive shock/vasoplegia: </span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Bolus 1 to 2 mg/kg once daily for up to 3 doses, if needed; administer over 15 minutes to 6 hours. </span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Continuous infusion (0.25 to 2 mg/kg/hour for up to 48 hours) after administration of the initial bolus dose. </span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Some adverse effect to note are bluish-green discoloration of the urine (resolves after discontinuation), increasing the risk of serotonin syndrome if combine with SSRIs, SNRIs, MAOI and TCI. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Ultimately, MB is seldom used and is not part of the routine standard of care and more studies needs to be done as there is paucity of information on the use of MB as first line therapy (Shanmugam, 2005). I think as an anesthesia assistant, it\u2019s important to know that there are more drugs to help with vasopressor therapy when standard of care medications fail to achieve hemodynamic stability, just like how I felt when caring for my patient who was very hypotensive despite all medical therapy. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Reference: </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Bistas, E., &amp; Sanghavi, D. K. (2023). Methylene blue. In <i>StatPearls</i>. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557593/</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Fischer, G. W., Bengtsson, Y., Scarola, S., &amp; Cohen, E. (2010). Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation. <i>Journal of Cardiothoracic and Vascular Anesthesia, 24</i>(3), 463-466. https://doi.org/10.1053/j.jvca.2008.07.015</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: black;background: white;\">Shanmugam, G. (2005). Vasoplegic syndrome\u2014the role of methylene blue. <i>European Journal of Cardio-Thoracis Surgery, 28</i>(5), 705-710. https://doi.org/10.1016/j.ejcts.2005.07.011</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">UpToDate Inc. (2024). Methlylene Blue. Lexi-Drugs, <i>UpToDate Lexidrug</i>. Retrieved October 10, 2024, https://online-lexi-com.uhn.idm.oclc.org/lco/action/doc/retrieve/docid/patch_f/7279?cesid=33y1FS0NmO3&amp;searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dmethylene%2Bblue%26t%3Dname%26acs%3Dtrue%26acq%3Dmethylene%2Bblue#</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:09.669Z"
            },
            {
                "Author": "Meera Sathananthan",
                "Content": "Hi Adrian and Tenzing,\nThank you both for your thoughtful contributions! I appreciate the discussion on optimizing fluid status\u2014it\u2019s such a key part of maximizing our arsenal of pressors.\nAdrian, your points about fluid administration and the study involving pregnant patients undergoing spinal anesthesia were really insightful. A timely fluid bolus can help minimize hypotensive episodes and lessen our reliance on pressors. While pressors can be effective, they might just be a Band-Aid fix if the underlying cause of hypotension is hypovolemia.\nTenzing, I found your insights on Methylene Blue (MB) particularly interesting! Thank you for sharing your personal experience - it adds a very unique perspective. That was very innovative thinking on that fellow&#39;s part! I have not yet encountered MB in my clinical experience and hadn\u2019t considered MB as a potential addition to our toolkit for managing vasoplegia, so your overview was really helpful. It\u2019s great to have options like this when traditional pressors don\u2019t quite cut it.\nThanks again for the great discussion! I initially wanted to explore the different causes of intraoperative hypotension, but there was so much to cover with vasopressors that I had to pivot. It\u2019s exciting to delve into these strategies together and enhance our holistic approach to management.\nSincerely,\nMeera",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:09.670Z"
            },
            {
                "Author": "Meera Sathananthan",
                "Content": "Hi all!<br/><br/>I came across a nice decision tree for diagnosing the cause of acute hypotension. As we mentioned, understanding the cause of a patient&#39;s intraoperative hypotension helps us determine the best course of action for optimal management, whether it is fluid resuscitation, vasopressor use, inotropic support or a combination of different techniques.<br/><br/><img src=\"/d2l/le/7298/discussions/posts/6454/ViewAttachment?fileId=472753\" style=\"max-width: 100%;\"/>\nFigure 1: Decision tree for diagnosing acute hypotension (1)<br/><br/>I thought it would be a nice quick flow chart to keep in mind when we come head to head with a hypotensive patient.&#160;<br/><br/>References<br/>1. Davis RP, Tremper KK. Anesthetic monitoring. In: Pardo MC Jr, editor. Miller&#39;s basics of anesthesia. 8th ed. Philadelphia: Elsevier; 2023. p. 351-382",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/6454/ViewAttachment?fileId=472753",
                        "filename": "Screenshot 2024-10-14 at 2.15.02\u202fpm.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:09.670Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Thanks everyone for your participation. I love all the visuals!<br/>Meera, an excellent summary of the different considerations in our choice of vasopressors, too!\nIntraoperative hypotension is very common in anesthesia. It can happen for various reasons, as all of you have alluded to. The most common cause of hypotension during surgery is the vasodilation effect of anesthetic drugs, along with pre-existing volume deficit from preoperative fasting. &#160;As Adrian suggested, giving a fluid bolus is the first step in managing this hypotension. If the patient is unresponsive to the fluid bolus, we should then treat it with vasopressors.&#160;\nAs Anesthesia Assistants, the vasopressors most commonly used to temporize hypotension are Phenylephrine and Ephedrine. &#160;In fact, these drugs are in our AA monitoring conscious sedation medical directives at the University Health Network, which allows us to administer them to patients right away. &#160;It will give us some time to diagnose the cause of hypotension, which is so important in its treatment. &#160;\nMeera has clearly explained that the choice between these two drugs mainly lies in the patient\u2019s heart rate. &#160;If the patient has a normal to high heart rate, I will give a 40 mcg IV bolus of Phenylephrine. &#160;If the patient has a lower heart rate, I will give a 5 \u2013 10 mg IV of Ephedrine. We always give Ephedrine in small boluses and never as an infusion, as mentioned by a couple of you, due to its potential for tachyphylaxis.\nWhen the patient\u2019s blood pressure is on the lower side pre-induction, we sometimes follow up with Phenylephrine right after administering our anesthetics in anticipation of their vasodilation effect. &#160;\nPatients who are treated with beta-blockers present a challenge in treating anesthesia-induced hypotension. &#160;Ephedrine may cause a more significant vasoconstriction effect but may be less effective in raising heart rate or cardiac output. &#160;Phenylephrine is usually avoided to prevent further reflex bradycardia.\nLastly, just a quick reminder that besides giving vasopressors in treating hypotension, don\u2019t forget to consider titrating the general anesthetics and treating any surgical-related disturbances.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:09.670Z"
            }
        ]
    },
    {
        "Thread Title": "Question 17",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/99/View",
        "Question": "<p>Question 17: From your experience, describe an adverse event resulting from any drug group covered in the pharmacology section.</p>",
        "Responses": [
            {
                "Author": "Deena Kurilsky",
                "Content": "<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><b><u><span style=\"font-size: 11pt;\">Adverse reaction to sedation with propofol:</span></u></b>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 11pt;\">A 72-year-old female came into the emergency department with a humorous fracture requiring a sedation for a closed reduction and realignment. Patient was previously healthy with no known drug allergies and an elevated BMI.</span>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><b><u><span style=\"font-size: 11pt;\">Events prior to the sedation:</span></u></b>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">On review of the patient\u2019s medical history, the patient\u2019s elevated BMI was a concern for potential risk of respiratory complications.</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">An airway assessment was completed. The patient had a good mouth opening and thyromental distance, good neck mobility and was classified as a mallampati class III. She denied any diagnosis of obstructive sleep apnea.</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">Baseline vitals were established, and pre-oxygenation was initiated via nasal prongs.</span></li>\n</ul>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><b><u><span style=\"font-size: 11pt;\">Procedural sedation:</span></u></b>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">The emergency physician administered a dose of fentanyl 25mcg for analgesia followed by a bolus of propofol of 50mg, after 1 minute the patient remained awake and alert.</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">A second bolus of 50mg of propofol was administered and shortly after the patient became drowsy with a reduced level of consciousness. Vitals remained stable.</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><b><u><span style=\"font-size: 11pt;\">Adverse Event:</span></u></b>\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">Approximately 2 minutes after the second bolus of propofol the patient began to exhibit a decreased respiratory effort and respiratory rate, SpO2 was 92%. The oxygen was increased from 4-6L and a jaw thrust was initiated to relieve any airway obstruction.</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">The blood pressure reading that followed indicated the patient was hypotensive. The patient now completely apneic began to desaturate. Bag-mask ventilation was initiated for a couple minutes, until regular respiratory efforts were maintained by the patient.</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">The patient\u2019s blood pressure remained labile, despite stimulation from the arm reduction. This required a bolus of phenylephrine 100mcg to normalize. No further sedation was required to finish the procedure. Within the following 10 minutes the patient was fully awake and alert, protecting their airway with stable vitals.</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><b><u><span style=\"font-size: 11pt;\">Key Observations:</span></u></b>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">Having an emergency plan for intervention in the case of an adverse reaction is important. In the sedation room we were prepared with oxygen equipment, suction, bag-valve mask, an oral airway and intubation equipment as well as phenylephrine available if needed.&#160;<br/><br/></span>\n<ul style=\"list-style-type: circle;margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">Phenylephrine is an alpha-1 agonist and potent peripheral vasoconstrictor; this makes it a very effective drug to treat hypotension (Pardo, 2022). In this case, the vasodilator effects of propofol were counteracted with phenylephrine to normalize the patient\u2019s blood pressure.<br/><br/></span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">An alternative medication to considered for hypotension during sedation is ephedrine. Ephedrine is a noncatecholamine sympathomimetic that acts at both alpha and beta receptors. Its effects on arterial blood pressure are useful in the hypotensive patient especially when accompanied by bradycardia. In this case, the patient\u2019s heart rate remained normal with only transient decreases in blood pressure (Pardo, 2022).<br/><br/></span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">If the analgesic effects had been prolonged or a larger dose of fentanyl had been administered, it may have been useful to have naloxone (narcan) available. Naloxone is an opioid antagonist used in the reversal of opioid-induced respiratory depression (Pardo, 2022). Had the synergistic respiratory depression of fentanyl and propofol lasted longer requiring prolonged manual ventilation, a dose of naloxone could have helped to reverse the effects quicker.<br/><br/></span></li>\n</ul>\n</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">Sedative selection is important when considering patients risk factors. I will discuss the medications used in this scenario and give insight into an alternative option.<br/><br/></span>\n<ul style=\"list-style-type: circle;margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">Propofol was administered alongside fentanyl. Propofol, a hypnotic agent with no analgesia, is often used in sedative procedures for its quick onset and short duration of action. Propofol is a known respiratory depressant with a narrow therapeutic range (Pardo, 2022). During this sedation, the bolus of propofol caused a decrease in tidal volume and respiratory rate and ultimately an apneic event. The hypotensive episode was caused by the vasodilatory effects that propofol has on the arterial and venous circulation, this required the use of phenylephrine as an intervention to normalize the blood pressure. (Pardo, 2022). An alternative sedative to consider in the future for this patient is ketamine. Ketamine has analgesic properties, but it also maintains respiratory drive as well as the upper airway and is more hemodynamically stable (Pardo, 2022). This would make it a safer option for an elderly patient with a large BMI that obstructs easily with sedation.</span></li>\n</ul>\n</li>\n</ul>\n<p style=\"margin: 0cm 0cm 0cm 72pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<ul style=\"margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">The following are additional adjuncts to therapy that could have been beneficial.<br/><br/></span>\n<ul style=\"list-style-type: circle;margin-top: 0px;margin-bottom: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">High flow oxygen therapy, as an alternative to nasal prongs. The higher flows and resulting dead space washout help to maintain oxygenation during prolonged periods of apnea. In turn, decreasing the likelihood and need for manual ventilation.<br/><br/></span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11pt;\">Use of end-tidal CO2 nasal prongs can provide earlier warning signs of respiratory depression before the onset of a hypoxic event. In the study published by Deitch et al. (2010) capnography decreased the rate of hypoxic events associated with propofol sedation and improved patient safety.</span></li>\n</ul>\n</li>\n</ul>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><b><span style=\"font-size: 11pt;\"></span></b>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><b><span style=\"font-size: 11pt;\"><br/>References:</span></b>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-size: 11pt;\">Deitch, K., Miner, J., Chudnofsky, C. R., Dominici, P., &amp; Latta, D. (2010). Does end tidal CO2 monitoring during emergency department procedural sedation and analgesia with propofol decrease the incidence of hypoxic events? A randomized, controlled trial.&#160;<i>Annals of Emergency Medicine,</i>&#160;<i>55</i>(3), 258-264. 10.1016/j.annemergmed.2009.07.030</span>\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 11pt;\">Pardo, M. C., Jr. (Ed). (2022).&#160;<i>Miller\u2019s basics of anesthesia</i>&#160;(8<sup>th</sup>&#160;ed.). Elsevier</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.675Z"
            },
            {
                "Author": "Janet Rozek",
                "Content": "Deena, great review of a real case!\nSounds like you did everything you could with the information you had regarding, patients age, anesthetic needs, and approach.&#160;\nI agree with your suggestions for therapy including:\n<ul>\n<li>&#160;-the use of ephedrine for the hypotension</li>\n<li>monitoring end tidal CO2 with nasal prongs and supplemental oxygen</li>\n</ul>\nHere is a little example from my experience:\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">Many years ago, I recall working in the OR during the start of a cesarean section for failure to progress. The patient had an epidural insitu for her labour so anesthesia decided to load the epidural with lidocaine and epimorph to optimize block for surgery.&#160; Within 10-15 minutes after bolus of medication, the patient was experiencing signs and symptoms of a High regional block. The patients signs and symptoms included severe hypotension, weakness and numbness in arms, patient was feeling very short of breathe and having some sedation effects. Anesthesia quickly identified the urgency and the Anesthesiologist and I were able to act quickly and safely. The surgery had begun, so baby was being delivered imminently, patient was needing &#160;oxygen and bag mask ventilation to assist her breathing. Patient needed rapid IV fluids and a phenylephrine infusion to help support her blood pressure. We continued to manually bag patient with CO2 monitoring throughout case, all emergency intubation drugs and equipment was prepped and ready in case of any further decline of patient. Uterus was already displaced in the start of the case to ensure proper blood flow to mom and baby. In this case the patient did not decline any further, by the end of the case patient was starting to become more alert and oriented to where she was.&#160; Patient did not become bradycardic and did not require intubation. Overall, patient was stabilized in the operating room before going to recovery room with her baby.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.676Z"
            },
            {
                "Author": "Deena Kurilsky",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Thank you for sharing this experience in the operating room during a cesarian section. Early recognition of the signs and symptoms of a high regional block was vital in managing this situation. I wonder if the baby had not been delivered when the phenylephrine infusion was initiated if a different vasopressor such as ephedrine or norepinephrine may have been used instead?\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">I have not had experience with a high or complete spinal block, so I wanted to add some information collected from an article.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Patients will experience symptoms based on the level of the anesthetic spread. Hypotension and bradycardia can result from vasodilation and reduced venous return. Once the abdominal and intercostal muscles are blocked the patient will experience shortness of breath and may feel numbness or weakness as you stated in their upper body.&#160;&#160;Respiratory arrest will occur if the diaphragm is paralysed leading to loss of consciousness and further decline. Supportive care in the form of supplemental oxygen and intubation if needed, as well as fluids with vasopressors to support the maternal blood pressure is important as the pregnant woman cannot withstand prolonged hypotension or hypoxia without damage to herself and the infant (Asfaw et al, 2020)&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Early recognition of these symptoms is important and changing the position of the patient can affect the progression of the block. If the patient has a progressing high spinal that has not progressed to a total spinal. it is not recommended to place the patient in the Trendelenburg position. Placing in the Trendelenburg position will result in a higher block and could progress to a total spinal (Asfaw et al, 2020)\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Asfaw, G., &amp; Eshetie, A. (2020). A case of total spinal anesthesia.&#160;<i>International journal of surgery case reports.</i>76, 237\u2013239. http://doi.org/10.1016%2Fj.ijscr.2020.09.177",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.677Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Thanks, Deena and Janet, for sharing your experience. This is the best way to draw connections between theories and practice.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">In both cases, I agree with the use of Phenylephrine and capnography monitoring. Phenylephrine is our first choice of pressor to temper hypotension without bradycardia. If the patient also presents bradycardia, we can use Ephedrine as it will increase both blood pressure and heart rate. Regarding capnography, it is a required monitoring for any type of anesthesia. As anesthesia assistants, we always use capnography not only for general and regional anesthesia but also for procedural sedation.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">I also want to share an adverse event that happened a couple of years ago. &#160;It was a case of a full-blown anaphylactic reaction to Rocuronium in a living-related liver donor, right after induction. &#160;We ended up canceling the case (and also the living-related liver recipient\u2019s case) and sent the patient intubated to the intensive care unit.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">When we have an allergic reaction in the operating room (OR), the triggers that first come to my mind are latex, antibiotics, and muscle relaxants. We don&#39;t have a lot of latex-containing equipment/supplies in the OR nowadays. &#160;In anesthesia, I can only think of the sterile gloves and the pulmonary artery catheter containing latex. &#160;It is always important to remind the surgical team to change to non-latex sterile gloves during anaphylaxis. &#160;Regarding muscle relaxants, Succinylcholine is the most common offender, and Rocuronium is also identified as producing an increased risk as a triggering agent in the non-depolarizing class, even though it does not release histamine.</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.677Z"
            },
            {
                "Author": "Dan Chen",
                "Content": "Thank you for the insightful story, Deena. You\u2019ve provided a comprehensive account of how propofol, despite its efficacy, can present challenges with respiratory and hemodynamic stability, especially in elderly patients with elevated BMIs. Your proactive management of these complications\u2014utilizing phenylephrine for hypotension and bag-mask ventilation for apnea\u2014really highlights the importance of being well-prepared for potential sedation-related complications.\nTo further elaborate on your alternative option of ketamine, it not only presents a safer choice for elderly patients with higher BMIs but also shows significant advantages for pediatric populations. At SickKids Emergency, ketamine is the first-choice drug for conscious sedation, and we rigorously monitor end-tidal CO2 with nasal prongs and provide supplemental oxygen to ensure safety.\nKetamine&#39;s unique pharmacologic properties make it highly suitable for conscious sedation. As a nonbarbiturate phencyclidine derivative, ketamine creates a &quot;dissociative sedation&quot; rather than typical conscious sedation. This dissociative state provides profound analgesia, amnesia, and preservation of protective airway reflexes, along with cardiopulmonary stability (Mistry &amp; Nahata, 2005).\nKetamine\u2019s ability to preserve spontaneous respirations and its hemodynamic stability (due to its indirect sympathomimetic effect) make it especially valuable for patients with compromised cardiovascular or respiratory function. However, it\u2019s essential to consider potential complications such as increased salivary secretions and emergence phenomena, which can be managed with the coadministration of anticholinergics and benzodiazepines (Mistry &amp; Nahata, 2005).\nEmergence phenomena are a well-known side effect of ketamine sedation, particularly noticeable during the recovery phase. These effects include vivid dreams, hallucinations, a floating sensation, delirium, agitation, and feelings of unease or discomfort (dysphoria). Ketamine&#39;s strong sedative properties can disrupt sensory processing in the brain, leading to these unsettling mental experiences after sedation.&#160;Certain groups, such as patients over 16 years of age and females, are more prone to experiencing these phenomena. The cause is believed to be ketamine&#39;s interference with auditory and visual pathways, resulting in misinterpretation of sensory inputs. This creates a dissociative state where reality can seem distorted, often manifesting as confusing or frightening experiences (Mistry &amp; Nahata, 2005).\nIn my experience working with patients who have undergone ketamine sedation, I\u2019ve seen firsthand how emergence phenomena not only cause discomfort for the child but also create distress for parents or caregivers who witness their child in this state. It\u2019s important to manage these effects carefully, not just for the patient\u2019s well-being but also for the peace of mind of those around them. Administering a benzodiazepine like midazolam or diazepam alongside ketamine can help mitigate these effects by reducing the severity of hallucinations and agitation, making the recovery process smoother (Mistry &amp; Nahata, 2005).\nReference:\nMistry, R. B., &amp; Nahata, M. C. (2005). Ketamine: A novel agent for pediatric sedation. _Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy_, _25_(8), 1104-1114. <a rel=\"noopener\" target=\"_new\">https://doi.org/10.1592/phco.2005.25.8.1104</a>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.677Z"
            },
            {
                "Author": "Deena Kurilsky",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Thank you for sharing your insights, Dan. Your approach to managing emergence phenomena with benzodiazepines for patient comfort is very important. I haven\u2019t worked with pediatrics in a while, but I\u2019m curious about your experience. Have you observed any changes in the duration of action or time to awakening in children who receive both ketamine and benzodiazepines together?\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Reflecting on my clinical experience, I was reminded of the use of ketamine for dental sedations at Mount Sinai. We conduct a weekly dental clinic in the operating room specifically for developmentally delayed patients requiring a general anesthetia, many of whom are non-verbal and can sometimes be quite combative. This makes it extremely challenging to gain their cooperation for intravenous insertions, which can be traumatic for both the patients and their caregivers. Using oral ketamine as a pathway to an inhaled induction for general anesthesia has proven to be effective, resulting in a better experience for both the patient and their caregivers. Ketamine proves to be very versatile in vulnerable populations.&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.678Z"
            },
            {
                "Author": "Kelly Gram",
                "Content": "Janet, very interesting case with the high regional block. I was working in ortho today and I assisted the anesthesiologist with a spinal which she used bupivicaine mixed with epimorph. This triggered a very interesting discussion regarding the risk of respiratory depression specifically with the use of epimorph. I learned today that whenever a patient is given epimorph, the standard of care is to monitor the patient very closely, usually APS follows, in hospital for at least 24 hours post administration as it is known to produce biphasic respiratory depression. This is because morphine is not metabolized in the CSF thus has prolonged activity at the receptor site.&#160; It must be absorbed into plasma before being metabolized and excreted.&#160; Although spinal vs epidural epimorph differs in terms of dosage and absorption, your post had me question whether this mom would have been at risk for a secondary phase respiratory depression? This prompted me to look up the mechanism for why the risk of respiratory depression can be so delayed specifically when given intrathecally.&#160; I found this article that explains that intrathecal epimorph can cause respiratory depression by way of rostral spread and slow penetration into the brainstem. This supra spinal redistribution of morphine leads to delayed activation of \u03bc-opioid receptors on the medulla that are responsible for the second phase or delayed respiratory depression that can happen up to 24 hours post administration. Even though the concentration of epimorph would be reduced over time, these \u03bc-opioid receptors are very sensitive to epimorph. Thankfully the second of the two phases of respiratory depression is generally less pronounced likely due to lower CSF drug concentrations but when it happens overnight in a low monitoring environment, the results could be catastrophic.&#160;\nSultan, P., Gutierrez, M.C. &amp; Carvalho, B. Neuraxial Morphine and Respiratory Depression.&#160;_Drugs_&#160;**71**, 1807\u20131819 (2011). <a rel=\"noopener\" href=\"https://doi.org/10.2165/11596250-000000000-00000\">https://doi.org/10.2165/11596250-000000000-00000</a>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.678Z"
            },
            {
                "Author": "Ryan Smith",
                "Content": "Deena\nThank you for the reminder that one of the pillars of anesthesia, propofol, with a relatively good safety profile and proliferative use still needs to be handled with caution and vigilance.\nI&#39;m reminded of a reduction in the trauma bay I will never forget and have passed on to many colleagues and students:\n<ul>\n<li>55 male involved in a motorcycle MVC</li>\n<li>Significant trunk road rash, broken ribs, small pnuemothorax and a closed femur fracture (standard fair in my beloved trauma room).</li>\n</ul>\nThe patient was treated with fentanyl by EMS and remained very stable through initial assessment, GCS 15 and pleasant throughout.&#160; An initial reduction of the femur was to be performed in the trauma bay before heading to CT scan (again standard fare).&#160; Induction dose for the femur reduction was 120mg ketamine (he was a large gentleman).&#160; Within 20 seconds the patient went into the most impressive trismus I have ever witnessed, and upper body rigidty, abdominal rectus rigidty and obviously apnea.&#160; Unfortunately it was COVID era within &quot;minimal staffing&quot; in our enclosed trauma bay (anesthesia was outside the see through doors at the head of a bed with the passenger of the MVC).&#160; We yelled for any available paralytic and it took aprx 60 seconds to draw it up and hand it into the room.&#160; The rocuronium was given and a further 60 seconds was needed before I could finally bag mask ventilate the patient.&#160; The desaturation was significant with concomitant bradycardia however CPR was never indicated (barely).&#160; The patient was intubated and recovered without any apparent neurological deficit.&#160; &#160;&#160;\nThe event drastically heightened my awareness of the potential dangers of the ever more popular Ketamine and the absolute necessity of having a NMB very close at hand for inductions.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.678Z"
            },
            {
                "Author": "Tenzing Choedar",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hi Deena and everyone else that contributed to this discussion post, </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Thank you for sharing your insights and reminding us that, even with a comprehensive understanding of the pharmacodynamics of anesthetic agents, adverse effects can still occur. This underscores the fact that, despite adherence to established guidelines and protocols, individual patient responses to medications can vary significantly. It highlights the critical importance of preoperative assessment and being prepared for any potential emergency, regardless of the controlled nature of the clinical setting. I am starting to appreciate Phoebe\u2019s favorite quote by Benjamin Franklin, \u201cBy failing to prepare, you are preparing to fail\u201d even more now. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">One key lesson I\u2019ve learned from my limited experience in the Cardiac Catheterization Lab and Coronary ICU is that managing procedural or deep sedation can be far more challenging than managing general anesthesia. With general anesthesia, the airway is already secured through tracheal intubation, allowing the focus to shift to maintaining hemodynamics and ensuring adequate sedation. In contrast, procedural sedation requires constant vigilance over both airway management and the patient\u2019s hemodynamic stability, making it a more complex balancing act. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">I\u2019d like to share one event that sort of made me dislike the medication dexmedetomidine. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">I had a patient who was undergoing a percutaneous transcatheter aortic valve replacement (TAVI) under conscious sedation with local anesthetic. This elderly patient from what I remember did not have any underlying renal or hepatic disease. His LV function was normal although with hypertrophic concentric remodeling due to chronic systolic overload from aortic stenosis. I was the circulating RN and the anesthesia fellow chose his conscious sedation strategy with a bolus of fentanyl and dexmedetomidine followed by dexmedetomidine infusion (1-1.5mcg/kg/h). The procedure which normally last about 45 minutes to an hour lasted about two hours due to a minor vascular complication which required me to hold the groin on the operating table for good 15 minutes. We transferred the patient over to the recovery unit without any problem and his blood pressure on the arterial line was reading around 90/60mmhg. Everything seemed fine and we handed the patient over to the recovery RN. He was mentating fine although a bit drowsy, GCS 14. After 30 minutes, I was called by the recovery RN and informed me that the patient\u2019s BP is slow to rise with lowest around 70/40 and HR in the 50s, and continued to stay around that region. We ruled out all the possible causes - bleed, tamponade, stroke, valve dislodgment etc. Nothing obvious noted on POCUS of the heart. One common complication of TAVI is the widening of QRS and the high chance of going into complete heart block. Pt\u2019s ECG was within baseline from pre-tavi although more brady. Ultimately, we decided it was probably the dexmedetomidine and the decision was made to start levophed infusion and transfer to CICU for monitoring.&#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">As great of a drug dexmedetomidine is\u2014providing analgesic and sedative effect without respiratory depression, one must remember that it is a sympatholytic agent that can cause bradycardia and hypotension (Bokoch &amp; Su, 2023). Furthermore, the elimination half time is 2 to 3 hours (Rathmell &amp; Dahan, 2022). Iirola et al. (2012) conducted a study to assess the pharmacokinetic profile of dexmedetomidine in critically ill patients requiring infusion longer than 48 hours. They found that pharmacokinetics of dexmedetomidine after long-term infusion remained consistent with those observed in shorter-term studies. However, elderly patients experience reduced drug clearance, and those with low plasma albumin levels have an increased volume of distribution, </span><img hspace=\"12\" align=\"left\" height=\"252\" width=\"254\" src=\"/d2l/le/7298/discussions/posts/5899/ViewAttachment?fileId=472493\"/><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">both of which contribute to a prolonged elimination half-life. We learned from Rathmell &amp; Dahan (2022) that dexmedetomidine is highly protein bound (&gt;90%). </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Therefore, in my case, Dexmedetomidine was probably the culprit due to the continuous infusion for two hours increasing the context sensitive half time and providing sympatholytic effects leading to hypotension and bradycardia. Perhaps my patient also had low albumin levels which contributed to its pharmacodynamic effects. Perhaps this </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">patient was also more dependent on HR for cardiac output as patients with hypertrophy of the LV can have reduced diastolic filling volume. Whatever the reason is, I have grown to be more cautious with this medication because it has happened multiple times in the cathlab recovery unit as well as in my ICU. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Reference:&#160;</span>\n<p style=\"margin-left: 36pt;text-indent: -36pt;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"color: #333333;\">Iirola, T., Ihmsen, H., Laitio, R., Kentala, E., Aantaa, R., Kurvinen, J., Scheinin, M., Schwilden, H., Sch&#252;ttler, J., &amp; Olkkola, K. T. (2012). Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.<span class=\"apple-converted-space\"><i>&#160;</i></span><i>British Journal of Anaesthesia: BJA,<span class=\"apple-converted-space\">&#160;</span>108</i>(3), 460-468.<span class=\"apple-converted-space\">&#160;</span>https://doi.org/10.1093/bja/aer441</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #333333;\">Bokoch, M. P., &amp; Su, P. P. (2023). Intravenous anesthetics. In M. C. Pardo (Ed.), <i>Miller\u2019s basics of anesthesia</i> (8th ed., pp. 107-124). Elsevier.</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Rathmell, J. P., &amp; Dahan, A. (2022). Intravenous sedatives and hypnotics. In P. Flood, J. P. Rathmell, &amp; R. D. Urman (Eds.), <i>Stoelting&#39;s pharmacology and physiology in Anesthetic Practice</i> (6th ed., pp. 206-245). Wolters Kluwer.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">Cheers,&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">Tenzing&#160;",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/5899/ViewAttachment?fileId=472493",
                        "filename": "image_78069686421728630743464.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:14.679Z"
            },
            {
                "Author": "Deena Kurilsky",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Hi Tenzing &amp; Ryan\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Tenzing, thank you for sharing your clinical experience with dexmedetomidine in the cardiac cath lab. I appreciate the time you took to talk about the pharmokinetics of dexmedetomidine including its advantages and disadvantages.&#160;&#160;Your experience really highlighted the complexity of using sedatives especially in elderly patients with specific cardiac issues.&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Given my limited experience with cardiac patients, I\u2019m interested in your insights. What types of sedation are you typically used to seeing used in the cardiac cath lab?\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Ryan, thank you for the reminder of the potential risks associated with ketamine. Your experience really highlighted the unpredictability of patient-drug reactions and the necessity of being prepared to handle complications during induction.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Thank you for your posts!",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:14.679Z"
            }
        ]
    },
    {
        "Thread Title": "Question 18",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/98/View",
        "Question": "<p>Question 18: Which types of drugs should be continued preoperatively? Which types of drugs should be discontinued preoperatively?</p>",
        "Responses": [
            {
                "Author": "Shawn Page",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">MEDICATIONS TO DISCONTINUE</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Something interesting came up in the research for this assignment. The use os herbal supplements kept coming up.&#160; Many popular supplements kept reappearing. </span>\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\" style=\"border-collapse: collapse;border: none;\">\n<tbody>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Name</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Perioperative effects</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Recommendations</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Echinacea</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Hepatotoxicity, interference with immune suppressive therapy (ie. Organ transplants)</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Discontinue as far in advance as possible</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Ephedra</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Ephedrine like SNS stimulation with increased HR, increased BP, dysrhythmias, MI, CVA</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Discontinue at least 24 hours pre Sx</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Ginkgo</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Inhibits platelet aggregation factor</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Discontinue at least 7 days prior (irreversible)</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Ginseng</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Hypoglycemia, inhibition of platelet aggregation and coagulation cascade</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Discontinue at least 7 days prior Sx</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Kava</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">GABA-mediated hypnotic effect and may decrease MAC</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Discontinue at least 24 hours prior Sx</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">St. John\u2019s Wart</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Inhibits serotonin, norepi and dopamine reuptake by neurons</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Discontinue at least 5 days prior</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Valerian</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">GABA -mediated hypnotic effects, may decrease MAC, benzodiazepine like withdrawl symptoms</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Taper dose weeks before Sx</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 155.8pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">(Morgan, G., 2002)</span>\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n<td valign=\"top\" style=\"width: 155.85pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Antiplatelets</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Antiplatelets ie. ASA, clopidogrel are often prescribed in the treatment for primary and secondary MI prevention (Urology, D.,2009). Platelet primary function is to stop hemorrhage after trauma or vascular injury.&#160; ASA is the most common antiplatelet prescribed, and it works by irreversibly inactivating the COX-1 enzyme, and as a result the pathway for thromboxane A2 synthesis is blocked.&#160; Since this is a potent platelet aggregator (as well as a vasoconstrictor), the bodies ability to develop clots is lost.&#160; (Urology, D., 2009)</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">ASA begins to act within 30 mins of administration and it\u2019s effects are irreversible.&#160; The average lifespan of a platelet is 8-10 days.&#160; If ASA is abruptly discontinued a rebound effect may occur.&#160; The intended therapy is no longer being provided but also an abnormally high level of thromboxane A@ occurs which increases a patients risk or cardiac events, TIS/CVA, and death. If intra-op bleeding occurs the patient should be treated with tranexamic acid (TXA), as well as a platelet infusion (Urology, D. 2009)&#160; A prophylactic dose of TXA may also be given intra-op. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">ACE Inhibitors</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">The renin-angiotensin-aldosterone system (RAAS) is important to target in the treatment for hypertension.&#160; ACE inhibitors block the conversion of angiotensin 1 into 2. Angiotensin 2 acts to narrow blood vessels, therefore it can increase blood pressure (Salim, F., 2020)</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">A 2019 study found that patients who use ACE inhibitors have a possibility of hypotension intraoperatively, especially within the first 30 mins of the procedure (Salin, F. 2020), however the still remains great debate about if and when to stop these pre-operatively.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">MEDICATIONS TO CONTINUE</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Beta Blockers</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Beta blockers are an important tool&#160; in preventing arrythmias.&#160; The discontinuation of these greatly increases a patients chance of developing an arrythmia, therefore they should no, and are safe not to stop.&#160; Beat blockers block the effect of epinephrine to maintain heart rate.&#160; Practitioners need to be aware if a patient is on this, and the HR may not increase in cases of shock, or painful stimuli.&#160; The also have the heart contract with less force, and it also acts as a vasodilator. There should be no interaction with anesthetic agents, or common intra-op medications so they are safe to continue (Irizarry-Alvarado, J., 2017).</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Insulin</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Stress from surgery and anesthesia increases the secretion of counterregulatory hormones ie. Glucagon.&#160; This process decreases insulin secretion and peripheral glucose utilization, and also increases insulin resistance (Dogra, P. 2024).&#160; Uncontrolled hyperglycemia introperatively in creases production of pro-inflammatory cytokines (Dogra, P. 2024).&#160; Patients are NPO for surgery so glucose monitoring is essential.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Long acting insulin should be decreased by 20-25% the evening before. Intermediate acting insulin, the patient should take their usual dose the night before, but decrease the dose by 50% the morning of surgery.&#160; This being said, institutions should create their own sliding-scale for insulin dosages.&#160; Critically ill diabetic patients should have an insulin drip intra-operatively (Dogra, P., 2024).</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Dogra P, Anastasopoulou C, Jialal I. Diabetic Perioperative Management. [Updated 2024 Jan 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK540965/</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Irizarry-Alvarado, J. (2017). Perioperative management of beta blockers and other antiarrhythmic medications. Current clinical pharmacology. https://pubmed.ncbi.nlm.nih.gov/28847276/</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Morgan, J., G. Edward, Mikhail, M. S., &amp; Murray, M. J. (2002). Clinical anesthesiology (3rd ed.). Lange.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Salim, F., Khan, F., Nasir, M., Ali, R., Iqbal, A., &amp; Raza, A. (2020, January 9). Frequency of intraoperative hypotension after the induction of anesthesia in hypertensive patients with preoperative angiotensin-converting enzyme inhibitors. Cureus. https://doi.org/10.7759%2Fcureus.6614</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;line-height: 107%;font-family: &#39;Times New Roman&#39;, serif;\">Urology, D. of. (2009). Antiplatelet drugs and the perioperative period: What every ...\u202f: Indian Journal of Urology. LWW. https://doi.org/10.4103%2F0970-1591.56174</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:19.681Z"
            },
            {
                "Author": "Teresa Nguyen",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Hi Shawn,</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Thank you for your insightful response. I found it interesting that you also included herbs and naturopathic medicine as these can be important considerations for pre-operative patients. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">In your answer, one of the medications to discontinue pre-operatively included acetylsalicylic acid (ASA). However, you also stated that abrupt discontinuation may cause a rebound effect and the intended therapy is no longer present. My question is, can you further explain what the rebound effect entails? If a patient requires surgery and must stop receiving ASA, what interventions would be done to address the rebound effect? &#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">A study by Maulaz et al. (2005) states that discontinuing aspirin therapy may increase risk of ischemic stroke in patients who have several cardiovascular risk factors. Withholding antiplatelet therapy pre-operatively in patients with ischemic heart disease may not always be beneficial (Maulaz, 2005). </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">I would also like to share some insight on another category of medications. Patients receiving psychotropic medications are generally instructed to continue treatment: antidepressants, selective serotonin reuptake inhibitors (SSRI), and antipsychotic medications (Karunarathna, n.d.). Abrupt cessation may lead to withdrawal symptoms and exacerbate psychiatric conditions (Karunarathna, n.d.). Additionally, monoamine oxidase inhibitors (MAOIs) should be stopped two weeks before anesthesia, as they can interact with anesthetics, potentially causing hypertensive crisis (Karunarathna, n.d.). Lithium should also be stopped 72 hours prior to surgery to avoid lithium toxicity or interference with anesthetics (Karunarathna, n.d.).</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">References</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Karunarathna, I., Bandara, S., Jayawardana, A., De Alvis, K., Gunasena, P., Hapuarachchi, T., </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;padding-left: 40px;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Ekanayake, U., Rajapaksha, S., Gunawardana, K., Aluthge, P., &amp; Gunathilake, </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">S. (n.d.). Pre-operative medication management: adjusting psychotropic and antiplatelet therapies for surgical patients.&#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Maulaz, A.B., Bezerra, D.C., Michel, P., &amp; Bogousslavsky, J. (2005). Effect of discontinuing aspirin </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;padding-left: 40px;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">therapy on the risk of brain ischemic stroke.&#160;<i>Arch Neurol, 62</i>(8), 1217-1220.&#160; </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">doi:10.1001/archneur.62.8.1217</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:19.682Z"
            },
            {
                "Author": "Minna Jin",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: black;\">Hi Shawn,&#160;</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Thank you for your detailed breakdown of both herbal supplements and conventional medicines. It is interesting to see how herbal supplements interact with some conventional medicines. </span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Among these medications, I am particularly interested in the protocols related to insulin therapy preoperatively. Thank you for illustrating the different guidelines around preoperative adjustments for long-acting and intermediate-acting insulin. I am also curious about whether the management of insulin therapy would differ for patients with type 1 diabetes versus those with type 2 diabetes preoperatively. Apparently, patients with type 1 diabetes must continue receiving basal insulin even while fasting to prevent the development of diabetic ketoacidosis (DKA) and hyperglycemia (Sreedharan et al., 2023). Other than that, the preoperative adjustment of different types of insulin slightly differs between type 1 and type 2 diabetes. As you mentioned, long-acting insulin should be reduced by 25% the evening before surgery. However, short-acting insulin should be withheld on the morning of surgery for type 2 diabetes, while correctional rapid-acting insulin can be given to treat hyperglycemia in type 1 diabetes (Pardo, 2023). Despite the protocols, the management of insulin therapy should always be based on patients\u2019 blood glucose levels.&#160;</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Sreedharan, R., Khanna, S., &amp; Shaw, A. (2023). Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery.&#160;<i>Perioperative Medicine</i>,&#160;<i>12</i>(13).<span style=\"color: black;\">&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1186/s13741-023-00291-w\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\"><span style=\"color: black;\">https://doi.org/10.1186/s13741-023-00291-w</span></a></span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt 36pt;line-height: 18.4px;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Pardo, M. C. (2023). Preoperative evaluation. In M. C. Pardo (Ed.),&#160;<i>Miller\u2019s basics of anesthesia</i>&#160;(8<sup>th</sup>&#160;ed., pp. 195-220). Elsevier.</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:19.682Z"
            },
            {
                "Author": "Kurt Protacio",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Thanks Shawn for the information regarding what to continue and discontinue preoperatively. I found it very refreshing as I am familiar with some of the drugs. As a nurse who works in Coronary Intensive Care, we often see physicians ordering to hold antiplatelets such as Clopedigrel (Plavix) five days before surgery, and/or anticoagulants such as Warfarin at least five days before cardiovascular surgery, or bridging to intravenous Heparin, which is shorter-acting and can be stopped an hour before surgery (depending on the policies of the institution). Acetylsalicylic acid (Aspirin) is an interesting one; it really depends on the situation. During emergent, life-threatening situations such as a ST elevation myocardial infarction (STEMI), Aspirin is given in bolus doses to combat platelet aggregation in the blocked arteries, and in some cases, the patient may need urgent coronary artery bypass grafting (CABG). The bleeding risk does not outweigh the benefit in these circumstances, and vice versa if patients are without coronary artery disease (CAD) (Prabhakaran &amp; Whinney, 2019).</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Theresa, the rebound effect that Shawn is referring to explains that the abrupt cessation of drugs like aspirin can lead to an increased risk of ischemic events such has MIs and strokes in patients with a history of CAD due to the increased platelet production and aggregation in the body (Ferrandis et al., 2009). Most cardiac patients with coronary stents are on both Aspirin and Plavix. We can attempt to avoid the rebound effect by discontinuing Clopidegrel at least 5 days before surgery and use a low-dose aspirin preoperatively to avoid risk of ischemic events (Ferrandis et al., 2009).</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Here&#39;s an algorithm suggested by the Prabhakaran &amp; Whinney (2019) in the Cleveland Clinic Journal of Medicine that outlines the use of antiplatelet therapy depending on the situation:</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><img src=\"/d2l/le/7298/discussions/posts/5519/ViewAttachment?fileId=468872\" style=\"max-width: 100%;\"/>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">References:</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Ferrandis, R., Llau, J., &amp; Mugarra, A. (2009). Perioperative Management of Antiplatelet-Drugs in Cardiac Surgery. <i>Current Cardiology Reviews</i>,&#160;<i>5</i>(2), 125\u2013132. https://doi.org/10.2174/157340309788166688.</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Prabhakaran, A., &amp; Whinney, C. (2019). Should we stop aspirin before noncardiac surgery?&#160;<i>Cleveland Clinic Journal of Medicine</i>,&#160;<i>86</i>(8), 518\u2013521. https://doi.org/10.3949/ccjm.86a.18075.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/5519/ViewAttachment?fileId=468872",
                        "filename": "image.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:19.683Z"
            },
            {
                "Author": "Gregori Kuran",
                "Content": "Thank you Shawn for sharing this overview on drugs to continue versus discontinue preoperatively. To add to your insightful information that was covered I\u2019d like to further add that anti-epileptic are another type of drug that needs careful consideration.\nPatients risks or seizures during the perioperative period is dependant their baseline control of their epilepsy, other factors such as anesthesia, metabolic derangement, drug and alcohol withdrawal and intracranial surgery are influential factors.(1) It is important that patients continue these anti-epileptic drugs preoperatively, as well as also ensuring that they promptly resumed during the post-operative period.(1) It is also important to be aware of the anesthetic agents used during surgery as they can have potential interactions with these anti-epileptic drugs.(2) As the presentation of seizures can change over time and become less clinically evident, the use of EEG monitoring intra-operatively is an important tool that can be utilized.(2)\n1. Dhallu MS, Baiomi A, Biyyam M, Chilimuri S. Perioperative Management of Neurological Conditions. Health Serv Insights [Internet]. 2017 Jun 12 [cited 2024 Oct 9];10:<a rel=\"noopener\" href=\"javascript://\">1178632917711942</a>. Available from: <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470849/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470849/</a>\n2. Perks A, Cheema S, Mohanraj R. Anaesthesia and epilepsy. British Journal of Anaesthesia [Internet]. 2012 Apr 1 [cited 2024 Oct 9];108(4):562\u201371. Available from:&#160;<a rel=\"noopener\" href=\"https://www.bjanaesthesia.org.uk/article/S0007-0912(17)32260-2/fulltext\">https://www.bjanaesthesia.org.uk/article/S0007-0912(17)32260-2/fulltext</a>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:19.683Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Thank everyone for sharing the different drugs that should be continued or discontinued preoperatively. &#160;\nRegarding preoperative management, I want to add that we need to be very clear with our instructions to our patients. &#160;Patients sometimes get confused that fasting would include holding their medications. &#160;Because of abruptly stopping their medications, I have had patients with extreme tachycardia or a systolic pressure of 190 mmHg coming in for an elective procedure that eventually got canceled.&#160;<br/>On the other extreme, I have patients who thought that NPO only applies to food that needs chewing. &#160;So, I have a couple of patients coming in for cataract removals under procedural sedation who had a big bowl of creamy soup or congee on the day of surgery. Ultimately, they stayed in the preoperative holding area for an extra couple of hours before we could perform the procedures.\nFor drugs that should be discontinued, I think drugs that increase the chance of bleeding are one of the many types that pose risks during surgery. &#160;This is especially important for patients going for regional anesthesia, such as a spinal or epidural block, where a normal international normalized ratio (INR) level is needed. &#160;They should be discontinued preoperatively, and some drugs may need to be discontinued up to days before surgery. &#160;Patients who need to continue their anticoagulant therapy may use Low Molecular Weight Heparin (LMWH) to bridge the gap during the discontinuation period. &#160;LMWH has a short half-life and does not require it to be discontinued too far in advance.\nAs suggested by Shawn, we also need to consider the over-the-counter herbal and vitamin supplements. They can pose risks to increased bleeding, cardiovascular instability, altered fluid and electrolyte status, altered drug metabolism, and synergism with sedative drugs. For example, St. John\u2019s wort, used to relieve depression and anxiety, can interfere with anesthetic agents and prolong their effects. Similarly, Valerian used as a sleep aid or to relieve anxiety, can also prolong the sedative effects of anesthetic agents. We usually ask patients to discontinue their herbal supplements 2 weeks before surgery, because most of them are not actually FDA-approved, and we cannot confirm the exact ingredients. We also need to be mindful that abrupt discontinuation of some herbal products, when used for long-term therapy, can cause withdrawal symptoms.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:19.683Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Hi Minna,\nAdding on to the preoperative management for patients with diabetes, most Type II diabetics are prescribed oral hypoglycemics, such as Metformin and Glyburide, instead of insulin. We usually ask our patients to discontinue their oral hypoglycemics on the morning of surgery, since they will be NPO for the surgery with an anticipated lower-than-normal blood sugar level. I absolutely agree with you that the key is to check the blood sugar level right before surgery because there are many causes, such as stress, that could increase blood sugar despite being NPO.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:19.684Z"
            },
            {
                "Author": "Shawn Page",
                "Content": "Hi Kurt,\nI work in a cardiac OR, so it is not uncommon for us to have emergent transfers from tertiary hospital, or from a hospital with a &quot;cath lab go wrong&quot; situation and they are filled with anticoagulants.&#160; So, we don&#39;t have the luxury of an emergent, elective case where a pt may stop plavix a few days before.&#160; So we will give a TXA bolus at the start of a case, and run it throughout the case.&#160; And then at the end we are pushing platletes, factor 7, RiaSTAP, or a Prothrombin complex concentrate, and a few units of RBC to try and get any clots to form.&#160; Then when they start clotting, we drop them off to your unit and head home and leave the rest for you an anesthesia!&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:19.684Z"
            },
            {
                "Author": "Kurt Protacio",
                "Content": "Hey Shawn,\nThanks for your reply! I totally agree with what you explained about the emergent cases where the physicians need to operate as time is not on your side. Had to look up what RiaSTAP was (learned something new!) but sounds like the type of surgeries you&#39;re a part of are pretty high risk. Thanks for sharing!&#160;&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:19.684Z"
            }
        ]
    },
    {
        "Thread Title": "Question 19",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/97/View",
        "Question": "<p>Question 19: Which emergency drugs would you draw up for each anesthetic case?</p>",
        "Responses": [
            {
                "Author": "Ryan Smith",
                "Content": "While this question is broad given the incredibly variable types of OR cases across demographics, geographical location, and complexity of surgery; there are some emergency drugs that one could consider essential to most crises that can arise. It is common practice in most all Ontario hospitals to have essential ACLS drugs available in sealed crash cart pharmacy pre-made trays. Thus the following is specific more to the operating theatre and the emergency drugs most anesthetic teams will commonly prepare at the start of the day, or per case.\n_**Phenylephrine**_\n<ul>\n<li>\nFavoured for hypotension _**without** bradycaria._\n</li>\n<li>\n\u03b1-1 adrenergic receptor agonist with minimal&#160;\u03b2-adrenergic activity.\n</li>\n<li>\nRaises mean arterial pressure (MAP) via vasoconstriction of veins and arteries raising systemic vascular resistance (SVR).\n</li>\n<li>\nRapid onset of 1-3 minutes, with short duration of action 5-20 minutes.<sup>1</sup>\n</li>\n<li>\nFavoured in peri-partum anesthesia as it has been shown to reduce risk of fetal acidosis.<sup>2</sup>\n</li>\n<li>\nTypical adult dose: 50-100mcg IV\n</li>\n</ul>\n_**Ephedrine**_\n<ul>\n<li>\nFavoured for hypotension _**with**__ bradycardia._\n</li>\n<li>\nAmine which acts as both a direct and indirect sympathomimetic.\n</li>\n<li>\nBinds directly to \u03b1 and \u03b2 adrenergic receptors.\n</li>\n<li>\nIndirectly, ephedrine inhibits neuronal norepinephrine (NE) reuptake, leading to longer NE binding at postsynaptic \u03b1 and \u03b2 adrenergic receptors.<sup>3</sup>\n</li>\n<li>\nOnset: 3-5 minutes, short duration of 10-15 minutes.\n</li>\n<li>\nTypical adult dose: 5-10mg IV\n</li>\n</ul>\n_**Atropine**_\n<ul>\n<li>\nFor symptomatic bradycardia.\n</li>\n<li>\nPotent antimuscarinic agent which competitively binds postganglionic acetylcholine receptors, allowing sympathetic tone to predominate.<sup>4</sup>\n</li>\n<li>\nIncreases heart rate and cardiac output.\n</li>\n<li>\nRapid onset of 2-4 minutes with a duration of 2-6 hours.\n</li>\n<li>\nTypical adult dose: 0.5-1.0mg/kg IV\n</li>\n</ul>\n_**Glycopyrrolate**_\n<ul>\n<li>\nFavoured for bradycardia during induction, intubation and vagal reflex associated arrhythmias. Direct suppression of salivary gland neuronal tone, which can be helpful pre and post operatively.\n</li>\n<li>\nSynthetically created quaternary amine anticholinergic (muscarinic receptor antagonist).<sup>5</sup>\n</li>\n<li>\nRapid onset of 1-2 minutes with a duration of 2-4 hours.\n</li>\n<li>\nTypical adult dose: 0.2-0.4mg IV\n</li>\n</ul>\n<ul>\n<li>\n</li>\n</ul>\n<h1><a rel=\"noopener\" name=\"_NBK499984_\"></a> _**Succinylcholine**_</h1>\n<ul>\n<li>\nFavoured for induction in rapid sequence, and laryngospasm due to its extremely rapid onset\n</li>\n<li>\nShort-acting depolarizing neuromuscular blockade via adhesion to post-synaptic&#160;cholinergic receptors of the motor neuronal junction.<sup>6</sup>\n</li>\n<li>\nVery rapid onset 45-60 seconds with a duration of 6-12minutes.\n</li>\n<li>\nTypical adult dose: 0.6-1mg/kg.\n</li>\n</ul>\nAlthough not routinely prepared in the morning before cases, anesthesia providers should be keenly aware of the location of a malignant hyperthermia (MH) toolbox/cart/kit. The hallmark medication for an MH crises is Dantrolene. Dantrolene functions by blocking postsynaptic acetylcholine receptors in skeletal muscle to reduce excitation-contraction of muscle fibres.<sup>7</sup> Dosing of Dantrolene is 2.5mg/kg initially IV, if symptoms persist repeat administrations of 1-2.5mg/kg can be given up to a maximum of 10mg/kg. Careful hemodynamic and temperature monitoring should be employed.\nReferences\n1. Richards E, Lopez MJ, Maani CV. Phenylephrine [Internet]. Treasure Island: StatPearls Publishing; 2023 Oct [cited 2024 Oct 3]. Available from: <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK534801/\">https://www.ncbi.nlm.nih.gov/books/NBK534801/</a>\n2. Dusitkasem S, Herndon BH, Somjit M, Stahl DL, Bitticker E, Coffman JC. Comparison of Phenylephrine and Ephedrine in Treatment of Spinal-Induced Hypotension in High-Risk Pregnancies. Front Med (Lausanne). 2017 Apr: 4.\n3. Statler AK, Maani&#160;CV, Kohli&#160;A. Ephedrine [Internet]. Treasure Island: StatPearls Publishing; 2023 May [cited 2024 Oct 3]. Available from: <a rel=\"noopener\" href=\"https://pubmed.ncbi.nlm.nih.gov/31613441/\">https://pubmed.ncbi.nlm.nih.gov/31613441/</a>\n4. McLendon K, Preuss CV. Atropine [Internet] Treasure Island: StatPearls Publishing; 2023 June [cited 2024 Oct 4]. Available from: <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK470551/\">https://www.ncbi.nlm.nih.gov/books/NBK470551/</a>\n5. Gallanosa A, Stevens JB, Quick J. Glycopyrrolate [Internet]. Treasuree Island: StatPearls Publishing; 2023 June [cited 2024 Oct 4]. Available from: <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK526035/\">https://www.ncbi.nlm.nih.gov/books/NBK526035/</a>\n6. Hager HH,&#160;Burns B. Succinylcholine [Internet]. Treasure Island: StatPearls Publishing; 2023 Feb [cited 2024 Oct 3]. Available from: <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK499984/\">https://www.ncbi.nlm.nih.gov/books/NBK499984/</a>\n7. Ratto D,&#160;Joyner RW. Dantrolene [Internet]. Treasure Island; StatPearls Publishing; 2023 Apr [cited 2024 Oct 4]. Available from: <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK535398/\">https://www.ncbi.nlm.nih.gov/books/NBK535398/</a>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:24.677Z"
            },
            {
                "Author": "Meera Sathananthan",
                "Content": "Thanks for the breakdown, Ryan! You\u2019ve done a great job covering the key emergency medications we should have ready to go in the OR. I particularly appreciate how you highlighted the roles of phenylephrine and ephedrine in managing hypotension\u2014definitely essential tools.\nOne other drug I\u2019d suggest keeping drawn up is propofol. While it\u2019s primarily used for induction and maintenance, it\u2019s incredibly helpful in emergencies when quick re-sedation is needed. For example, if a patient doesn\u2019t wake up as expected after a case or if laryngospasm occurs, propofol\u2019s fast onset (typically within a minute) allows for rapid sedation and regaining control of the airway (1). Its short duration and quick action make it a great option to have on hand when things don\u2019t go as planned. It also has the added benefit of acting as an antiemetic at certain doses, which may help with extubating patients after a case (1).\nI also completely agree with your point about being familiar with the MH cart. While dantrolene is crucial, close monitoring of hemodynamics and temperature is just as important in managing an MH crisis. Having propofol ready in these situations can help with managing sedation while other interventions are being carried out.\nLooking forward to hearing if other people have seen other things drawn up in case of emergencies!\n**References:**\n1. Folino TB, Muco E, Safadi AO, Parks LJ. Propofol. In: StatPearls [Internet]. StatPearls Publishing; 2023 [cited 2024 Oct 6]. Available from:&#160;<a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK430884/\" target=\"_new\">https://www.ncbi.nlm.nih.gov/books/NBK430884/</a>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:24.678Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Excellent discussion! &#160;\nThis question is a quick introduction to the different aspects of setting up the operating room (OR). What drugs to set up really depends on the patient history as well as the type and location of the procedure. OR setup is something we will work on in the residential week simulations next semester. &#160;It is one of the competencies that you need to sign off on during your clinical semester.&#160;\nPersonally, for all types of anesthesia, I always draw up Phenylephrine, Ephedrine, and Atropine as mentioned by Ryan. Atropine drawn up is a must in any pediatric case, as pediatrics are prone to have bradycardia. I also agree with Meera in drawing up a 10 mL syringe of Propofol to have it ready in case I need to deepen sedation right away. &#160;Other than for gaining control of the airway, this is also important for those critical moments during a procedure where the patient needs to be extremely calm and still. For example, we do cornea transplants under procedural sedation. &#160;There is a moment when the eye is cut open that any excessive coughing or movement from the patient will cause surgical complications that will lead to blindness. &#160;Other times, I may need to quickly deepen the patient that has been disinhibited, a classic feature of stage 2 anesthesia (see Mary\u2019s post in Question 12). &#160;Regarding Succinylcholine, I may not draw it up but I&#39;ll make sure there is a vial with a 10 mL syringe ready to go.\nI absolutely agree with the point of knowing the location of the malignant hyperthermia crisis cart. In addition to Dantrolene, we should be aware of the location of the reversal agents, too. Other than Neostigmine, I have never needed to use any others. Flumazenil and Naloxone are very rarely needed if you have given the proper dosage of anesthetics. However, it is important for us to have quick access to these drugs. &#160;I usually would not have these pre-drawn, but they should be within arms\u2019 reach in the drug cart inside the OR room. &#160;In addition, we need to know the location of other emergency drugs, such as Sugammadex.\nLastly, a quick note regarding to location. &#160;It is important to ensure you know what types of drugs are available within arms\u2019 reach at the location for the procedure, especially as our roles expand more and more to locations beyond the OR. &#160;You may need to prepare potentially more in volume and variety. &#160;For example, when I go to provide procedural sedation for transesophageal echocardiography (TEE) at the echo lab at Toronto Western, I am known as Ms. Santa Claus as I always bring with me a box of \u201cgoodies\u201d from drugs to saline flushes to IV lines and bags.&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:24.678Z"
            },
            {
                "Author": "Gregori Kuran",
                "Content": "Thank you Ryan for covering some of the emergency drugs you would draw for you anesthetic case, this will be a valuable resource when reviewing throughout the term. Phoebe I also agree with you that the emergency drugs you prepare are very much dependant on the patient history and the type of surgery being performed.\nI\u2019d like to share some personal experience with a relatively new procedure that we have been seeing more at SickKids in our neuro interventional rooms. We have been treating more and more retinoblastoma patients with intraarterial chemotherapy (IAC). As our department started getting exposed to more and more of these cases we started encountering very severe cardiorespiratory event with these patient upon the injection of the chemotherapy drug, and usually this was seen after the first treatment. As these events became more frequent the anesthesia group initiated a standard setup for all these patient, specifically having epinephrine + phenylephrine bags prepared and ready as setting a standard workflow of how they would manage these patient during these events. There have been multiple studies that have shown that these sudden and severe cardiopulmonary events during IAC treatment are likely to the trigemino-cardiac reflex (TCR), are likely to occur once the patient has become sensitized to the chemo after the first treatment.1\n1.Mulin M. Anesthetic Implications Of Intraarterial Chemotherapy For Retinoblastoma: A Literature Review [Internet]; England: University of England; 2020 [cited 2024 Oct 9] <a rel=\"noopener\" href=\"https://dune.une.edu/cgi/viewcontent.cgi?article=1034&amp;context=na_capstones#:~:text=Pediatric%20anesthesia%20for%20IAC%20for,ophthalmic%20artery%20under%20fluoroscopic%20visualization.\">https://dune.une.edu/cgi/viewcontent.cgi?article=1034&amp;context=na_capstones#:~:text=Pediatric%20anesthesia%20for%20IAC%20for,ophthalmic%20artery%20under%20fluoroscopic%20visualization.</a>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:24.678Z"
            },
            {
                "Author": "Shawn Page",
                "Content": "Good call Ryan with the ACLS drugs handy.&#160; I find the drug trays in our <span style=\"font-size: 0.95rem;letter-spacing: 0.02rem;\">main OR&#39;s (non cardiac) have all the essentials from ACLS, to bronchodilators, to steroids.&#160; One thing I always make sure is drawn up is phenylephrine, as you mentioned.&#160; Our main OR drug trays come with pre filled syringes of 50 mg/ml, but some anesthetists like a stronger dose of 80 or 100mg/ml.&#160; The pre filled syringes are easily identifiable, but I always ask what the concentration is when an&#160; has&#160;</span><span style=\"letter-spacing: 0.4px;font-size: 0.95rem;\">anethestist has </span><span style=\"font-size: 0.95rem;letter-spacing: 0.02rem;\">made their own.&#160;</span>\nAnother drug I have drawn up is Nitro for hypertension.&#160; We watch the pressures in all surgeries, but in cardiac, depending on where they are in attaching the conduits, we need different pressures. And some surgeons want a pressure dropped faster, than increasing sevo, or adjusting the bed into reverse Trendelenburg, or weaning a levo drip can deliver.&#160; I also like nitro as it doesn&#39;t change the pts anesthesia like giving a dose of propofol.\nAlso, depending on if there is a roc infusion or not, I also like having roc drawn up in case the paralytic stops working and the pt starts to move intraop.&#160; I have seen this only a handful of times during cardiac surgery, and it&#39;s always scary as heck because of the fine nature of suturing the anastomosis, so not having to turn around, find the vial, draw it up and then push - having it already drawn up saves a few seconds, and we can just push right away.\nAnother drug in cardiac OR i have drawn up is a larger, By-pass dose of heparin, when we are doing an &quot;off pump&quot; case.&#160; I like to have 30 000 units drawn, my organizations max one time dose, so that if the pt crashes intraop and we are doing a &quot;crash onto pump&quot; the room gets suddenly chaotic, and if that heparin is already drawn, all we have to do is push it, and then move onto the next task.&#160; This will have me push it, while anesthesia is pushing pre-arrest drugs, and we work in tandem to get the pt ready for a crash pump.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:24.678Z"
            }
        ]
    },
    {
        "Thread Title": "Question 2",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/114/View",
        "Question": "<p>Question 2: Discuss the differences between agonists, antagonists, and agonist-antagonists. Provide an example for each.</p>",
        "Responses": [
            {
                "Author": "Laryssa Hartmann",
                "Content": "<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">An agonist is a chemical or drug that has an affinity for a specific receptor and activates it, thereby producing a biological response (demonstrating efficacy) (Gardenhire, 2020, p. 91). There are full agonist and partial agonist. Full agonist are drugs that achieve maximal effect. Partial agonist is those that have a less than maximal effect. To fully understand the difference between Full agonist and partial agonist, one must understand how efficacy is affected. \u201cEfficacy is a measure of drug effectiveness once it occupies a receptor\u201d (Kim et al., 2023.,&#160;p. 42). Similar drugs that work through the same receptor may have varying degrees of effectiveness despite occupying the same receptor site (Kim et al., 2023.,&#160;p. 42-45). As shown in Figure 1 (Gardenhire, 2020, p. 91) a full agonist and partial agonist may occupy the same receptor site, however, full agonist has an overall higher maximal response than a partial agonist. </span>\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"><img alt=\"A graph of a functionDescription automatically generated with medium confidence\" height=\"352\" width=\"624\" src=\"/d2l/le/7298/discussions/posts/3777/ViewAttachment?fileId=430406\"/></span>\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><b><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Figure 1</span></b><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">: Dose response curve for full and partial agonists. Adapted from <i>Rau\u2019s respiratory care pharmacology</i> (Gardenhire, 2020, p. 91)</span>\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">An example of a partial agonist is buprenorphine. Buprenorphine is a synthetic opioid used to treat pain and opioid disorder <a rel=\"noopener\" name=\"_Hlk177824302\">(Kumar et al., 2024)</a>. Buprenorphine is a partial agonist that acts on the opioid MU (\u03bc) receptor. &#160;Unlike a full agonist, buprenorphine exerts a milder effect. Buprenorphine is a potent analgesic that acts on the central nervous system and has unique properties due to its partial agonism at the mu receptor (Kumar et al., 2024). Partial agonist can sometimes act as an antagonist when given in high concentrations and in conjunction with a full agonist. For instance, buprenorphine will block morphine (full agonist) and cause competitive inhibition (Cummings III &amp; Naguib, 2022.,&#160;p. 795-796).</span>\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Epinephrine is an example of a full agonist. Epinephrine is a full alpha and beta agonist. This drug produces the same intensity or maximal effect as endogenous epinephrine. It effects both the alpha- and beta-adrenergic receptors using a G protein linked second messenger system. Epinephrine increases vascular smooth muscle contraction, increases heart rate and myocardial contractility (Dalal &amp; Grujic, 2024). &#160;</span>\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">In comparison to an agonist, an antagonist is a chemical or drug that also has an affinity to a corresponding receptor, however, does not initiate a response (demonstrates zero efficacy). The antagonist blocks the receptor site, in turn preventing endogenous chemicals from occupying and activating the receptor site (Gardenhire, 2020, p. 91). </span>\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Antagonist can be further divided into competitive and noncompetitive. Competitive antagonists compete with the agonist at the receptor site and prevent it from binding (Flood &amp; Shafer, 2022.,&#160;p.139). Increasing amounts of the agonist would be needed to outcompete the binding site on the receptor. For instance, Naloxone is a competitive antagonist. Naloxone has a binding affinity to Mu (\u03bc) opioid receptors, it blocks other opioids like morphine and reverses the effects of an opioid overdose (Saari et al., 2024). </span>\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">There is also noncompetitive antagonist where after the antagonist drug is administered, it binds to a different site on the receptor altering the receptors conformation where an agonist will no longer be able to bind. Even if you increase the amount of agonist available, it will still not be able to bind to the receptor site (Flood &amp; Shafer, 2022.,&#160;p.139). Ketamine would be an example of a noncompetitive antagonist. Ketamine noncompetitively binds to the NMDA receptors changing the way the receptor functions and inhibits glutaminergic transmission (Rathmell &amp; Dahan, 2022.,&#160;pp. 628-630).</span>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;References:\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Cummings III, K. C., &amp; Naguib, M. A. (2022). In K. Donnellan &amp; A. Fischer (Eds). <i>Stoelting&#39;s pharmacology and physiology in anesthetic practice</i> (6th ed., 795-796. 722-845). Wolters Kluwer. </span><a rel=\"noopener\" href=\"https://lccn.loc.gov/2020052843\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">https://lccn.loc.gov/2020052843</span></a>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Dalal, R., &amp; Grujic, D. (2024). Epinephrine. In <i>National Library of Medicine</i>. </span><a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK482160/\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">https://www.ncbi.nlm.nih.gov/books/NBK482160/</span></a>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Flood, P. F., &amp; Shafer, S. L. (2022). In K. Donnellan &amp; A. Fischer (Eds). <i>Basic Principles of Pharmacology</i>. (6th ed., 139. 137-237). Wolters Kluwer. </span><a rel=\"noopener\" href=\"https://lccn.loc.gov/2020052843\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">https://lccn.loc.gov/2020052843</span></a>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Gardenhire, D. S. (2020). Principles of Drug Action. In D. S. Gardenhire (Ed). <i>Rau\u2019s respiratory care pharmacology</i> (10th ed., 91. 49-95). Elsevier.</span>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Kim, T. K., Obara, S., &amp; Johnson, K. B. (2023). Basic Pharmacologic Principles. In M. C. Pardo Jr. (Ed). <i>Miller&#39;s basics of anesthesia</i> (8th ed.,42-45.31-49). Elsevier </span>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Kumar, R., Viswanath, O., &amp; Saadabadi, A. (2024). Buprenorphine. In <i>National Library of Medicine</i>. </span><a rel=\"noopener\" target=\"_new\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK459126/\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">https://www.ncbi.nlm.nih.gov/books/NBK459126/</span></a>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Rathmell, J. P., &amp; Dahan, A. (2022). In K. Donnellan &amp; A. Fischer (Eds). <i>Intravenous Sedatives and Hypnotics</i>. (6th ed., 628-630. 544-690). Wolters Kluwer. </span><a rel=\"noopener\" href=\"https://lccn.loc.gov/2020052843\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">https://lccn.loc.gov/2020052843</span></a>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Saari, T. L., Strang, J., &amp; Dale, O. (2024). Clinical pharmacokinetics and pharmacodynamics of naloxone. In <i>National Library of Medicine</i>. https://pubmed-ncbi-nlm-nih-gov.michener.idm.oclc.org/38485851/ </span>",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/3777/ViewAttachment?fileId=430406",
                        "filename": "image_24556321021727653893512.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:28.771Z"
            },
            {
                "Author": "Ryan Christopher Floro",
                "Content": "<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Hi Laryssa,\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">I found your discussion of agonists and antagonists interesting especially noting how partial agonists can become antagonists in some cases. It had me wondering \u2013 would it also be possible for antagonists to function as agonists on some cases? Whether in drug combinations like <span style=\"font-size: 11.0pt;line-height: 107%;font-family: Aptos, sans-serif;\">buprenorphine and morphine or in their own right?</span>\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">What I came across while searching were inverse agonists. Instead of enhancing or blocking a given receptor, their binding to the receptor will produce a negative or opposite effect (Berg &amp; Clarke, 2018). As an example, olmesartan binds to the angiotensin 2 type 1 receptor, leading to lower blood pressure (Canadian Society of Pharmacology and Therapeutics, n.d.). Such receptors have a basal level of activity even without an agonist or ligand present, which is then suppressed by the inverse agonist (Berg &amp; Clarke, 2018). In contrast, a neutral antagonist might not change the receptor\u2019s baseline activity but rather prevent an agonist or ligand from enhancing the activity (Berg &amp; Clarke, 2018).\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">References\n<p style=\"margin: 0cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Berg, K. A., Clarke, W. P. (2018). Making sense of pharmacology: Inverse agonism and functional selectivity. <i>International Journal of Neuropsychopharmacology, 21</i>(10), 962-977. <a rel=\"noopener\" href=\"https://doi.org/10.1093/ijnp/pyy071\">https://doi.org/10.1093/ijnp/pyy071</a>\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 1cm;text-indent: -1cm;font-size: 11pt;font-family: Aptos, sans-serif;\">Canadian Society of Pharmacology and Therapeutics. (n.d.). <i>Glossary of pharmacology: Inverse agonist.</i> <a rel=\"noopener\" href=\"https://pharmacologycanada.org/Inverse-Agonist\">https://pharmacologycanada.org/Inverse-Agonist</a>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:28.772Z"
            },
            {
                "Author": "Laryssa Hartmann",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Hey Ryan!\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Thanks for sharing your thoughts on agonists and antagonist! You are right that partial agonists can act as antagonist in certain contexts, especially when they bind to receptors that are already activated by a full agonist<span style=\"color: #202122;background: white;\"> </span>(Cummings III &amp; Naguib, 2022.,&#160;p. 795-796). As for inverse agonists, its very interesting to consider how they work and what they do at the receptor level. Like you mentioned, inverse agonists reduce the basal activity of receptors that have some intrinsic activity, they inhibit spontaneous receptor signaling that occurs in the absence of an agonist (Klein et al., 1996). This can lead to effects that might resemble agonists activity.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">In terms of drug combinations, like buprenorphine and morphine. Buprenophrine is a long-acting analgesic designed for pain relief and opioid use disorder<span style=\"font-size: 13.5pt;line-height: 115%;font-family: Arial, sans-serif;color: #333333;background: white;\"> </span>(Poliwoda et al., 2022). It has a unique profile that contributes to its effectiveness in managing both pain and opioid dependence.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Buprenorphine acts as a partial agonist at opioid<span style=\"color: #202122;background: white;\"> </span>MU (\u03bc) receptors. It can exhibit antagonist properties, when morphine (a full agonist) is also administered alongside buprenorphine (Kumar et al., 2024). Buprenorphine can exhibit antagonist properties by partially blocking the effects of morphine.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">I really appreciate your explanation of neutral antagonists. From my understanding they prevent agonists from enhancing the receptors action, but they do not suppress any natural signaling that occurs when no agonists are present<span style=\"font-size: 13.5pt;line-height: 115%;font-family: Arial, sans-serif;color: #333333;background: white;\"> </span>(Klein et al., 1996).\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">To simply compare an inverse agonist and neutral antagonist. An inverse agonist actively decreases activity whereas a neutral antagonist does not. Understanding these receptor interactions is important for making an effective plan for therapy. &#160;Thank you for contributing!\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">References :\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Cummings III, K. C., &amp; Naguib, M. A. (2022). In K. Donnellan &amp; A. Fischer (Eds).&#160;<i>Stoelting&#39;s pharmacology and physiology in anesthetic practice</i>&#160;(6th ed., 795-796. 722-845). Wolters Kluwer.&#160;<a rel=\"noopener\" href=\"https://lccn.loc.gov/2020052843\">https://lccn.loc.gov/2020052843&#160;</a>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Klein, E. S., Pino, M. E., Johnson, A. T., Davies, P. J., Ngpal, S., Thacher, S. M., Krasinski, G., &amp; Chandraratna, R. A. (1996, September). Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonist<i>s</i>. In <i>Science Direct</i>. Retrieved October 2, 2024, from <a rel=\"noopener\" href=\"https://www.sciencedirect.com/science/article/pii/S0021925819618089\">https://www.sciencedirect.com/science/article/pii/S0021925819618089</a>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Kumar, R., Viswanath, O., &amp; Saadabadi, A. (2024). Buprenorphine. In _National Library of Medicine_.&#160;<a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK459126/\">https://www.ncbi.nlm.nih.gov/books/NBK459126/</a>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Poliwoda, S., Noor, N., Jenkins, J. S., Stark, C. W., Steib, M., Hasoon, J., Varrassi, G., Urits, &#160;I., Viswanath, O., Kaye, A. M., &amp; Kaye, A. D. (2022). Buprenorphine and its formulations: A comprehensive review. In <i>National Library of Medicine</i>. Retrieved October 2, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392838/",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:28.772Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Thanks, Laryssa and Ryan, for a great review on how drugs can interact with receptors as agonists, partial agonists, antagonists, and inverse agonists.\nI want to add the concept of allosteric modulation. As we have discussed, agonist drugs typically bind to the same place on the receptor as the substance that naturally activates the receptor, or the endogenous agonist. These agonist drugs can further be divided into 3 categories. Full agonists generate a maximal response at a receptor. Partial agonists can only generate a fraction of the possible response at a receptor. Inverse agonists produce effects that are opposite to those of an agonist.\nSome drugs may bind to a receptor at a different site from where an agonist binds, and influence the function of the receptor. These drugs are often called allosteric modulators. Positive allosteric modulators increase the likelihood of an agonist binding to a receptor and enhance the effects an agonist has when it does bind. An example is benzodiazepines. These drugs bind to an allosteric site of the GABA-A receptor and enhance the inhibitory effects of GABA. On the other hand, negative allosteric modulators decrease the affinity or efficacy of the agonist. For example, Flumazenil competitively antagonizes the allosteric sites where benzodiazepine binds and reverses the effects of benzodiazepines. It is important to note that allosteric modulators only function in the presence of the bound endogenous agonist.\nLastly, non-competitive antagonists do not compete with the agonist for the same binding site. As Laryssa mentioned, they bind to a different site on the receptor, and cause a change in the receptor activity so that even a high concentration of agonist cannot completely overcome the antagonism. An example is Ketamine, a non-competitive antagonist of the NMDA receptor, which prevents the receptor from being activated by glutamate.&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:28.772Z"
            }
        ]
    },
    {
        "Thread Title": "Question 20",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/96/View",
        "Question": "<p>Question 20: Discuss the role and effectiveness of anti-emetic agents in preventing postoperative nausea and vomiting. What factors should be considered when choosing an anti-emetic regimen?</p>",
        "Responses": [
            {
                "Author": "Adrian Harris",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Post-operative nausea and vomiting (PONV) can impact on patients from the emergence phase of the procedure up to 48-72 hrs after, potentially affecting a patient\u2019s quality of recovery, length of stay, fluid and electrolyte imbalance, an airway free from aspirate, and wound healing among other challenges </span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">To understand which antiemetics should be offered to prevent PONV, we should first briefly understand the physiological processes and the risk factors behind both nausea and vomiting, as one process can occur without the other (1)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Stimulus from the vestibular (inner ear), visceral (internal organs), the cerebral cortex and limbic system (cognitive and emotional centres) in the central nervous system (CNS), and vagal stimulus in the peripheral and autonomic nervous system (PNS/ANS) can all lead to the sensation of nausea, although its mechanism is still truly not well-understood (2)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">The brain\u2019s chemoreceptor trigger zone (CRTZ), which is outside of the blood-brain barrier (BBB), is impacted by either activation or inhibition of neurotransmitters such as dopamine, histamine, acetylcholine, substance P and serotonin; the CRTZ relays signals to the vomiting centre where cranial nerves then result in a motor process to induce vomiting (1)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Determining the risk of PONV can be utilized via the Apfel Score, where one point is given for each of the risk factors, with each factor adding about 20% to likelihood of PONV (3); similarly, one point given for each risk factor for pediatric patients (4), illustrated in figure 2 below</span></li>\n</ul>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><img alt=\"A graph with numbers and a bar chartDescription automatically generated with medium confidence\" height=\"164\" width=\"240\" src=\"/d2l/le/7298/discussions/posts/4233/ViewAttachment?fileId=439898\"/>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 8.0pt;font-family: Calibri, sans-serif;\">Figure 1. Simplified Apfel score for adults (5)</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">PONV Risk Factors in Children</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><img alt=\"A graph of points and a number of pointsDescription automatically generated\" height=\"115\" width=\"230\" src=\"/d2l/le/7298/discussions/posts/4233/ViewAttachment?fileId=439899\"/>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 8.0pt;font-family: Calibri, sans-serif;\">Figure 2. Simplified PONV risk score for children (6)</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Furthermore, increased length of surgery, surgical procedures such as cholecystectomy, laparoscopy and gynecologic surgery and patients receiving inhalational anesthesia are all associated with increased occurrence of PONV; with all these potentially compounding risks, the goal in managing PONV should be in its prevention (7)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Recent evidence-based consensus on PONV management recommended that:</span>\n<ul style=\"list-style-type: circle;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Prophylactically preventing PONV should be forefront </span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Patients with 1-2 risk factors should receive 2 antiemetic agents</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Patients with &gt; 2 risk factors should receive 3-4 antiemetic agents </span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">If the appropriate number of antiemetics were received at the appropriate time but PONV has still occurred, then offering another dose of antiemetics of the same class(es) will not be effective within 6 hours of the original dose; the provider should offer a different antiemetic class to assist with persistent symptoms (7)</span></li>\n</ul>\n</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Antiemetic offerings for PONV should be tailored to the patient\u2019s individual needs (7)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\" style=\"width: 766px;border-collapse: collapse;border: none;\">\n<tbody>\n<tr>\n<td valign=\"top\" style=\"width: 99.3pt;border: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Antiemetic</span>\n</td>\n<td valign=\"top\" style=\"width: 127.55pt;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Mechanism of Action </span>\n</td>\n<td valign=\"top\" style=\"width: 92.15pt;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Dosage</span>\n</td>\n<td valign=\"top\" style=\"width: 9.0cm;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Side Effects/Relevant Information</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 99.3pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">5-HT3 antagonists</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">(ondansetron/</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Zofran) </span>\n</td>\n<td valign=\"top\" style=\"width: 127.55pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-selectively binds to 5-HT3 receptors are found in the brain around the CRTZ and the gastrointestinal </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">(GI) tract (1)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n<td valign=\"top\" style=\"width: 92.15pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Adult: 4-8 mg IV (over 2-5 min) immediately before induction</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Peds: 0.05-0.10 mg/kg IV pre- or intra-op (1)</span>\n</td>\n<td valign=\"top\" style=\"width: 9.0cm;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">- free of neurologic side effects (1)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-risk of QTc prolongation \u2013 avoid in patients with long QT syndrome, bradyarrhythmias, or patients who are receiving meds that prolong QT (6)</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 99.3pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Histamine-receptor antagonists</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">(dimenhydrinate/</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Gravol)</span>\n</td>\n<td valign=\"top\" style=\"width: 127.55pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-binds to histamine-receptor subtype H1 receptors in the vomiting centre and blocks muscarinic receptors in the vestibular system (1)</span>\n</td>\n<td valign=\"top\" style=\"width: 92.15pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Adult: 1mg/kg IV (5)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Peds (&lt;12yrs): 0.5-1.25 mg/kg IV/IM/PR (9)</span>\n</td>\n<td valign=\"top\" style=\"width: 9.0cm;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-can cause paradoxical CNS stimulation or CNS depression, drowsiness or sedation (9)</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 99.3pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Corticosteroids</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">(dexamethasone)</span>\n</td>\n<td valign=\"top\" style=\"width: 127.55pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-unclear mechanism of action (1)</span>\n</td>\n<td valign=\"top\" style=\"width: 92.15pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Adult: 4-10 mg IV once before or after induction (10)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n<td valign=\"top\" style=\"width: 9.0cm;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-perioperative hyperglycemia may be seen in high BMI and diabetic patients (1)</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 99.3pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Dopamine-receptor antagonists</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">(metoclopramide/</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Maxeran/Reglan)</span>\n</td>\n<td valign=\"top\" style=\"width: 127.55pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-decreases signal sensitivity from GI tract to CRTZ</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-accelerates gastric emptying and increases resting tone of lower esophageal sphincter &#160;</span>\n</td>\n<td valign=\"top\" style=\"width: 92.15pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Adult: 10 mg IV administered near the end of the case (11)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n<td valign=\"top\" style=\"width: 9.0cm;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-especially useful in patients with gastroesophageal reflux disease (11)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-avoid use in patients with Parkinson disease or with dopamine-inhibition movement disorders </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-may cause sensations of restlessness; use with caution in patients with restless leg syndrome (1)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">-avoid in any patients with potential GI obstructions (7)</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" colspan=\"4\" style=\"width: 574.15pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Other pharmacologic options with antiemetic properties:</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Scopolamine \u2013 transdermal patch applied behind the ear (1)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Benzodiazepines \u2013 midazolam: shown in meta-analysis from 2016 to have some antiemetic properties (12)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Hypnotics \u2013 propofol: use of total intravenous anesthesia (TIVA) with propofol has been found to have anti-emetic effects (7)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Antihistamines \u2013 diphenhydramine: first generation H1-receptor antagonist widely-used for allergic rhino-conjunctivitis (13)</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" colspan=\"4\" style=\"width: 574.15pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Non-pharmacologic therapy:</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Isopropyl alcohol pads \u2013 several studies, including one published by the Journal of the College of Family Physicians of Canada suggest holding pads 1-2 cm below the nares; multiple pads can be used for relief of nausea within about 10-15 min (14); anecdotal evidence from the anesthesia assistants at Unity Health Toronto-St Michael\u2019s strongly support this! </span>\n</td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">References</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Lam CM, Murray MJ. Antiemetics. In: Flood P, Rathmell JP, Urman RD, editors. Stoelting\u2019s pharmacology &amp; physiology in anesthetic practice. 6th ed. Philadelphia: Wolters Kluwer; c2021. p. 707-716.</span></li>\n</ol>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"2\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Singh P, Yoon SS, Kuo B. Nausea: a review of pathophysiology and therapeutics. Therap Adv Gastroenterol [Internet]. 2016 Jan [cited 2024 Sep 30] 9(1):98-112. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699282/</span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"3\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Cook DC, Hemmings Jr HC. Inhaled anesthetics. In: Miller\u2019s basics of anesthesia. 8<sup>th</sup> ed. Philadelphia: Elsevier Inc; c2023. p. 82-106.</span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"4\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Gottlieb EA, Andropoulos DB. Pediatrics. In: Miller\u2019s basics of anesthesia. 8<sup>th</sup> ed. Philadelphia: Elsevier Inc; c2023. p. 612-660.</span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"5\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Simplified apfel score [image on internet]. [cited 2024 Oct 1]. Available from: </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">https://gas.careteamapp.com/<span style=\"color: black;\">Apfel</span></span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"6\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Gan TJ, Diemunsch P, Habib A, Kovac A, Kranke P, Meyer TA, et al. Consensus guidelines for the management of post-operative nausea and vomiting [image on internet] 2014 April [cited 2024 Oct 1]. Available from: https://www.researchgate.net/profile/Sergio-Bergese/publication/314927778/ figure/fig1/ AS:496944338685952@1495492171543/Simplified-risk-score-for-POV-in-Children-Simplified-risk-score-from-Eberhart-et-al-48.png</span></li>\n</ol>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"7\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Braehler MR, Mizrahi I. Postanesthesia recovery. In: Miller\u2019s basics of anesthesia. 8<sup>th</sup> ed. Philadelphia: Elsevier Inc; c2023. p. 697-715.</span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 4.7pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"8\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Ondansetron. In: UpToDate Lexidrug [database on the Internet]. Philadelphia: Wolters Kluwer; c2024 [cited 2024 Oct 1]. Available from: https://online.lexi.com with authorized username and password</span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 4.7pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"9\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Dimenhydrinate.</span><span style=\"font-size: 11.0pt;color: black;\"> In: UpToDate Lexidrug [database on the Internet]. Philadelphia: Wolters Kluwer; c2024 [cited 2024 Oct 1]. Available from: https://online.lexi.com with authorized username and password</span></li>\n</ol>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"10\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Dexamethasone. </span><span style=\"font-size: 11.0pt;color: black;\">In: UpToDate Lexidrug [database on the Internet]. Philadelphia: Wolters Kluwer; c2024 [cited 2024 Oct 1]. Available from: https://online.lexi.com with authorized username and password</span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"11\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Isola S, Hussain A, Dua A, Singh K, Adams N. </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Metoclopramide</span><span style=\"font-size: 11.0pt;color: black;\">. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; c2024-.&#160;[Updated 2023 Sep 4; cited 2024 Oct 1].</span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"12\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Grant MC, Kim J, Page AJ, Hobson D, Wick E, Wu CL. The effect of intravenous midazolam on postoperative nausea and vomiting: a meta-analysis. Anesth Analg [Internet] 2016 Mar [cited 2024 Oct 2];122(3):656-663. Available from: https://pubmed.ncbi.nlm.nih.gov/26332858/</span></li>\n</ol>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"13\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Lam CM, Murray MJ. Antacids and gastric motility drugs. In: Flood P, Rathmell JP, Urman RD, editors. Stoelting\u2019s pharmacology &amp; physiology in anesthetic practice. 6th ed. Philadelphia: Wolters Kluwer; c2021. p. 717-732.</span></li>\n</ol>\n<p style=\"margin: 0cm 0cm 0cm 36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<ol start=\"14\" style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Lindblad AJ, Ting R, Harris K. Inhaled isopropyl alcohol for nausea and vomiting in the emergency department. Canadian Family Physician [Internet]. 2018 Aug [cited 2024 Oct 2] 64(8):580. Available from: https://www.cfp.ca/content/64/8/580</span></li>\n</ol>",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4233/ViewAttachment?fileId=439898",
                        "filename": "image_88841530021727898759024.jpg"
                    },
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4233/ViewAttachment?fileId=439899",
                        "filename": "image_21092043531727898759025.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:33.685Z"
            },
            {
                "Author": "Deena Kurilsky",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Hi Adrian! Thank you for your overview on post-operative nausea and vomiting (PONV). I appreciate the detailed breakdown of the various antiemetic options. The inclusion of the Apfel score and its application to both adult and pediatric populations is particularly valuable. It provides a clear framework for assessing risk and guiding PONV treatment. The diagrams included are very helpful.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">My question for you is how can the timing of administering antiemetics be optimized to enhance their effectiveness in preventing PONV?\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">In my experience, I have observed that during longer surgical procedures, anesthesia typically administers an antiemetic towards the end of the case, usually just before surgical closure. This was supported in an article by Cruz et al. (2008) that suggested administration of ondansetron 30 minutes prior to the end of the case proved to be more effective in prevention of PONV then given earlier on. I wonder if you have had similar experiences or if this differs with different antiemetics or length of surgeries.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Cruz, N. I., Portilla, P., &amp; Vela, R. E. (2008). Timing of ondansetron administration to prevent postoperative nausea and vomiting.&#160;<i>Puerto Rico health sciences journal</i>,&#160;<i>27</i>(1), 43\u201347. https://pubmed.ncbi.nlm.nih.gov/18450232/",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:33.686Z"
            },
            {
                "Author": "Junia Isaac",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Hi Adrian and Deena! Thank you both for the valuable insights on post-operative nausea and vomiting (PONV) management! Adrian, I appreciate your detailed breakdown of the physiology behind nausea and vomiting, as well as the Apfel score for risk assessment. The evidence-based recommendations you included on tailoring antiemetic regimens based on the number of risk factors are extremely helpful, especially the guidance on not repeating the same class of antiemetics within 6 hours. It highlights the importance of understanding the pharmacodynamics of these agents in clinical practice.&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Deena, your question on the timing of antiemetics brings up an excellent point about their efficacy depending on when they\u2019re administered. I agree that timing plays a crucial role, especially during longer surgeries. I\u2019ve also seen evidence supporting the idea that antiemetics like ondansetron are more effective when administered closer to the end of surgery (Sun et al., 1997; Cruz et al., 2008). Do you think this is mainly due to the half-life of the drugs or could it be more related to the patient\u2019s individual metabolism or the type of anesthesia being used? Also, Adrian, based on your discussion about different neurotransmitter pathways, do you think certain antiemetics are better suited to be administered earlier or later in surgery? It would be interesting to explore if optimizing timing based on these factors could further improve PONV prevention, especially in high-risk patients. Looking forward to hearing your thoughts!\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Sun, R., Klein, K. W., &amp; White, P. F. (1997). The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery.&#160;<i>Anesthesia and analgesia</i>,&#160;<i>84</i>(2), 331\u2013336.&#160;<a rel=\"noopener\" href=\"https://doi-org.uhn.idm.oclc.org/10.1097/00000539-199702000-00016\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi-org.uhn.idm.oclc.org/10.1097/00000539-199702000-00016</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Cruz, N. I., Portilla, P., &amp; Vela, R. E. (2008). Timing of ondansetron administration to prevent postoperative nausea and vomiting.&#160;<i>Puerto Rico health sciences journal</i>,&#160;<i>27</i>(1), 43\u201347.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:33.686Z"
            },
            {
                "Author": "Janet Rozek",
                "Content": "Thanks Adrian for a great clear overview of the important antiemetics used daily in the operating room setting!&#160;\nDeena and Junia I am also interested in what you have brought up regarding timing of anti-emetics.&#160;\nFrom my experiences in the OR, most of my anesthesia colleagues will always give Decadron (dexamethasone) IV during induction or shortly after induction and will given Zofran IV before closing and waking up the patient to ensure a smooth transition in the recovery phase of anesthesia.&#160;\nOther things I like to review with my patient pre-op is if they have a history of PONV with previous anesthetics. If that is the case, we often try and optimize the patients recovery and may add another anti-emetic to the patients anesthesia plan like Metoclopramide!&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:33.687Z"
            },
            {
                "Author": "Reneerose Ong",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Thank you, Adrian your post provides a thorough explanation of the physiological mechanisms, behind post-operative nausea and vomiting (PONV). Your table outlining the various anti-emetic options is helpful as a quick reference with dosages, side effects and mechanism of action.&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">I particularly appreciated your discussion of the Apfel score in adults and children, and how essential it is in identifying patients at high risk for PONV, allowing for pre-emptive action. As you pointed out, patients with multiple risk factors should receive more aggressive prophylactic treatment, with the guidelines suggesting 2-4 antiemetic agents depending on the severity of the risk (Gan et al., 2020). This is critical in surgical environments, as preventing PONV can lead to improved patient outcomes and satisfaction (Gan et al., 2020). Like Janet\u2019s experience, I have also seen the anesthesiologist give dexamethasone IV shortly after induction and ondansetron IV towards the end of the procedure, before waking up the patient to mitigate any PONV. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">I was surprised to learn about the use of isopropyl alcohol pads. It sounds to be an excellent non-pharmacological method, and useful in cases where medication may be less effective or contraindicated. I am amazed that the simple act of inhaling isopropyl alcohol vapor can significantly reduce nausea within minutes (Lindblad et al., 2018). Its a technique I would like to implement in my current practice when appropriate. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\"></span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">References:</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Gan, T. J., Belani, K. G., Bergese, S., Chung, F., Diemunsch, P., Habib, A. S., Jin, Z., Kovac, A. </span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">L., Meyer, T. A., Urman, R. D., Apfel, C. C., Ayad, S., Beagley, L., Candiotti, K., </span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Englesakis, M., Hedrick, T. L., Kranke, P., Lee, S., Lipman, D., Minkowitz, H. S., \u2026 </span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Philip, B. K. (2020). Fourth Consensus Guidelines for the Management of </span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Postoperative Nausea and Vomiting. _Anesthesia and analgesia, 131_(2), 411-448 &#160;</span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"><a rel=\"noopener\" href=\"https://doi.org/10.1213/ANE.0000000000004833\">https://doi.org/10.1213/ANE.0000000000004833</a> </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Lindblad, A. J., Ting, R., &amp; Harris, K. (2018). Inhaled isopropyl alcohol for nausea </span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">and vomiting in the emergency department. Canadian family physician</span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><i><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Medecin de famille canadien</span></i><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"><span style=\"text-align: start;float: none;\">,&#160;</span><i style=\"text-align: start;\">64</i><span style=\"text-align: start;float: none;\">(8), 580.</span></span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:33.687Z"
            },
            {
                "Author": "Paula Watkis",
                "Content": "Hi Adrian,\nThis is a thorough explanation of the topic I completely agree with your perspective points. Based on the literature I have reviewed, I completely agree with your perspective on the role of effectiveness antiemetics agents in preventing PONV and the factors to be considered when choosing those drugs.&#160; The use of antiemetics can make a significant difference in patient recovery in reducing discomfort to preventing complications. In previous practice, in oncology, a multimodal approach was used, where ondansetron and dexamethasone would be combined due to its efficacy in high risk patients. After reading the topic, there were some new information garnered especially on ondansetron, since it is more commonly used in my current practice setting&#160;\nI am aware of the risk of hyperglycemia however to add to your point, there have been concerns surrounding the use of dexamethasone in the<span lang=\"EN-US\">&#160;pediatric oncology population. For those patients </span><span lang=\"EN-US\">who undergo anesthesia for bone marrow biopsy or lumbar puncture, the mechanism of action is unclear, but it is stated that glucocorticoids can interfere with cell counts and chemotherapy management and in rare cases can cause tumor lysis syndrome.</span>\nThe use of the isopropyl is an old practice for many in the caribbean,, without them knowing the implications. It has been used very extensively by the older population and is used for every ailment including regular nausea and vomiting, pyrexia just to name a few things.\nReferences:\nFeinlab, J. Kwan, L. &amp; Yammani, A. (September, 2024). Postoperative nausea and vomiting. <a rel=\"noopener\" href=\"https://www.uptodate.com/contents/postoperative-nausea-and-vomiting?search=antiemetics%20of%20choice%20for%20post%20operative%20nausea%20and%20vomiting&amp;source=search_result&amp;selectedTitle=2%7E150&amp;usage_type=default&amp;display_rank=2\">Postoperative nausea and vomiting - UpToDate</a>\nStoelting, R. K., Flood, P., Shafer, S. L., &amp; Rathmell, J. P. (2014). Stoelting&#39;s Handbook of Pharmacology and Physiology in Anesthetic Practice. LWW\n<p style=\"margin: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:33.687Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Thanks, Adrian, for a detailed review on anti-emetics.&#160;\nNausea and vomiting are the most common post-anesthetic complications. Aside from unpleasantness for the patient and staff, postoperative nausea and vomiting (PONV) poses medical risks. Increased intra-abdominal pressure and forceful vomiting jeopardize abdominal suture lines or can disrupt hemostasis at the surgical site of neurosurgical, head and neck, thoracic, and intraabdominal surgeries. Elevated central venous pressure increases morbidity after ocular, tympanic, or intracranial procedures. PONV also increases the risk of aspirating gastric contents, especially if airway reflexes are impaired. Movement during PONV worsens postoperative pain and accentuates autonomic responses. Finally, PONV can delay discharge or necessitate the admission of ambulatory patients.\nAlthough routine anti-emetic prophylaxis is clearly unjustified, patients at high risk for PONV&#160;should receive special consideration. Therefore, the identification of at-risk patients is the keystone in management.&#160;\nAdding onto Adrian\u2019s risk factors, we can group them into three categories.&#160;\nPatient-specific factors:\n<ul>\n<li>Female</li>\n<li>Non-smoking status</li>\n<li>History of PONV or motion sickness</li>\n<li>History of migraines \u2013 This has been identified as a new risk factor.</li>\n</ul>\nAnesthetic risk factors:\n<ul>\n<li>Use of volatile anesthetics within 2 hours</li>\n<li>Use of nitrous oxide</li>\n<li>Use of intraoperative and postoperative opioids</li>\n</ul>\nSurgical risk factors:<br/><span style=\"font-size: 0.95rem;letter-spacing: 0.02rem;\"></span>\n<ul>\n<li><span style=\"font-size: 0.95rem;letter-spacing: 0.02rem;\">Duration of surgery \u2013 Each 30-minute increase in surgical duration increases PONV risk by ~20%</span></li>\n<li>Type of surgery \u2013 laparoscopy, ear-nose-throat, neurosurgery, breast, strabismus, laparotomy, plastic surgery</li>\n<li>Significant blood loss during surgery can also contribute</li>\n</ul>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:33.687Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Hi Paula,\nThanks for sharing that isopropyl is a Caribbean remedy. It reminds me of a Chinese remedy of peppermint oil and white flower oil that my grandmother always applies below her nose to alleviate nausea.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:33.687Z"
            }
        ]
    },
    {
        "Thread Title": "Question 21",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/95/View",
        "Question": "<p>Question 21: What are some anesthesia considerations regarding patients taking Semaglutide (Ozempic)?</p>",
        "Responses": [
            {
                "Author": "Gregori Kuran",
                "Content": "The use of semaglutide and other glucagon-like peptide-1 (GLP-1) drugs have surged in popularity since their FDA approval in 2017.[1] While initially approved as a drug to aid in the management of blood sugar levels when paired with lifestyle changes such as diet and exercise, it has since gained popularity as a weight loss drug amongst the general population.1,2 Semaglutide works by stimulating the release of insulin and in turn leads to delayed gastric emptying.2 This delayed gastric emptying leads to concerns for patient who are fasting in anticipation for a general anesthetic. These incidences have been observed with patient undergoing elective esophagogastroduodenoscopy.2 With the delayed gastric emptying that occurs with semaglutide/GLP-1 drugs comes the increased risk gastric regurgitation and aspiration during anesthesia.3\nAs these are relatively new drugs (GLP-1) that have quickly gained popularity in recent years there are differing opinions on how to manage patients taking semaglutide (GLP-1) while receiving a general anesthetic. For example the American Society of Anesthesiologist recommends that patients stop taking semaglutide (GLP-1) one day before receiving a general anesthetic for those taking daily injections. While those who are on a weekly dose should stop 1 week before.2 An editorial published in the Canadian Journal of Anesthesiology gave similar recommendations but differing lengths of cessation of the drug. The recommendation given in this editorial was to stop semaglutide 3 weeks prior to general anesthesia.3 It is important to be cognizant of those patients taking semaglutide for type 2 diabetes versus weight loss management, a joint decision should be made in consultation with their endocrinologist on risk/benefits of the cessation of the drug prior to anesthesia.3\nThe cessation of the injection/drug prior to anesthesia may not be feasible in every situation, in such cases it should be assumed that the patient has a full stomach and a rapid sequence induction should be considered.3,4 Increasing the fasting period for patients taking semaglutide remains controversial as their isn\u2019t clear evidence on its safety nor how long would be required to ensure gastric emptying.3,4\nOther important factors to consider:\n&#183;&#160;&#160;&#160;&#160;&#160; Patients undergoing a procedure with moderate/deep sedation are particularly at risk as they do not have a protected airway in the event of gastric regurgitation.2\n&#183;&#160;&#160;&#160;&#160;&#160; Patients taking higher doses of semaglutide for weight loss management versus those taking lower doses as typically seen in type 2 diabetes management are hypothesized to be at a higher risk of delayed gastric emptying.3\n&#183;&#160;&#160;&#160;&#160;&#160; Patients who have recently started taking semaglutide (GLP-1) are at a increased risk of gastric emptying as well as those experiencing gastrointestinal side effects from the drug such as nausea, vomiting, and abdominal distension.3\n&#183;&#160;&#160;&#160;&#160;&#160; An abdominal ultrasound can be used prior to anesthesia to verify the gastric contents.3,4\n&#160;\n1.Research C for DE and. Drug Trial Snapshot: Ozempic. FDA [Internet]. 2020 Aug 20 [cited 2024 Oct 5]; Available from: <a rel=\"noopener\" href=\"https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trial-snapshot-ozempic\">https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trial-snapshot-ozempic</a>\n&#160;\n2.Fezza R, Rains B, Fezza T, Fezza JP. Emerging Anesthesia Risks with Semaglutide. Plast Reconstr Surg Glob Open [Internet]. 2023 Nov 21 [cited 2024 Oct 4];11(11):e5427. Available from: <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662908/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662908/</a>\n3. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Risk of Aspiration during Anesthesia [Internet]. [cited 2024 Oct 5]. Available from: <a rel=\"noopener\" href=\"https://ismpcanada.ca/bulletin/glucagon-like-peptide-1-glp-1-receptor-agonists-risk-of-aspiration-during-anesthesia/\">https://ismpcanada.ca/bulletin/glucagon-like-peptide-1-glp-1-receptor-agonists-risk-of-aspiration-during-anesthesia/</a>\n&#160;\n4. &#160;Canadian Anesthesiologists&#39; Society. CAS Medication Safety Bulletin. [document on the internet]. Toronto, Ontario: 2023 [cited 2024 Oct 5]. Available from: <a rel=\"noopener\" href=\"https://www.cas.ca/CASAssets/Documents/Advocacy/Semaglutide-bulletin_final.pdf\">https://www.cas.ca/CASAssets/Documents/Advocacy/Semaglutide-bulletin_final.pdf</a>\n&#160;\n&#160;\n&#160;",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4794/ViewAttachment?fileId=445450",
                        "filename": "Pharmacology Key Question copy.docx"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:37.805Z"
            },
            {
                "Author": "Mary Johnsy Joseph",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Hi Gregori, thank you for explaining anesthesia considerations regarding patients taking </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Semaglutide (Ozempic). It is interesting to know that semaglutide may cause delayed &#160;&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">gastric emptying and residual gastric contents, controversies arise on preoperative </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">medication management, adequate preoperative fasting periods, utilization of gastric </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">ultrasound, and rapid sequence induction and intubation to mitigate the risks of </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">regurgitation and pulmonary aspiration of gastric contents during anesthesia care (Beam, </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">et, al., 2014). </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160; In my workplace, all ophthalmologists instruct the patient who undergoes cataract </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">surgery to hold Ozempic for one week before surgery. People with diabetes sometimes </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">experience abnormally high blood sugar levels, which can cause blood vessels in the eye to </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">leak. This is a leading cause of vision loss. &#160;There is a potential risk of the development of </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">non-arteritic ischemic optic neuropathy (NAION) (Hazanchuk, 2024).&#160; Semaglutide helps </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">people lose weight and control their blood sugar by releasing the hormone called GLP-1, </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">also prompts the body to create more insulin, which reduces blood sugar. When the body </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">experiences a change in sugar level, it can affect the shape of the&#160;eye\u2019s lens causes </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">diabetic retinopathy. This change is what causes blurry vision, a side effect of semaglutide </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">(Hazanchuk, 2024).</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; American society of anesthesiologists (2023) explained that the Day or week prior to the procedure:</span>\n<ul type=\"disc\" style=\"margin-top: 0cm;margin-bottom: 0cm;\">\n<li style=\"margin-top: 0cm;margin-right: 0cm;margin-bottom: 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hold GLP-1 agonists on the day of the procedure/surgery for patients who take the medication daily.</span></li>\n<li style=\"margin-top: 0cm;margin-right: 0cm;margin-bottom: 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hold GLP-1 agonists a week prior to the procedure/surgery for patients who take the medication weekly.</span></li>\n<li style=\"margin-top: 0cm;margin-right: 0cm;margin-bottom: 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Consider consulting with an endocrinologist for guidance in patients who are taking GLP-1 agonists for diabetes management to help control their condition and prevent hyperglycemia (high blood sugar).</span></li>\n</ul>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: center;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">References</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hazanchuk, V. (2024). Can Ozempic Affect Eye Health? Here\u2019s What Ophthalmologists </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Want You to Know. In <i>American academy of ophthalmology.</i> EyeSmart Publications. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a rel=\"noopener\" href=\"https://www.aao.org/eye-health/news/can-ozempic-affect-eye-health-here-s-what-%20%20%20ophthalm\">https://www.aao.org/eye-health/news/can-ozempic-affect-eye-health-here-s-what-&#160;&#160; ophthalm</a></span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Pai, S., Smith, A. M., Beam, W. B., &amp; Harbell, W. M. (2014). Perioperative Considerations for </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Patients on Semaglutide. In<i> SpringerNature. </i>SpringerNature Publications<i>.</i> </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><a rel=\"noopener\" href=\"https://link.springer.com/article/10.1007/s40140-024-00611-6\">https://link.springer.com/article/10.1007/s40140-024-00611-6</a> </b>14, 152-160</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">American Society of Anesthesiologists (2023). Patients Taking Popular Medications for &#160;&#160;&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Diabetes and Weight Loss Should Stop Before Elective Surgery, ASA Suggests, In <i>ASA, </i></span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ASA Publications. <a rel=\"noopener\" href=\"https://www.asahq.org/research-and-publications\">https://www.asahq.org/research-and-publications</a></span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:37.805Z"
            },
            {
                "Author": "Janelyne Mandegarian",
                "Content": "<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Hello Gregory and Mary,</span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">&#160;</span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Gregory thank you for clarifying the considerations of semaglutides and the increased risk for aspiration. Also, thank you Mary for tying this practice into your workplace. Very informative from both of you.&#160;</span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">I wanted to touch more on the point of care ultrasound for patients who are on semaglutides. The American Society of Anesthesiologist (ASA) recommends doing one at bedside, but it is to the discretion of the anesthesiologists. Ultrasounds are non-invasive, does not cause increased risk of radiation prior to surgery and simple to complete. It mitigates the risks of aspiration or to the least allows for health care providers to have the best plan of action and preparedness if risks is involved. If gastric contents are visualized, then risk must be evaluated on whether to continue with the procedure to lessens the level of risk either by delaying surgery, rescheduling date or proceeding with caution and discuss with the patient the risk or regurgitation and aspiration. If empty proceed as normal. If ultrasound is inconclusive or not possible, the presumptive action is they have \u201cfull stomach\u201d and proper precautions to be taken.</span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Interestingly, I found the parameters for Canadian Journal of anesthesiology (CJA) recommendation of 3 weeks to be lengthy but again the half life of semaglutides is 7 days and I want to note that my organizations uses the ASA recommendation as you both stipulated above (1 week).&#160;<span style=\"font-size: 12pt;line-height: 115%;\">It has been discussed there may be increased risk for patients undergoing conscious sedation or deep sedation as there is no endotracheal tube (ETT) protecting the airway (Fezza, 2023). <span style=\"font-size: 12pt;line-height: 115%;font-family: arial, helvetica, sans-serif;\">There is varying level of the severity for aspiration like hypoxia, airway obstruction, acute respiratory distress syndrome (ARDS), complete respiratory failure or death. Gastric contents can change the level of severity with PH, volume aspirated and sterility of the contents (Nason, 2015). If doing a point of care ultrasound mitigates the unnecessary pulmonary aspiration risk which in turns alleviates the potential for rapid intubation and ICU admission, should it not be done pre-operatively and put into protocol?&#160;</span></span></span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">&#160;</span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">References</span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\"></span>\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">The American Society of Anesthesiologists. (2023). <i>Patients Taking Popular Medications for Diabetes and Weight Loss Should Stop Before Elective Surgery, ASA Suggests</i> <a rel=\"noopener\" href=\"https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/patients-taking-popular-medications-for-diabetes-and-weight-loss-should-stop-before-elective-surgery\">https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/patients-taking-popular-medications-for-diabetes-and-weight-loss-should-stop-before-elective-surgery</a></span>\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\"></span>\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Fezza, R., Rains, B., Fezza, T., &amp; Fezza, J. P. (2023). Emerging Anesthesia Risks with Semaglutide. <i>Plastic and reconstructive surgery. Global open</i>,&#160;<i>11</i>(11), e5427. <a rel=\"noopener\" href=\"https://doi.org/10.1097/GOX.0000000000005427\">https://doi.org/10.1097/GOX.0000000000005427</a></span>\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\"></span>\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Nason K. S. (2015). Acute Intraoperative Pulmonary Aspiration.&#160;<i>Thoracic surgery clinics</i>,&#160;<i>25</i>(3), 301\u2013307. <a rel=\"noopener\" href=\"https://doi.org/10.1016/j.thorsurg.2015.04.011\">https://doi.org/10.1016/j.thorsurg.2015.04.011</a></span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: arial, helvetica, sans-serif;\"><b>&#160;</b></span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:37.805Z"
            },
            {
                "Author": "Meera Sathananthan",
                "Content": "Hello Gregori, Mary, and Janelyne,\nThank you all for your discussion on the anesthesia management of patients taking semaglutide (Ozempic). It&#39;s especially important with more people using it off-label nowadays for diet regimens.&#160; Off-label use of semaglutide for weight loss carries potential risks, such as gastrointestinal side effects, dehydration, and possible electrolyte imbalances, which can also complicate anesthesia management. These risks are highlighted in clinical literature that associates GLP-1 receptor agonists with delayed gastric emptying and gastrointestinal disturbances (1).\nAs a respiratory therapist, I\u2019d like to expand a bit more on the airway management considerations and monitoring strategies in these high-risk patients, particularly with the increased risk of aspiration.&#160;\nPatients on semaglutide are at increased risk of having delayed gastric emptying, which can lead to residual gastric contents and subsequently increases the risk of regurgitation and aspiration during anesthesia. For these patients, I would emphasize the importance of a rapid sequence induction (RSI) approach, as Gregori mentioned, with cricoid pressure as part of standard airway management (1, 2). Cricoid pressure involves applying pressure to the cricoid cartilage to occlude the esophagus, thereby reducing the risk of gastric content regurgitation during induction (Figure 1.0). This provides an extra layer of safety when a full stomach is assumed.<br/><br/><img alt=\"Technique to apply cricoid pressure\" src=\"https://i0.wp.com/airwayjedi.com/wp-content/uploads/2022/02/Cricoid-blog.png?resize=780%2C528&amp;ssl=1\" style=\"max-width: 100%;\"/>\n_Figure 1: The application of cricoid pressure during intubation. Not only does this help provide a better view of the airway but helps in occluding the esophagus, acting as a barrier for potential gastric aspiration (3)._\n<br/>Additionally, it&#39;s important to consider the use of a laryngeal mask airway (LMA) carefully. Given the risks, it would be prudent to avoid LMAs in patients on semaglutide when possible, as they do not provide the level of airway protection as endotracheal intubation. LMAs do not create a complete seal against gastric regurgitation, which increases the risk of aspiration in high-risk patients (2). Instead, opting for endotracheal intubation would better protect the airway in the event of regurgitation, particularly during general anesthesia or deep sedation.\nMonitoring for signs of aspiration is crucial during the perioperative and postoperative periods. Specific monitoring techniques such as capnography, auscultation, and close observation of oxygen saturation can help in detecting early signs of aspiration. Indicators such as a sudden drop in oxygen saturation, increasing ventilation pressures, wheezing, or respiratory distress should prompt rapid intervention to prevent further complications like acute respiratory distress syndrome (ARDS) or even respiratory failure (2).\nFurthermore, the use of sedation techniques can also significantly impact risk. Procedures involving moderate or deep sedation should be approached with caution, given that the lack of a protected airway increases the risk for aspiration if gastric contents are present (1). Where possible, regional anesthesia might be considered as an alternative to general anesthesia, especially in patients with poorly controlled diabetes or those at a higher risk due to residual gastric contents.\nLastly, the use of bedside gastric ultrasound as a standard practice for patients on semaglutide could aid in visualizing gastric contents, thereby allowing for a more tailored anesthesia approach. As Janelyne pointed out, if ultrasound findings suggest full gastric contents, RSI or even postponing surgery may be warranted (1). Given the non-invasive nature and utility of ultrasound, incorporating it into preoperative protocols could significantly reduce unnecessary aspiration risks. Other considerations is potentially asking patients to fast longer; some sources even suggest 36 hour long liquid diets prior to OR if patients are on Ozempic in order to reduce the risk of a full stomach (4).\nThank you again for this informative thread\u2014I hope my perspective on airway management and the use of sedation techniques adds to the discussion. It will be interesting to go back to work to see if there are any guidelines or procedures in place for patients in the OR on semaglutides.&#160;<br/><br/>Sincerely,<br/><br/>Meera\n<div>**References**</div>\n1. Fezza R, Rains B, Fezza T, Fezza JP. Emerging Anesthesia Risks with Semaglutide. Plast Reconstr Surg Glob Open. 2023 Nov 21;11(11). Available from:&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1097/GOX.0000000000005427\">https://doi.org/10.1097/GOX.0000000000005427</a>\n2. Nason KS. Acute Intraoperative Pulmonary Aspiration. Thoracic surgery clinics. 2015;25(3):301-307. Available from:&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1016/j.thorsurg.2015.04.011\">https://doi.org/10.1016/j.thorsurg.2015.04.011</a>\n3. Whitten C. Cricoid pressure requires communication &amp; teamwork [Internet]. The Airway Jedi; 2022 Feb 22 [cited 2024 Oct 6]. Available from:&#160;<a rel=\"noopener\" href=\"https://airwayjedi.com/2022/02/22/cricoid-pressure-requires-communication-teamwork/\">https://airwayjedi.com/2022/02/22/cricoid-pressure-requires-communication-teamwork/</a>\n4. Fujino E, Cobb KW, Schoenherr J, Gouker L, Lund E. Anesthesia considerations for a patient on semaglutide and delayed gastric emptying. Cureus. 15(7):e42153.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:37.806Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Excellent contribution from everyone! This is a great venue to share our institutions&#39; current practice with Semaglutide.&#160;\nAt the University Health Network, we ask patients who use Semaglutide for weight loss to stop three weeks before surgery. For diabetes, we ask the patient to stop one week before surgery. I have also attached our pre-operative guide for Semaglutide.\nI want to add to Janey\u2019s post that the pH and volume of gastric contents can affect the aspiration severity level. Aspiration of a gastric fluid volume &gt; 25 mL with a pH &lt; 2.5 will cause pulmonary injury. In addition to rapid-sequence induction, we can give oral antacids or histamine-2-receptor antagonists as preventive measures. Oral antacids like sodium citrate can be given 15 \u2013 30 minutes before the induction of anesthesia. It effectively neutralizes stomach acid, reducing the risk of aspiration pneumonitis. Histamine-2-receptor antagonists reduce gastric acid secretion by blocking the ability of histamine to induce acidic secretion. However, they do not reliably affect gastric fluid volume or gastric-emptying time.&#160;\nEven with all the preventive measures, if aspiration occurs and gastric contents are noted in the pharynx, the head should immediately be displaced laterally, the pharynx cleared by suction, and the patient should be intubated if pharyngeal reflexes are absent. Also, the head-down position will facilitate the removal of secretions and prevent gastric contents from tracking down the trachea from the pharynx by gravity. Patients should then be observed for 24 to 48 hours for aspiration pneumonitis.&#160;",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/6692/ViewAttachment?fileId=474863",
                        "filename": "Semaglutide Guideline Flow Diagram.pdf"
                    }
                ],
                "Timestamp": "2024-12-07T22:57:37.806Z"
            }
        ]
    },
    {
        "Thread Title": "Question 22",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/94/View",
        "Question": "<p>Question 22: Compare and contrast the advantages and disadvantages of different routes of administering analgesics for managing postoperative pain.</p>",
        "Responses": [
            {
                "Author": "Teresa Nguyen",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">By effectively treating post-operative pain, healthcare providers can help improve surgical outcomes and lower cost of hospitalizations (3). Every patient is different. Choosing the most appropriate form of analgesia for the patient requires considering the route of administration, dosage, limitations and contraindications (3). I have summarized the advantages and disadvantages into the following table: </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\" style=\"border-collapse: collapse;border: none;\">\n<tbody>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Oral</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Simple and non-invasive compared to other routes (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Good efficacy (similar to the IV route) (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Can be immediate release or controlled release (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Contraindicated in patients experiencing vomiting or delayed gastric emptying (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Risk of \u201cdumping effect\u201d which occurs when patients ingest oral analgesics before they gain regular gastric motility leading to accumulated doses entering the intestine at the same time leading to systemic uptake of a large amount of analgesics (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">IV</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages: </span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Fastest route (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">IV route ensures rapid onset of pain relief without the uncertainty of other medications absorbed by other routes (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">PCA (Patient Controlled Analgesia) allows patients who have adequate cognitive function to gain flexibility to use their PCA pump independently (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">More costly in terms of opioids, paracetamol or nonsteroidal anti-inflammatory drugs (NSAID) (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">PCA pumps with a continuous infusion increases risk of nausea, vomiting and respiratory events (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Certain IV medications have less bioavailability and tolerability when compared to their oral version (e.g. paracetamol) (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">IM/ subcut</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Enters systemic circulation, bypassing the first-pass metabolism (1)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Muscles are highly vascularized (1)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Poor perfusion (e.g hypovolemia or hypothermia) can impact absorption leading to inadequate pain relief and/or late side effects when the medication distributes when perfusion improves (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Transdermal</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Non-invasive and easy to apply (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">When applied to the skin, analgesics are systemically absorbed (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Onset and offset times are slow (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Unable to titrate medications on a short-term basis (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Transmucosal</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Rapidly enters the systemic circulation bypassing hepatic metabolism (first-pass metabolism) (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Routes include sublingual, buccal, intranasal and rectal (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Can be self-administered (2)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages: </span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Limited if patient experiences emesis (sublingal and buccal route cannot be given) (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Drug dissolution and absorption is a challenge with patients who have dry mucosa (e.g. dry mouth condition) (2)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Risk of choking and aspiration in young or elderly patients (2)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Small surface area for absorption (2)</span></li>\n</ul>\n<p style=\"margin: 0cm 0cm 0cm 18pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Rectal</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Fairly easy to administer (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Rapid systemic drug absorption as the rectal mucosa is highly vascularized (2)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Not limited by emesis (2)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Varying absorption and rectal irritation amoung patients (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Contraindicated in patients who are immunocompromised, patients with pre-existing rectal lesions, and patients who recently underwent colorectal surgery (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Poor patient acceptance (2)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Leakage may occur (2)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Epidural</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Higher efficacy than IV opioids (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Suggested for high-risk patients (e.g. increased risk of cardiac or pulmonary complications and prolonged ileus) during thoracic, abdominal and lower limb surgery (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Can be used adjunctively with opioids or local anesthetics to improve pain relief (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Epidural infusions have higher effectiveness and less adverse effects in comparison to PCA infusions (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Adverse effects include respiratory depression and severe hypotension (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">There is risk of epidural hematoma or epidural abscess which may cause paraplegia (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Requires close monitoring (e.g insertion, catheter removal, dose de-escalation, and antagonist administration) (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Intrathecal</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Better pain control compared to IV administration (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">More frequent side effects than IV opioids: respiratory depression, urinary retention, nausea, vomiting and pruritis (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 77.75pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Peripheral Block</span>\n</td>\n<td valign=\"top\" style=\"width: 389.75pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Advantages: </span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Recommended for specific procedures: breast surgery, cesarean section, thoracotomy, and abdominal surgeries (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Highly suggested for surgeries of the extremities (3)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Disadvantages:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Risk of local anesthetic systemic toxicity and nerve injury (however, ultrasound guidance will greatly reduce these risks) (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Other risks include bleeding and infection (3)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Clinicians must adhere to specific guidelines when administering peripheral blocks (3)</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">1. Gutierrez, J., &amp; Munakomi, S. (2023).&#160;<i>Intramuscular injection.</i> StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK556121/</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">2. Lam, J., Cheung, C., Chow, M., Harrop, E., Lapwood, S., Barclay, S., &amp; Wong, I. (2020). Transmucosal drug administration as an alternative route in palliative and end-of-</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;padding-left: 40px;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">life&#160;</span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">care during the covid-19 pandemic. <i>Advanced Drug Delivery Reviews, 160</i>, 234-243. https://doi.org/10.1016/j.addr.2020.10.018</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">3. Puntillo, F., Giglio, M., &amp; Varrassi, G. (2021). The routes of administration for acute postoperative pain medication.&#160;<i>Pain Therapy, 10</i>(2), 909-925. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;padding-left: 40px;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">https://doi.org/10.1007/s40122-021-00286-5</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.679Z"
            },
            {
                "Author": "Mary Johnsy Joseph",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hi Teresa, thank you for sharing in detail regarding management of post operative pain. The table describes summary of each administration route, advantages and disadvantages.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160; Brennan et. al., (2023) stated that it is very important to know that post operative pain management is best tailored to individual and recommends that clinicians provide patient and family-centered, individually tailored education to the patient (and/or responsible caregiver), including information on treatment options for management of postoperative pain, and document the plan and goals for postoperative pain management.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">To discuss about intrathecal drug administration, orthopedic surgeons at my workplace use a triple mix solution. It is a periarticular cocktail injection consisting of 60 mL of normal saline, 30mL of 10% ropivacaine, ketorolac 30 mg, and 1 mL of adrenaline (total volume: 92 mL). This injection is administered after total joint implants placement. The organization policy recommends the use of periarticular infiltration is an effective adjunct to multimodal pain management following a joint replacement. The decision to administer triple mix solution is discussed during the briefing period of surgical procedures in which the patient and entire surgical team pauses to do the surgical safety checklist. One of the discussion sections is regarding the administration of triple mix solution. Adverse effects of ketorolac are similar to those of other NSAIDs, including gastrointestinal bleeding, nausea/vomiting, peptic ulceration, renal failure and increased bleeding due to inhibited platelet function, which may limit its effectiveness in many patients receiving total knee arthroplasty (King et. al., 2023) During perioperative checking, glomerular filter rate and creatinine clearance values are also mentioned during briefing time before surgery begins. Patients with impaired renal function receive a double mix solution which excludes ketorolac.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: center;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">References</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">King, G. A., Le, Alexander., Nickol Michaela., Sarkis, Bianca., Merwe, M. Johannes., (2023) &#160;&#160;&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;Periarticular infiltration used in total joint replacements: an update and review article. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <i>Journal of orthopedic surgery and research.</i></span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641975/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641975/</a><span style=\"color: #212121;background: white;\">13;18(1):859. </span></span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">Roger, Chou., Gordon, B. Debra., Leon-Casasola, A. Oscar., Rosenberg, M. Jack,, Bickler, &#160;&#160;&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;Stephen., Brennan, Tim., Carter, Todd., Cassidy, L. Carla., Chittenden, H. Eva., &#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Degenhardt, Edith., Griffith, Scott., Manworren, Renee., McCarberg, Bill., </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Montgomery, Robert., Murphy, Jamie., Perkal, F. Melissa., Suresh, Santhanam., </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Sluka, Kathleen., Strassels, Scott., Thirlby, Richard., Viscusi, Eugine., Walco, A. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Garry., Warner, Lisa., Weisman, J. Steven., &amp; Wu, L. Christopher. (2016). </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management of postoperative pain: A clinical practice guideline from the </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;American pain society, the American society of regional anesthesia and pain </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; medicine, and the American society of Anesthesiologists&#39; committee on regional </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; anesthesia, executive committee, and administrative council. In <i>Pubmed,</i> Elsevier </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: #212121;background: white;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; publications. <a rel=\"noopener\" href=\"https://pubmed.ncbi.nlm.nih.gov/26827847/\">https://pubmed.ncbi.nlm.nih.gov/26827847/</a> 17(2):131-57.</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.679Z"
            },
            {
                "Author": "Laryssa Hartmann",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hi Teresa, </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">I really appreciated the comparison that you made between the different routes of administrations for managing postoperative pain. The table was very helpful in understanding the advantages and disadvantages of each route of administration. I think it is important to carefully consider both the disadvantages and advantages to make the right decision for the patient.&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Mary, I also appreciated your example from your workplace. It is essential to consider a multimodal analgesia approach when managing postoperative pain. One study I found analyzed data from over 1.5 million patients who had hip or knee surgery from 2006 to 2016 (Memtsoudis et al., 2018). Patients were divided into two groups: the first group was only given only opioids as a post operative pain management, while the second group was given a combination of opioids and other methods (such as peripheral nerve blocks, acetaminophen, steroids, NSAIDs, cyclooxygenase 2 inhibitors or ketamine). This study showed that patients receiving a combination of opioids with other methods had fewer respiratory complications, fewer gastrointestinal complications and a decrease in length of hospital stay (Memtsoudis et al., 2018). This research supports the combination method that Mary uses at her workplace as a better pain management approach after surgery. &#160;The American Society of Anesthesiologists also recommends using a multimodal approach to manage acute pain after surgery to target different pain pathways (Helander et al., 2017). Utilizing this approach enhances pain relief and overall patient comfort. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">References: </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;<span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Helander, E. M., Medard, B. L., Harmon, C. M., Homra, B. K., Allain, A. V., Bordelon, G. J., Wyche, M. Q., Padnos, I. W., Lavrova, A., &amp; Kaye, A. D. (2017). Multimodal analgesia, current concepts, and acute pain considerations. In <i>Springer Link</i>. Retrieved October 5, 2024, from https://link.springer.com/article/10.1007/s11916-017-0607-y </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Memtsoudis, S., Poeran, J., Zubizarreta, N., Cozowicz, C., M&#246;rwald, E., Mariano, E., &amp; Mazumdar, M. (2018). Association of Multimodal Pain Management Strategies with Perioperative Outcomes and Resource Utilization. In <i>ASA Publications</i>. Retrieved October 5, 2024, from https://pubs.asahq.org/anesthesiology/article/128/5/891/18261/ Association-of-Multimodal-Pain-Management</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.679Z"
            },
            {
                "Author": "Janelyne Mandegarian",
                "Content": "<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Hi Theresa and Mary!\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">I appreciate the thorough break down of the routes of analgesia and the highlights it provides. I also agree with the multimodal approach with postoperative pain as it reduces length of hospital stay, greater outcome for pain management, it was reported that less than 50% of patient\u2019s have proper pain control and 39% of those experience severe or extreme levels of pain (Cheung et al, 2022).\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">I concur pain is subjective to each individual and it can have varying factors that contribute to a patient\u2019s tolerance, threshold and previous experiences. It is important to mention that pain management does not start intraoperatively, it can be initiated in stages through their process through different routes. I think in anesthesia it is important to have protocols and guidelines in place to accomplish early recovery after surgical procedures using evidence-based practice (Melnyk et al, 2011) like Enhanced Recovery After Surgery (ERAS) protocol which is a multimodal perioperatively pathways. In Mary\u2019s example of patients with total knee arthroplasty (TKA) I can also corroborate the intrathecal administration cocktail of medication but more so prior to surgery anesthesiologist order Celebrex 200mg and Tylenol 1 gram PO pre-operatively at least 1 hours before their surgery in my organization and observed to be effective as it effects different pathways and they work synergistically when combined (Cheung et al, 2022). It should also be pointed out that patients who undergo TKA can have spinals and peripheral nerve blocks which has shown patients mobilize earlier, reduce narcotic consumption, have improved pain scores and decreased hospitalization stay (Hasegawa, 2022). This last point is especially important if TKA are elective same day surgery and by experience the multimodal pain management been successful for our patients to going home the same day after TKA and can clear physiotherapy and to continue further success at home. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Melnyk, M., Casey, R. G., Black, P., &amp; Koupparis, A. J. (2011). Enhanced recovery after surgery (ERAS) protocols: Time to change practice?.&#160;<i>Canadian Urological Association journal = Journal de l&#39;Association des urologues du Canada</i>,&#160;<i>5</i>(5), 342\u2013348. <a rel=\"noopener\" href=\"https://doi.org/10.5489/cuaj.11002\">https://doi.org/10.5489/cuaj.11002</a>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Cheung, C. K., Adeola, J. O., Beutler, S. S., &amp; Urman, R. D. (2022). Postoperative Pain Management in Enhanced Recovery Pathways.&#160;<i>Journal of pain research</i>,&#160;<i>15</i>, 123\u2013135. <a rel=\"noopener\" href=\"https://doi.org/10.2147/JPR.S231774\">https://doi.org/10.2147/JPR.S231774</a>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Hasegawa, M., Singh, D., Urits, I., Pi, M., Nakasone, C., Viswanath, O., &amp; Kaye, A. D. (2022). Review on Nerve Blocks Utilized for Perioperative Total Knee Arthroplasty Analgesia.&#160;<i>Orthopedic reviews</i>,&#160;<i>14</i>(3), 37405. https://doi.org/10.52965/001c.37405",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.679Z"
            },
            {
                "Author": "Mary Johnsy Joseph",
                "Content": "Please see the references with correction, my apologies.\n<p style=\"text-align: center;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">References</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">King, G. A., Le, A., Nickol M., Sarkis, B., &amp; Merwe, M. J. (2023). &#160;Periarticular infiltration used </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; in total joint replacements: an update and review article. <i>Journal of orthopedic surgery </i></span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><i><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and research.</span></i>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641975/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641975/</a>13;18(1), 859.</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Roger, C., Gordon, B. D., Leon-Casasola, A. O., Rosenberg, M. J., Bickler,&#160;S., Brennan, T., Carter, &#160;</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; T., Cassidy, L. C., Chittenden, H. E., Degenhardt, E., Griffith, S., Manworren, R., &#160;</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; McCarberg, B., Montgomery, R., Murphy, J., Perkal, F. M., Suresh, S.,&#160;Sluka, K., </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Strassels, S., Thirlby, R., Viscusi, E., Walco, A. G., Warner, L., Weisman, J. S., &amp; Wu, L. </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; C. (2016). Management of postoperative pain: A clinical practice guideline from the </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; American pain society, the American society of regional anesthesia and pain medicine, and &#160;</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the American society of Anesthesiologists&#39; committee on regional anesthesia, executive </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; committee, and administrative council. In&#160;<i>Pubmed,</i>&#160;Elsevier Publications.</span>\n<span style=\"font-size: 12.0pt;line-height: 115%;font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a rel=\"noopener\" href=\"https://pubmed.ncbi.nlm.nih.gov/26827847/\">https://pubmed.ncbi.nlm.nih.gov/26827847/</a>&#160;17(2), 131-57</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.679Z"
            },
            {
                "Author": "Reneerose Ong",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Thank you for providing a detailed comparison of the different routes of administration for post-operative analgesia. Your table clearly outlines the advantages and disadvantages of each route, making it easier to understand their clinical applications.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">I agree that effective pain management is crucial for improving patient outcomes, as post-operative pain can significantly impact recovery time and overall patient satisfaction (Puntillo et al., 2021). A common goal for surgical centers is to provide painless hospitalization, with an emphasis on a short hospital stay, early home discharge, and quick return to normal activities (Zieli\u0144ski et al., 2022). This aligns with the effective management of post-operative pain, which also helps prevent complications that could lead to re-hospitalization. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">I\u2019d like to expand on Janelyne\u2019s point that pain management doesn\u2019t begin intraoperatively but can start in the pre-operative phase. At my workplace it is common practice for patients to receive acetaminophen pre-operatively. &#160;Surgeries like adenoidectomy, tonsillectomy, and adenotonsillotomy, which are among the most common pediatric surgeries worldwide, are associated with severe post-operative pain (Zieli\u0144ski et al., 2022). Research on pain management has led to the introduction of pre-emptive analgesia, where analgesics are administered before the onset of surgical pain stimuli and continued intraoperatively (Zieli\u0144ski et al., 2022). Zieli\u0144ski et al. (2022) randomized control trial, demonstrated that pre-operative administration of acetaminophen significantly reduced post-operative pain in children undergoing otolaryngology procedures, highlighting the effectiveness of pre-emptive analgesia administration.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Overall, your post illustrates the complexity of post-operative pain management and the need for individualized approaches. Each method has its own benefits and limitations, and the choice of analgesia should strike a balance between maximizing pain relief and minimizing adverse effects.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;\">Reference: </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Zieli\u0144ski, J., Morawska-Kochman, M., Dudek, K., Czapla, M., &amp; Zato\u0144ski, T. (2022). The </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Effect of Pre-Emptive Analgesia on the Postoperative Pain in Pediatric </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Otolaryngology: A Randomized, Controlled Trial. _Journal of clinical_&#160; </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><i><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">medicine</span></i><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"><span style=\"text-align: start;float: none;\">,&#160;</span><i style=\"text-align: start;\">11</i><span style=\"text-align: start;float: none;\">(10), 2713. <a rel=\"noopener\" href=\"https://doi.org/10.3390/jcm11102713\">https://doi.org/10.3390/jcm11102713</a> </span></span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Puntillo, F., Giglio, M., &amp; Varrassi, G. (2021). The Routes of Administration for Acute </span>\n<p style=\"text-indent: 36pt;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\">Postoperative Pain Medication. _Pain and therapy, 10_(2), 909-925.&#160;&#160;</span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Calibri Light&#39;, sans-serif;color: #212121;background: white;\"><a rel=\"noopener\" href=\"https://doi.org/10.1007/s40122-021-00286-5\">https://doi.org/10.1007/s40122-021-00286-5</a> </span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.679Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "I just want to clarify some terminology.&#160;\nIntrathecal administration is when we inject medication directly into the subarachnoid space in the spinal cord to mix with the cerebrospinal fluid. By bypassing the blood-brain barrier, intrathecal administration allows for more effective delivery of drugs to the brain and spinal cord. This route is used in spinal blocks for procedures done under regional anesthesia. Residual of the spinal block may be carried postoperatively. However, it is rarely indicated for just for acute postoperative pain management.\nThe periarticular injection, mentioned by Mary, is more commonly known as local infiltration analgesia. This is when the surgeon injects medication around a joint to manage pain during or after surgery. This can also be used to supplement partial or patchy regional blocks or extend the wearing-off of single-shot blocks.\nThe most common approach to using local anesthetics in postoperative pain management is through local infiltration shots and boluses or infusion via an epidural catheter or peripheral nerve catheter.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.679Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Excellent discussion!&#160;\nAll of you have brought different important aspects of postoperative pain management. Multimodal analgesia is the way to go, where we use a combination of different medications and techniques to target various pain pathways and mechanisms so that we can provide more effective pain relief while minimizing the side effects associated with high doses of a single medication.\nAs Janey and Renee pointed out, multimodal analgesia is not limited to postoperatively but is incorporated throughout the preoperative, intraoperative, and postoperative phases. Furthermore, especially with the opioid epidemic, we are looking into other medications to reduce opioid consumption while enhancing pain control and improving overall patient outcomes. Other medications include non-opioid analgesics, local anesthetics, Ketamine, and adjuvant medications such as Gabapentinoids, antidepressants, anxiolytics, and muscle relaxants. Even non-medicinal approaches can play a role, such as music therapy, meditation, and acupuncture, to name a few.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.680Z"
            },
            {
                "Author": "Shawn Page",
                "Content": "Teresa, that was a great post.&#160; &#160;I&#160; found it very clear, and was a great summary and comparison without being all wordy.\nMary, I&#39;d like to expand on what you said about pain control being tailored to each pt. I am going to be personal here.&#160; Last week I had hip resurfacing surgery, I was planning on same day discharge. However plans changed when my BP dropped to the 80s whenever I tried to ambulate, and I am not a small guy.\nMy pain was 10/10 and despite multiple tabs of hydromorphone it would not change.&#160; Then I was switched to hydromorph injections about Q30-45mins.&#160; It took the edge off, but I was still at 9/10.&#160; The pain team came and assessed me, and I was switched to a hydromorph PCA.&#160; I was finally able to get the pain down to a 4 and was able to get a tiny bit of sleep that night.&#160; I know that I was under a pain management order set.&#160; But I appreciate that my nurse saw that it wasn&#39;t working and activated the pain team to come and see me.&#160; I was assessed, and a new plan of care was created that ended up working for me.&#160; So I am totally glad that you mentioned that pain control should always be pt specific.&#160; Thank you for including this.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:42.680Z"
            }
        ]
    },
    {
        "Thread Title": "Question 3",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/113/View",
        "Question": "<p>Question 3: Compare and contrast the advantages and disadvantages of general and regional anesthesia.</p>",
        "Responses": [
            {
                "Author": "Kurt Protacio",
                "Content": "When it comes to the option of using general versus regional anesthesia during a case, there are many factors to consider. General anesthesia (GA) is used to induce the entire body, maintain loss of consciousness, and after the procedure, provides the patient with no recollection of the operation. On the other hand, regional anesthesia (RA) is an option in which a portion of the body, usually lower, is anesthetized to provide a numbing and pain-free effect. Ongoing studies are being performed and reviewed to determine which route of anesthesia is best suited for different types of operations. A recent study in 2020 reviewed the use of GA and RA in Ontarians and concluded that the use of RA was linked to less days spent in hospital post operation combined with less in-hospital cardiovascular and renal complications (Roberts et al., 2020). On the other hand, RA provided to patients undergoing surgery did not significantly reduce the occurrence of postoperative delirium compared to GA and further studies are still needed to explore the best choice of anesthesia (Zhou, Zhang, Si &amp; Shen, 2023). In addition, a combination of both GA, RA and monitored anesthesia care (MAC) techniques can be beneficial in patient comfort during a procedure. For example, patients undergoing cerebral aneurysm coiling may start by receiving MAC, but can convert to using GA by the anesthesia provider should the need arise (Pardo, 2022).&#160; I have summarized and provided a list of other advantages and disadvantages of both GA and RA split into child and adult categories:\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\" style=\"width: 1102px;border-collapse: collapse;border: none;height: 688px;\">\n<tbody>\n<tr style=\"height: 47.0312px;\">\n<td valign=\"top\" style=\"width: 155.133px;border: 1pt solid windowtext;padding: 0cm 5.4pt;height: 47.0312px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><b>&#160;</b>\n</td>\n<td valign=\"top\" colspan=\"2\" style=\"width: 455.164px;border-top: 1pt solid windowtext;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-image: initial;border-left: none;padding: 0cm 5.4pt;height: 47.0312px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><b>Regional Anesthesia</b>\n</td>\n<td valign=\"top\" colspan=\"2\" style=\"width: 444.531px;border-top: 1pt solid windowtext;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-image: initial;border-left: none;padding: 0cm 5.4pt;height: 47.0312px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><b>General Anesthesia</b>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><b>&#160;</b>\n</td>\n</tr>\n<tr style=\"height: 23.5156px;\">\n<td valign=\"top\" style=\"width: 155.133px;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0cm 5.4pt;height: 23.5156px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><b>&#160;</b>\n</td>\n<td valign=\"top\" style=\"width: 241.508px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 23.5156px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">Advantages\n</td>\n<td valign=\"top\" style=\"width: 198.266px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 23.5156px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">Disadvantages\n</td>\n<td valign=\"top\" style=\"width: 186.102px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 23.5156px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">Advantages\n</td>\n<td valign=\"top\" style=\"width: 243.039px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 23.5156px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">Disadvantages\n</td>\n</tr>\n<tr style=\"height: 188.438px;\">\n<td valign=\"top\" style=\"width: 155.133px;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0cm 5.4pt;height: 188.438px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><b>Infant/Child</b>\n</td>\n<td valign=\"top\" style=\"width: 241.508px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 188.438px;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Minimal exposure to general anesthetics</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Minimal disruption in feeding schedule/nursing</span></li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 198.266px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 188.438px;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Limited duration (Spinal)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Limited choice of local anesthetic (avoidance of amide-group due to hepatic clearance under 1 year of age)</span></li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 186.102px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 188.438px;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Rapid onset and reliability</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Airway control (preoxygenation, ventilator use)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Inhaled anesthetic is preferred option over intravenous</span></li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 243.039px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 188.438px;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Postoperative apnea and bradycardia in younger (preterm) infants</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Risk of pulmonary complications (children are at higher risk of atelectasis compared to adults)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: Times New Roman, serif;\"><span style=\"font-size: 14.6667px;\">Possible risk of neurological development delay after surgery with prolonged use of GA</span></span></li>\n</ul>\n</td>\n</tr>\n<tr style=\"height: 423.984px;\">\n<td valign=\"top\" style=\"width: 155.133px;border-right: 1pt solid windowtext;border-bottom: 1pt solid windowtext;border-left: 1pt solid windowtext;border-image: initial;border-top: none;padding: 0cm 5.4pt;height: 423.984px;\">\n<p style=\"text-align: center;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><b>Adult</b>\n</td>\n<td valign=\"top\" style=\"width: 241.516px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 423.984px;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Safer for patients undergoing minor procedures/surgical operations (lower extremities, lower abdomen, perineum)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">No loss of consciousness</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Target area provides nerve block, usually peripheral nerves</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Local muscular relaxation</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Minimized intraoperative blood loss</span></li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 198.289px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 423.984px;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Patient refusal</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Limited duration</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">if inadequate block performed, the anesthesia provide has option to convert to GA</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Risk of infection at site of injection (septic meningitis, cauda equina syndrome)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Temporary or permanent neuropathic pain management due to post-operative puncture</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Higher risk of Local Anesthesia Systemic Toxicity (LAST)</span></li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 186.109px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 423.984px;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Preferred for major surgeries</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Intravenous anesthesia is preferred over inhaled</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Provides total CNS depression &amp; body muscle relaxation</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Can easily extend duration of operation</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">preferred option for those with potential airway compromise and/or cardiovascular instability</span></li>\n</ul>\n</td>\n<td valign=\"top\" style=\"width: 243.094px;border-top: none;border-left: none;border-bottom: 1pt solid windowtext;border-right: 1pt solid windowtext;padding: 0cm 5.4pt;height: 423.984px;\">\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Riskier in patients with multiple comorbidities or currently deteriorating</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Emergent tracheostomy (awake intubation) if difficulty managing airway via mask</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Post-operative nausea/vomiting</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Variable hemodynamic monitoring/changes in all 3 operative phases</span><span style=\"font-size: 11.0pt;font-family: &#39;Times New Roman&#39;, serif;\"></span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">(Lagier et al., 2021; Pardo, 2022; Westfall &amp; Sager, 2015; Zhou et al., 2023)\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">References:\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Lagier, D., Zeng, C., Fernandez-Bustamante, A., &amp; Vidal Melo, M. F. (2021). Perioperative Pulmonary Atelectasis: Part II. Clinical Implications.&#160;<i>Anesthesiology</i>,&#160;<i>136</i>(1), 206\u2013236. https://doi.org/10.1097/aln.0000000000004009</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Pardo, M. C. (2022). Choice of anesthetic technique. In M. C. Pardo (Ed.),&#160;_Miller&#39;s basics of anesthesia_ (8th ed., pp. 221-228). Elsevier.</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Roberts, D. J., Nagpal, S. K., Kubelik, D., Brandys, T., Stelfox, H. T., Lalu, M. M., Forster, A. J., McCartney, C. J., &amp; McIsaac, D. I. (2020). Association between neuraxial anaesthesia or general anaesthesia for lower limb revascularisation surgery in adults and clinical outcomes: population based comparative effectiveness study. <i>BMJ</i>,&#160;<i>371</i>. https://doi.org/10.1136/bmj.m4104</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Westfall, L., &amp; Sager, S. L. (2015). Anesthetic considerations for common procedures in children. In L. S. Aglio, R. W. Lekowski, &amp; R. D. Urman (Eds.),&#160;<i>Essential Clinical Anesthesia Review: Keywords, Questions and Answers for the Boards</i>&#160;(pp. 408\u2013410). chapter, Cambridge: Cambridge University Press.</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 12.0pt;font-family: &#39;Times New Roman&#39;, serif;\">Zhou, S. L., Zhang, S. Y., Si, H. B., &amp; Shen, B. (2023). Regional versus general anesthesia in older patients for hip fracture surgery: a systematic review and meta-analysis of randomized controlled trials.&#160;<i>Journal of orthopaedic surgery and research</i>,&#160;<i>18</i>(1), 428. https://doi.org/10.1186/s13018-023-03903-5</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:46.662Z"
            },
            {
                "Author": "Laryssa Hartmann",
                "Content": "<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Hi Kurt,\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Your summary of regional and general anesthesia was really detailed and in depth. I really appreciated the table that you provided listing advantages and disadvantages of the two. I found it helpful in visualizing which technique would be better suited for patient population.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">The potential for combining general, regional and monitored anesthesia care is particularly intriguing. I understand that this approach allows anesthesiologists to tailor anesthesia to specific needs of the patient which would overall enhance patient comfort.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Do you think anxiety levels play an important role in influencing the choice between general and regional anesthesia? Do you think preoperatively this could be addressed and in turn change the choice of anesthetic technique?\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:46.662Z"
            },
            {
                "Author": "Kelly Gram",
                "Content": "Hi Kurt,&#160;\nHaving started working in the OR in the past month, one of the areas I work a lot in is the regional block room. This is new for me and I&#39;ve done a lot of learning about it. Your chart is a great way to compare and contrast the pros and cons of each method of anesthesia.&#160; It seems to me that regional anesthesia (RA) is a sort of up and coming type of anesthesia that is rapidly changing and expanding, with some centers doing huge amounts of them while others less so.&#160; One of the main advantages to the use of RA is the significant reduction in need for opioids post operatively. Patients with high risk factors of opioid related complications like patients with high BMI, OSA, elderly benefit greatly.&#160;\nTo comment on your question Laryssa, anecdotally in the past few weeks, I&#39;ve seen a large number of nerve blocks and spinal anesthetics administered. At my institution, the typical patient will receive midazolam prior to the nerve block/spinal to help ease the anxiety of the procedure, which seems to work very well.&#160; On the odd occasion we&#39;ve had patients refuse nerve blocks while awake, and they&#39;ve been done after induction as the benefit of post operative pain control and reduced need for opioids is so high in some patients.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:46.662Z"
            },
            {
                "Author": "Junia Isaac",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Thank you, Kurt, for your detailed response and for highlighting the potential of combining general anesthesia (GA), regional anesthesia (RA), and monitored anesthesia care (MAC) to enhance patient comfort. I completely agree with your observation that tailoring anesthesia to the patient\u2019s specific needs is a key strength of this approach. Thank you, Kelly, for your thoughtful contribution and for sharing your recent experiences in the OR, particularly with the administration of nerve blocks and spinal anesthetics.&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Laryssa, in response to your question about the influence of anxiety levels on the choice between GA and RA, I believe anxiety can indeed play a significant role. Patients who experience high levels of preoperative anxiety may be more inclined to prefer GA because of the comfort that comes from being unconscious and having no recollection of the procedure. Interestingly, studies suggest that patients with anxiety disorders tend to have an elevated perception of pain, which could further influence the decision to opt for GA over RA (Kim et al., 2020). However, addressing anxiety preoperatively through education, counselling, or anxiolytic medications can sometimes shift the preference towards RA, especially if the patient understands its advantages, such as faster recovery and reduced postoperative nausea (Yilmaz &amp; Yanar, 2022). It\u2019s possible that offering these interventions early could reduce the patient&#39;s anxiety enough for them to consider RA as a safer or more favourable option. Additionally, it\u2019s important to consider how personal experiences and psychological conditioning might impact anesthetic choice. For example, patients who have had prior positive experiences with RA may be more comfortable choosing it again, while those who had complications may prefer GA. Have any of you noticed any patterns in how previous surgical experiences influence patient decisions? Another thought is how the patient&#39;s understanding of the procedure itself might affect their anxiety. Do you think a deeper understanding of the surgical process, or the role of anesthetics could help lower anxiety and shift preferences toward RA?\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Finally, while anxiety plays an important role, it might be valuable to revisit the potential risks of using anxiolytic medications preoperatively, especially in patients already at risk for postoperative cognitive dysfunction. Could balancing anxiolytics and other sedatives affect the choice of RA versus GA? Additionally, I wonder if patients\u2019 prior experiences with RA or GA affect their willingness to undergo nerve blocks while awake. Have you observed any trends in how previous experiences influence their openness to RA? Perhaps more personalized preoperative consultations and education could help make RA more approachable for those who might be hesitant.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">References:&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Fitzgerald, J. E., Roberts, H., &amp; Ferguson, H. J. (2021). Perioperative anxiety and anesthetic technique: Does it influence patient outcomes?&#160;<i>European Journal of Anaesthesiology</i>,&#160;<i>38</i>(4), 255-262.&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1097/EJA.0000000000001356\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi.org/10.1097/EJA.0000000000001356</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Kim, J. H., Lee, H. J., &amp; Kim, D. K. (2020). Impact of preoperative anxiety on anesthetic choice.&#160;<i>Journal of Clinical Anesthesia</i>,&#160;<i>65</i>, 109885.&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1016/j.jclinane.2020.109885\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi.org/10.1016/j.jclinane.2020.109885</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Yilmaz, S., &amp; Yanar, K. (2022). Preoperative anxiety management and its influence on anesthesia choice.&#160;<i>Journal of Perioperative Medicine</i>,&#160;<i>5</i>(3), 143-147.&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1097/JPM.0000000000000123\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi.org/10.1097/JPM.0000000000000123</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:46.663Z"
            },
            {
                "Author": "Janelyne Mandegarian",
                "Content": "<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Hello Kurt and Junia, I just want to add to your question at the end there.&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">I have seen in practice (same day surgery and PACU) patients for orthopedic surgeries have repeat regional anesthesia (spinal and blocks) when it is time for their second knee replacement. They noted that pain was properly managed, early mobilization and short hospital stay proved to be enticing still. My experience with patients has been positive for the most part and with decreased anxiety during the intraoperative phase the second time. Anxiety levels can be varying and subjective like pain, one study noted that anesthesiologists tend to underestimate patients\u2019 anxiety levels and inaccurately assess it. In a survey conducted in 2010 for anesthesiologists to report about their experiences with regional anesthetics, 39% of anesthesiologist stated the anxiety of patients can also affect their confidence perform the RA. Surprisingly 63% &#160;felt that patients anxiety may affect the block success. They also noted that the average response for anxiety were fear of anesthesia, fear of surgery, unsuccessful block and misinformation (Jlala, Bedford &amp; Hardman).\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;Anesthesia care team (ACT) should be mindful in consultation phase to provide information of the whole process. It isn\u2019t uncommon for pre-op nurses to give anxiolytic medication such as Ativan SL or patients are advised to take their own Ativan the morning of surgery if already taking due to their previous history. Benzos like Versed can also be given in the block room IV if needed. The other option my facility provides is deep sedation with propofol infusion. When I was discussing with the AA assisting with the spinals and blocks, he stated normally 75 mcg/kg/min or lower due to avoidance of using instrumenting the airway, however if needing to run the infusion high may necessitate securing the airway for increased risk of aspiration or obstruction. To mitigate the risk, oral airway, capnography and face mask to supplement 02 can prevent desaturation.\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Jlala, H. A., Bedforth, N. M., &amp; Hardman, J. G. (2010). Anesthesiologists&#39; perception of patients&#39; anxiety under regional anesthesia.&#160;<i>Local and regional anesthesia</i>,&#160;<i>3</i>, 65\u201371. <a rel=\"noopener\" href=\"https://doi.org/10.2147/lra.s11271\">https://doi.org/10.2147/lra.s11271</a>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:46.663Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Thanks, everyone, for an excellent discussion so far!</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Like everything else in medicine, there is a fine balance between risks and benefits. We may run into trouble with an unanticipated difficult airway during the induction of general anesthesia, but I will definitely pick general over regional anesthesia if we run into a crisis during a surgical procedure. &#160;As Kurt pointed out, we already have complete control of the airway under general anesthesia, so we can focus more on the hemodynamics and other aspects. &#160;General anesthesia is also more adaptable when the length of surgery needs to be extended due to a surgical complication. &#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">With general anesthesia, we can use inhaled anesthetics. &#160;Inhaled anesthetics allow for an easy, titratable depth of anesthesia with the added ability to bronchodilate. We can also provide anesthesia for patients without venous access. However, inhaled anesthetics contribute to operating room pollution.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Regional anesthesia requires additional skills and experience to insert regional blocks. &#160;In addition to the different block complications, there is always a risk of block failure or inadequacy, as Kurt mentioned. &#160;I also agree that the anxiety level can be an issue, especially hearing the surgeon hammering at the knee replacement in the background, for example. However, as many of you mentioned, regional blocks have so much potential for better postoperative pain management, leading to a quicker recovery and shortened length of hospital stay. &#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">I also like Kurt\u2019s idea of combining the types of anesthesia. &#160;We often utilize this format in our thoracic and Whipple procedures as well. We would insert an epidural catheter before inducing the patient for general anesthesia. The epidural catheter is mainly for post-operative management, but it can be used intraoperatively to decrease the use of opioids.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">There is an interesting study by Schuster et al. (2005) on the costs of different anesthesia techniques: general anesthesia, spinal anesthesia, epidural anesthesia, and brachial plexus block. They found that spinal anesthesia was more cost-effective in short and longer cases, but epidural anesthesia did not differ too much from general anesthesia. &#160;Brachial plexus blocks were more expensive for short cases but more cost-effective for longer cases. &#160;Their study compared the techniques in terms of anesthesia costs and duration of surgery. &#160;I wonder if there are any cost shifts if the results also included postoperative management. By the way, if you are interested in the anesthesia costs, there is an appendix at the end of the article comparing the cost of anesthetic drugs and supplies between regional and general anesthesia.&#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Whether to go with general anesthesia or regional anesthesia is a decision that all patients must make. &#160;Obviously, certain surgical procedures dictate the type of anesthesia. For example, spinal anesthesia is the preferred choice of anesthesia for transurethral resections of the prostate (TURP) procedures because the signs and symptoms of TURP syndrome can easily be masked under general anesthesia. On the other hand, it is impossible to do a heart transplant under procedural sedation. However, if there is no absolute requirement, the decision ultimately lies with the patient. &#160;As members of the Anesthesia Care Team, our responsibility is to know the pros and cons of the different types of anesthesia and help our patients make the best-informed decision.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">If you are a patient with no absolute contraindications to either general or regional anesthesia, which type of anesthesia would you pick?</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">References</span>\n<p style=\"margin: 0cm 0cm 8pt 14.2pt;text-indent: -14.2pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: Lato, sans-serif;color: black;font-size: 19px;\">Schuster, M., Gottschalk, A., Berger, J., &amp; Standl, T. (2005). A retrospective comparison of costs for regional and general anesthesia techniques. <i>Anesthesia and Analgesia, 100</i>(3): 786-794. <a rel=\"noopener\" href=\"https://doi.org/10.1213/01.ANE.0000148685.73336.70\"><span style=\"color: black;\">https://doi.org/10.1213/01.ANE.0000148685.73336.70</span></a></span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:46.663Z"
            }
        ]
    },
    {
        "Thread Title": "Question 4",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/112/View",
        "Question": "<p>Question 4: Compare the past and present role of barbiturates in anesthesia.</p>",
        "Responses": [
            {
                "Author": "Dong Yue Yu",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">Barbiturates have historically been a widely prescribed class of drugs&#160;due to their&#160;<span style=\"color: rgb(21, 21, 21);\">sedative, hypnotic, or anticonvulsant effects.</span> It is classifieds as controlled substances due to the vast prevalence of developing side effects includes physical dependence, withdraw symptoms and overdose potential</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;\"><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(21, 21, 21);\">Barbiturates&#160;</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">introduced in&#160;<span style=\"color: rgb(21, 21, 21);\">1904 by the Farbwerke Fr Bayer and Co,&#160;&#160;the first agent called diethyl-barbituric acid,&#160;&#160;also known as barbital, malonal, or gardenal.used to treat psychiatric and neurological disorders&#160;</span>(L&#243;pez-Mu&#241;oz, Ucha-Udabe, &amp; Alamo, 2005).<span style=\"color: black;background-color: white;\">&#160;Barbiturates works by enhance&#160;</span></span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: black;background-color: white;\">postsynaptic gamma-aminobutyric acid, GABA-A receptor, increase chloride ion flux and, induce postsynaptic hyperpolarization and central nervous system (CNS) depression.</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">&#160;concomitant<span style=\"color: rgb(38, 38, 38);\">use&#160;</span>with other CNS depressants, such as benzodiazepines and opioids, can cause severe&#160;respiratory&#160;depression, profound sedation, coma, and death (</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(33, 33, 33);background-color: white;\">Suddock,Kent,Regina &amp; Cain,2024).&#160;</span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;\"><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(21, 21, 21);\">Between the 1930s and 1940s, barbiturates were the most widely used drugs as sedatives and hypnotic, The year between 1957\u20131963, 8469 cases of barbiturate overdose reported and 1165 deaths&#160;</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(38, 38, 38);\">(Sharpless, 1970 ),&#160;&#160;</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">Federal Comprehensive Drug Abuse and Control Act of 1970, Barbiturates classified as Schedule II to IV substance.</span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;\"><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">Withdrawal symptoms nervousness, tremors, agitation, hypotension, delirium and grand mal seizures usually develop after 2 to 8 days abrupt cessation,&#160;&#160;the therapeutic range for Phenobarbital is of 10 to 30 mg/L versus the fatal dose is 80 mg/L (</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(33, 33, 33);background-color: white;\">Suddock,Kent,Regina &amp; Cain,2024).</span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;\"><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(21, 21, 21);\">B</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(21, 21, 21);\">enzodiazepine introduced at 1960s and replaced barbiturates rapidly, the current use of barbiturates is restricted to certain medical conditions.</span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;\"><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(21, 21, 21);\">Phenobarbital and primidone are still used to treat partial and tonic-clonic generalized seizures, convulsions associated with tetanus, eclampsia, cerebral hemorrhage, status epilepticus&#160;</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">(</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(33, 33, 33);background-color: white;\">Suddock,Kent,Regina &amp; Cain,2024).</span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;\"><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(21, 21, 21);\">Thiopental still used as an intravenous anesthetic because of the fast onset and short action period make it perfect for the surgical interventions&#160;</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">(</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(33, 33, 33);background-color: white;\">Suddock,Kent,Regina &amp; Cain,2024).</span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;\"><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">High dose of barbiturates have been used since the 1970s to manage acute traumatic brain injury by reducing metabolism and lowering intracranial pressure&#160;</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\">(</span><span style=\"line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(33, 33, 33);background-color: white;\">Suddock,Kent,Regina &amp; Cain,2024).</span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: center;\"><span style=\"font-size: 18px;line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(33, 33, 33);background-color: white;\">References</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 18px;\">&#160;</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt 36pt;line-height: 29.333335876464844px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-size: 18px;line-height: 32px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(21, 21, 21);\">L&#243;pez-Mu&#241;oz, F., Ucha-Udabe, R., &amp; Alamo, C. (2005). The history of barbiturates a century after their clinical introduction.&#160;<i>Neuropsychiatric disease and treatment</i>,&#160;<i>1</i>(4), 329\u2013343.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt 36pt;line-height: 29.333335876464844px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\"><span style=\"font-size: 18px;\"><span style=\"line-height: 32px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(33, 33, 33);background-color: white;\">Suddock, J. T., Kent, K. J., Regina, A. C., &amp; Cain, M. D. (2024<i>). Barbiturate Toxicity.</i>&#160;</span><span style=\"line-height: 32px;font-family: &#39;Times New Roman&#39;, serif;color: rgb(26, 26, 26);\">[Updated 2024 Feb 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Retrieved from:&#160;<a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK499875/\" style=\"color: rgb(149, 79, 114);text-decoration: underline;\">https://www.ncbi.nlm.nih.gov/books/NBK499875/</a></span></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt;line-height: 16.866666793823242px;font-size: 11pt;font-family: Calibri, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\"><span style=\"font-size: 12pt;line-height: 18.399999618530273px;font-family: &#39;Times New Roman&#39;, serif;\"></span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:50.662Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "As pointed out by April, the usage of barbiturates in anesthesia has dramatically declined. The only usage in anesthesia nowadays is in electroconvulsive therapy (ECT), which involves inducing seizures. Methohexital is the preferred agent in ECT because it lowers the seizure threshold and has a longer seizure duration than other intravenous anesthetics such as Propofol. &#160;&#160;\nPreviously, the barbiturate of choice was Thiopental because of its quick onset as an induction agent and neuroprotection properties. Thiopental is a potent vasoconstrictor, which decreases cerebral blood flow, cerebral blood volume, and cerebral metabolic oxygen requirements. It can be used to initiate barbiturate comas, which have been used in patients with ischemic neurological deficits due to cerebral vasospasm after subarachnoid hemorrhage. Also, Thiopental used to be the gold standard agent for rapid sequence induction.&#160;\nHowever, with the introduction of non-barbiturates such as Propofol and Ketamine, Thiopental lost its popularity. &#160;In addition to its inadequacy in suppressing airway reflexes during airway manipulation, another major disadvantage of Thiopental is its long half-life and prolonged recovery period due to the retention of drugs by fat tissues. It also induces histamine release. In addition, Thiopental has no analgesic properties when compared to Ketamine.\nIn fact, Thiopental has no longer been manufactured since 2011 due to the public becoming aware of its use in capital punishment (application of lethal injection in the death penalty), which led to the sole manufacturer, Hospira, stopping the production of the drug.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:50.662Z"
            }
        ]
    },
    {
        "Thread Title": "Question 5",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/111/View",
        "Question": "<p>Question 5: Explore the effects of giving an opioid and a benzodiazepine together for sedative purposes.</p>",
        "Responses": [
            {
                "Author": "Reneerose Ong",
                "Content": "<p style=\"text-align: center;margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>Explore the effects of giving an opioid and a benzodiazepine together for sedative purposes</b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">Administering an opioid and a benzodiazepine together for sedation can have significant effects on the central nervous system, requiring careful consideration of their pharmacodynamic properties. This combination is frequently used during procedural sedation and anesthesia. Commonly used benzodiazepines in the perioperative setting include diazepam, midazolam, and lorazepam (Bokoch &amp; Su, 2023), while morphine, fentanyl, and remifentanil are the opioids most often used <span style=\"color: black;\">(Egan, 2023). </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>&#160;</b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>Synergistic Effect - Analgesia and Amnesia: </b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">Opioids and benzodiazepines differ in their mechanism of action, but both cause depression of the central nervous system (CNS). Benzodiazepines are often used as premedication or for procedural sedation due to their amnesic (anterograde), anxiolytic and sedative properties (Bokoch &amp; Su, 2023).&#160; They are also used as anticonvulsants for treating seizures. Benzodiazepines work by enhancing the effect of \u03b3-aminobutyric acid (GABA) at GABA<sub>A </sub>receptors (Bokoch &amp; Su, 2023).<span style=\"color: #0d0d0d;\"> &#160;</span>However, they lack hypnotic and analgesic properties (Bokoch &amp; Su, 2023).\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">In contrast, opioids primarily bind to mu-opioid receptors, inhibiting pain transmission and producing analgesia and sedation or drowsiness <span style=\"color: black;\">(Egan, 2023). </span>However, opioids alone do not consistently cause unresponsiveness or amnesia <span style=\"color: black;\">(Egan, 2023). </span>When opioids and benzodiazepines are used together, they exhibit synergistic effects, providing better sedation, analgesia and intraoperative conditions (Yeo &amp; Shehabi, 2023). Synergistic effects are the interaction of two or more drugs, when combined, their overall effect is greater than sum of individual effects.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">Combining an opioid with benzodiazepine provides both analgesic effects (from opioid) and sedation and amnesic effects (from benzodiazepine) (Bokoch &amp; Su, 2023; <span style=\"color: black;\">Egan, 2023).</span> It is advantageous for procedures that require both pain relief and memory suppression. &#160;This combination is beneficial for patients undergoing brief but painful procedures, as it helps reduce pain while minimizing the chance of remembering the procedure i.e. biopsies in pediatric patients.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>&#160;</b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>Respiratory Depression: &#160;</b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">Both opioids and benzodiazepines inhibit respiratory function. Opioids primarily reduce respiratory rate through direct inhibition of mu receptors in the brainstem, while benzodiazepines decrease respiration by decreasing tidal volume (Boon et al., 2020). When administered together, the risk of respiratory depression significantly increases, leading to airway obstruction or apnea (Bokoch &amp; Su, 2023). Both drug classes also impair upper airway patency, exacerbating the risk of significant apnea or hypoventilation (<span style=\"color: black;\">Egan, 2023)</span>.\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>&#160;</b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>Cardiovascular Effects:</b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">Both opioids and benzodiazepines can contribute to hypotension and bradycardia (Bokoch &amp; Su, 2023). When administered in small doses, benzodiazepines generally cause minimal changes in heart rate or blood pressure. However, large doses can lead to peripheral vasodilation and a decrease in blood pressure (Bokoch &amp; Su, 2023). Similarly, opioids in isolation usually have minimal cardiovascular effects, but they can cause vasodilation and bradycardia by increasing vagal nerve tone in the brainstem <span style=\"color: black;\">(Egan, 2023). </span>These effects are more pronounced in patients with underlying conditions i.e. congestive heart failure or hypovolemia, where the risk of significant hypotension and bradycardia is higher (Bokoch &amp; Su, 2023).\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>&#160;</b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b>Clinical consideration:</b>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">Close monitoring of vital signs: respiratory and heart rate, blood pressure, oxygen saturation and capnography are essential for patient safety when opioids and benzodiazepines are given together <span style=\"color: black;\">(Egan, 2023). </span>Capnography can detect early signs of hypoventilation or apnea.</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">All doses must be titrated carefully to achieve desired effect, taking into consideration patient population and procedural stimuli (Lobb et al., 2018). Begin sedation with the lowest effective dose and increase gradually as needed.</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">Extra caution is needed for higher risk populations: elderly or patients with renal or hepatic impairment, or multiple co-morbidities (Bokoch &amp; Su, 2023<span style=\"color: black;\">; Egan, 2023</span>). They are more susceptible to pronounced synergistic effects.</li>\n<li style=\"margin: 0cm 0cm 8pt 0px;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\">Flumazenil reverses the action of benzodiazepines, while naloxone reverses action of opioids (Bokoch &amp; Su, 2023<span style=\"color: black;\">; Egan, 2023). </span>Having both reversal agents readily available is essential. Repeat dosing maybe required due to short half life of reversal agents (Bokoch &amp; Su, 2023)</li>\n</ul>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b><span style=\"color: black;\">&#160;</span></b>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><b><span style=\"color: black;\">References: </span></b>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;line-height: 200%;font-size: 11pt;font-family: Calibri, sans-serif;\"><span style=\"color: black;background: white;\">Bokoch, M. P., &amp; Su, P. P. (2023).&#160;Intravenous anesthetics. In M. C. Pardo (Ed.),&#160;<i>Miller\u2019s basics of anesthesia </i>(8<sup>th</sup>&#160;ed., pp. 107-124). Elsevier.</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><span style=\"color: #212121;background: white;\">Boon, M., van Dorp, E., Broens, S., &amp; Overdyk, F. (2020). Combining opioids and </span>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><span style=\"color: #212121;background: white;\">benzodiazepines: effects on mortality and severe adverse respiratory events.&#160;</span><i style=\"text-align: start;\">Annals of</i>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 107%;font-size: 11pt;font-family: Calibri, sans-serif;\"><i><span style=\"color: #212121;background: white;\">palliative medicine</span></i><span style=\"color: #212121;background: white;\"><span style=\"text-align: start;float: none;\">,&#160;</span><i style=\"text-align: start;\">9</i><span style=\"text-align: start;float: none;\">(2), 542\u2013557. <a rel=\"noopener\" href=\"https://doi.org/10.21037/apm.2019.12.09\">https://doi.org/10.21037/apm.2019.12.09</a></span></span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;line-height: 200%;font-size: 11pt;font-family: Calibri, sans-serif;\"><span style=\"color: black;background: white;\">Egan, T.D. (2023).&#160;Opioids. In M. C. Pardo (Ed.),&#160;<i>Miller\u2019s basics of anesthesia </i>(8<sup>th</sup>&#160;ed., pp. 125-142). Elsevier.</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;line-height: 200%;font-size: 11pt;font-family: Calibri, sans-serif;\"><span style=\"color: #212121;background: white;\">Lobb, D., Clarke, A., &amp; Lai, H. (2018). Administration order of midazolam/fentanyl for moderate dental sedation.&#160;</span><i style=\"text-align: start;\">Journal of dental anesthesia and pain medicine</i><span style=\"text-align: start;float: none;\">,&#160;</span><i style=\"text-align: start;\">18</i><span style=\"text-align: start;float: none;\">(1), 47\u201356. <a rel=\"noopener\" href=\"https://doi.org/10.17245/jdapm.2018.18.1.47\">https://doi.org/10.17245/jdapm.2018.18.1.47</a> </span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;line-height: 200%;font-size: 11pt;font-family: Calibri, sans-serif;\"><span style=\"color: #212121;background: white;\">Yeo, X. H., &amp; Shehabi, Z. (2023). Effectiveness and safety of dentist-led conscious sedation using fentanyl with midazolam in dentistry: a five-year retrospective service evaluation.&#160;</span><i style=\"text-align: start;\">British dental journal</i><span style=\"text-align: start;float: none;\">, 1\u20136. Advance online publication. <a rel=\"noopener\" href=\"https://doi.org/10.1038/s41415-023-5889-3\">https://doi.org/10.1038/s41415-023-5889-3</a>&#160;</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:55.701Z"
            },
            {
                "Author": "Junia Isaac",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;\">Hi Reneerose, I really enjoyed reading your detailed and insightful post! You&#39;ve done an excellent job outlining the pharmacodynamics of combining opioids and benzodiazepines for sedation, as well as the potential risks associated with their synergistic effects. Your discussion on the interplay between these agents&#39; sedative and analgesic properties really stood out to me, especially in terms of how they are commonly used during procedural sedation.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;\">Your points about the heightened risk of respiratory depression when these two drug classes are combined are particularly important&#160;</span><span style=\"font-size: 11pt;color: black;background-color: white;\">(</span><span style=\"font-size: 11pt;\">Bokoch &amp; Su, 2023). This has me thinking more about how clinicians can balance the need for effective sedation with minimizing these risks, especially in patients with pre-existing respiratory conditions. In practice, how do you think we can best mitigate this risk when titrating doses in high-risk populations like the elderly or those with comorbidities? Would the use of adjunct agents, such as dexmedetomidine, help in providing sedation without exacerbating respiratory depression?</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\"><span style=\"font-size: 11pt;\">Lastly, I appreciate that you brought up the need for close monitoring and the use of reversal agents like flumazenil and naloxone&#160;</span><span style=\"font-size: 11pt;color: black;background-color: white;\">(</span><span style=\"font-size: 11pt;\">Bokoch &amp; Su, 2023; Egan, 2023). It made me wonder, how frequently are these reversal agents required in routine clinical practice, and do you think the reliance on them could influence decisions on whether to use this drug combination for sedation in certain populations? This topic has made me reconsider the complexities of using these drugs together and think deeper about the strategies we use to maintain patient safety during sedation.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: justify;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\"><span style=\"font-size: 11pt;\">References&#160;</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\"><span style=\"font-size: 11pt;\"></span>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\"><span style=\"font-size: 11pt;\">Bokoch, M. P., &amp; Su, P. P. (2023). Intravenous anesthetics. In M. C. Pardo (Ed.),&#160;<i>Miller\u2019s basics of anesthesia</i>&#160;(8th ed., pp. 107-124). Elsevier.</span>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\"><span style=\"font-size: 11pt;\">Egan, T.D. (2023).&#160;Opioids. In M. C. Pardo (Ed.),&#160;<i>Miller\u2019s basics of anesthesia&#160;</i>(8<sup>th</sup> ed., pp. 125-142). Elsevier.</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:55.702Z"
            },
            {
                "Author": "Reneerose Ong",
                "Content": "<p style=\"margin: 0cm 0cm 12pt;background: white;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 14px;font-family: Lato, sans-serif;color: rgb(32, 33, 34);\">Hi Junia,</span>\n<div style=\"border: none;border-bottom: solid windowtext 1.5pt;padding: 0cm 0cm 1.0pt 0cm;background: white;\">\n<p style=\"margin: 6pt 0cm 0cm;background: white;border: none;padding: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 14px;font-family: Lato, sans-serif;color: rgb(32, 33, 34);\">Thank you for your thorough response. I agree that dexmedetomidine is an excellent adjunct, offering sedation without suppressing airway reflexes or ventilation. Its additional analgesic properties are also a valuable benefit, especially in reducing opioid requirements.</span>\n<p style=\"margin: 6pt 0cm 0cm;background: white;border: none;padding: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 14px;font-family: Lato, sans-serif;color: rgb(32, 33, 34);\">While specific statistics on the frequency of reversal agent use in clinical practice are hard to pinpoint, it is well-known that flumazenil (for benzodiazepines) and naloxone (for opioids) are generally reserved for emergent situations or when a patient unintentionally reaches deeper sedation levels (Wong, 2022). These agents require careful postoperative monitoring due to the potential for &quot;bounce-back&quot; effects after the reversal wears off, while the sedative or opioid may still be active (Wong, 2022).</span>\n<p style=\"margin: 6pt 0cm 0cm;background: white;border: none;padding: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 14px;\">&#160;</span>\n<p style=\"margin: 6pt 0cm 0cm;background: white;border: none;padding: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 14px;font-family: Lato, sans-serif;color: rgb(32, 33, 34);\">Reference:</span>\n<p style=\"margin: 6pt 0cm 0cm;background: white;border: none;padding: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 14px;font-family: Lato, sans-serif;color: rgb(32, 33, 34);\">Wong M. (2022). Reversal Agents in Sedation and Anesthesia Practice </span>\n<p style=\"margin: 6pt 0cm 0cm;text-indent: 36pt;background: white;border: none;padding: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 14px;font-family: Lato, sans-serif;color: rgb(32, 33, 34);\">for Dentistry.&#160;<i>Anesthesia progress</i>,&#160;<i>69</i>(1), 49\u201358. </span>\n<p style=\"margin: 6pt 0cm 0cm;text-indent: 36pt;background: white;border: none;padding: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 14px;font-family: Lato, sans-serif;color: rgb(32, 33, 34);\"><a rel=\"noopener\" href=\"https://doi.org/10.2344/anpr-69-01-09\">https://doi.org/10.2344/anpr-69-01-09</a></span>\n</div>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:55.702Z"
            },
            {
                "Author": "Adrian Harris",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Hi Reneerose and Junia, </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Thanks for sharing this valuable insight on the potential synergistic sedative effects of opioids combined with benzodiazepines, as well as the safety considerations and mitigating risk when using them during procedural sedation.&#160; This brings up an interesting talking point about the varying thoughts around the use of benzodiazepines for pre-sedation.&#160; As Junia alluded to in her response, how best can we mitigate risk with the use of benzodiazepines for sedation within the elderly population? &#160;For the AAs at my institution, anecdotally there appears to be two varying schools of thought around the use of midazolam in the elderly patient requiring sedation in the perioperative setting. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">There is one camp that follows the idea that midazolam use in elderly patients leads to increased risk of post-operative confusion, delirium or cognitive impairment. and will avoid its use for pre-sedation or during any type of procedural sedation. &#160;Their belief is supported by theory that midazolam use in the elderly can cause exacerbated amnestic action at the g amino butyric acid (GABAA) receptors, resulting in post-procedural cognitive changes with some residual amnestic effects (1). &#160;At my institution, these AAs will avoid the use of midazolam for sedation in elderly patients, instead relying on other non-benzodiazepines (like dexmedetomidine, for example). </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">The other camp believes wholeheartedly in its use, especially for patients who are on some form of anti-anxiety medication at home, and who don\u2019t have a diagnosis of dementia or cognitive impairment.&#160; These AAs have seen no post-procedure neurological concerns in the stable elderly population who received pre-sedation or procedural sedation using midazolam.&#160; </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Interestingly, a recent study published in the Journal of Clinical Anesthesiology, evaluated premedication using midazolam in patients 70 years of age and older, and reviewed their incidence of post-operative delirium (2).&#160; After receiving intravenous midazolam administration prior to an induction with general anesthesia, 1973 patients who were undergoing non-cardiac procedures were determined to have experienced no delirium post-operatively (2).&#160; The study concluded with the suggestion that lower-dose (3.75mg) midazolam could safely be used in the elderly population for a non-cardiac surgery with no expected increased risk of post-operative delirium (2).</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">While the risk may not outweigh its benefits, pre-medicating or procedural sedation in the elderly with midazolam should be considered with caution. &#160;As discussed by Reneerose above, the known synergistic effects between benzodiazepines and other CNS depressants are well-known (3) and such, the use of benzodiazepines should always be carefully contemplated, especially in the elderly population.&#160; </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">1. Walling A, Caspray D. Effects of benzodiazepines after procedures in elderly patients. Am Fam Physician [Internet]. 2002 [cited 2024 Oct 8] 9:online-only-. Available from: https://www.aafp.org/pubs/afp/issues/2002/0501/ol2.html</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">2. Zarour S, Weiss Y, Kieselevich Y, Iacubovici L, Karol D, Shaylor R et al. The association between midazolam premedication and postoperative delirium - a retrospective cohort study. J Clin Anesth. [Internet]. 2024 Feb [cited 2024 Oct 8] 92:111113. Available from: https://pubmed.ncbi.nlm.nih.gov/37280146/</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><b><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">&#160;</span></b>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">3.</span><span style=\"font-size: 11.0pt;color: black;\"> </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Egan TD. Opioids. In: Miller\u2019s basics of anesthesia. 8<sup>th</sup> ed. Philadelphia: Elsevier Inc; c2023. p. 125-142.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:55.703Z"
            },
            {
                "Author": "Ryan Smith",
                "Content": "Thank you Reneerose, Junia and Adrian for your thoughtful insights into benzodiazepine and opioids used concurrently. Indeed caution and vigilance is required when administering these agents together. It prompted me to recall a somewhat novel benzodiazepine Remimazolam and its use in conscious sedation procedures such as endoscopy with concurrent short acting opioids such as alfentenil.\nIn a recent RCT comparing Remimazolam (RM) vs propofol with concurrent alfentenil infusions for hysteroscopy, the RM group showed a statistically significantly higher mean arterial pressure, heart rate and mean SpO2 (n=208). A Dixon\u2019s regression model was used post hoc to determine an ED50 of 0.244mg/kg.<sup>1</sup> In a slightly smaller RCT published the same year for patients undergoing laparoscopic urologic surgery, RM with remifentanyl vs desflourane with remifantanyl, the RM group showed improved post operative pain scores.<sup>2</sup> Several other small to medium scale RCTs and anecdote are emerging, and clearly this drug needs to find its place in anesthesia providers experience. It is encouraging to note that as time has marched forward in anesthesia over the past decades, the pharmaceutical regimens available are making pre, peri and post operative care for the patients better and safer.\nReferences\n1. Huang B, Nan-Ping L, Gang-Kai T, &#160;Liang Na. Effectiveness and safety of remimazolam combined with alfentanil in hysteroscopic examination: A prospective, randomized, single-blind trial. Medicine. 2024 Apr; 103(15) 376\n2. Lee C, Lim J, Hong H, Yu H, Lee H. Effect of Remimazolam on Pain Perception and Opioid-Induced Hyperalgesia in Patients Undergoing Laparoscopic Urologic Surgery\u2014A Prospective, Randomized, Controlled Study. Medicina. 2024 Jan; 60(1): 123.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:55.703Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Answering Junia\u2019s question on reversal agents, they should be rarely used, especially in procedural sedation administered by the Anesthesia Care Team. I agree with Renee that these agents are reserved for emergent situations and should not be used to justify administering large boluses of anesthetics simply because reversal agents are available. However, I recognize that procedural sedation performed in other settings by different healthcare professionals may involve a higher frequency of reversal agent use. I have been invited to provide talks on procedural sedation and the use of reversal agents in some departments.</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:55.704Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Great contribution, everyone!\nRenee has nicely reminded us that the synergism between a benzodiazepine and an opioid not only potentiates their therapeutic effects, but also their side effects.&#160;\nThe advantage of synergism is that we can now use a lower dose of each drug to achieve the same level of effect. &#160;Therefore, toxicity and unwanted side effects are reduced, while still achieving the desired effects. This will also result in a quicker recovery, which is especially important for outpatient sedative procedures. &#160;\nI commonly use 0.5 \u2013 2 mg Midazolam and 25 \u2013 50 mcg Fentanyl (and sometimes together with 25 \u2013 50 mg Propofol) for procedural sedation procedures such as cataract removal, corneal transplant, and transesophageal echocardiography (TEE). &#160;The small dosage of opioid in this combination is mainly to enhance the sedative effect of the benzodiazepine as opposed to making use of its analgesic effect. &#160;The procedural pain is usually taken care of by local infiltration or nerve blocks with local anesthetics.\nAnother sedation cocktail that I know some institutions commonly use is \u201cketofol,\u201d which combines Ketamine and Propofol. Propofol tends to cause hypotension and bradycardia, whereas ketamine causes hypertension and tachycardia. It seems that the side effects of each drug balance off each other.&#160;\nIn addition, interactions between various intravenous drugs and inhaled volatiles are synergistic as well. &#160;For example, there is a synergistic effect between narcotics and inhaled volatiles.\nDo you know of any other sedation combinations that are used at your institution?&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:55.704Z"
            },
            {
                "Author": "Tenzing Choedar",
                "Content": "<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">Thank you Reneerose for reminding us that the clinical synergy observed between benzodiazepines and opioids when administered concomitantly is a significant consideration in the realm of anesthesia and sedation. The combined pharmacodynamic effects of these two classes of drugs result in an enhanced level of sedation and analgesia, a phenomenon often described as supra-additive. This means that the overall sedative and analgesic effects exceed the simple sum of the individual drug effects, making it imperative to adjust dosages accordingly. As such, this interaction underscores the importance of caution when administering multiple sedatives together. Dosing strategies should err on the conservative side, as the potentiation of their effects can lead to profound sedation, respiratory depression, or other adverse outcomes if not carefully managed as you have pointed out nicely.\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">To add to Adrian\u2019s comment, I definitely err on the side of caution when I have very elderly patients in my cathlab. Especially if they are over 85 years old, I tend to only start of with 0.5mg of Midazolam with 12.5-25mcg of Fentanyl depending on their co-morbidities, medication hx and baseline vitals. However, there are times when I wish I could switch up some of these medications when I am providing conscious sedation; but as a nurse I am limited to my intra procedure medication orders which are usually only midazolam and fentanyl. During my literature review, I found multiple studies looking at the synergistic effects of multiple sedatives when given together. Babu et al. (2024) investigated the synergistic effects of dexmedetomidine in combination with propofol, comparing the results to a group that received only propofol for patients undergoing ERCP. In the study, 80 patients aged 18 to 60 were randomly assigned to two groups. The dexmedetomidine + propofol group (group DP) received an initial infusion of dexmedetomidine at a dose of 1 mcg/kg in 100 mL of saline over 10 minutes, while the propofol group (group P) received 100 mL of plain normal saline over the same time. Both groups were then administered a bolus dose of propofol at 1 mg/kg for sedation. Following this, a continuous infusion of propofol at 50 mcg/kg/min was maintained throughout the procedure. If signs of inadequate sedation or analgesia were observed, a rescue bolus of 20 mg of propofol was given to patients in both groups. They found that dexmedetomidine, when used as an adjunct to propofol, improved sedation quality, reduced the need for additional propofol, and contributed to more stable hemodynamics in patients undergoing ERCP. Another study by Nejati et al. (2011) conducted a prospective, double-blind, randomized trial comparing the ketamine/propofol (ketofol) combination with midazolam/fentanyl (MF) for procedural sedation and analgesia (PSA) in emergency department patients requiring treatment for deep lacerations or bone fractures. They found that there were<span> </span><span>no</span><span> </span><span>signi\ufb01cant</span><span> </span><span>differences</span><span> </span><span>in</span><span> </span><span>sedation</span><span> </span><span>time but ketofol group had deeper sedation and analgesia, however the rate of desaturation was greater in the MF group. Emergence phenomenon did occur in 9 patients out of 31 with one requiring intervention with midazolam. </span>\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">Ultimately, I am recognizing that balanced anesthesia is the optimal approach. With a variety of drug combinations available\u2014such as midazolam with fentanyl, ketamine with propofol, and dexmedetomidine with propofol\u2014having a deep understanding of the pharmacokinetics and pharmacodynamics of these commonly used agents is essential. Equally important is a comprehensive awareness of the patient\u2019s medication history and comorbidities. Coupled with a well-prepared strategy for managing potential adverse effects, this knowledge enables us to select the most appropriate sedative regimen, ensuring both efficacy and safety in procedural sedation. For example, if a pt has a very high risk of aspiration or respiratory compromise, then ketofol is probably the way to go.\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;Reference:\n<p style=\"margin-left: 36pt;text-indent: -36pt;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"color: #333333;\">Babu, T. R., Kumar, M. R. A., Anup, N. R., &amp; Shetty, S. M. (2024). Dexmedetomidine as an adjunct to propofol in patients undergoing elective endoscopic retrograde cholangio-pancreaticography - A double-blind randomized controlled study.<span class=\"apple-converted-space\"><i>&#160;</i></span><i>Journal of Pharmacy &amp; Bioallied Science,<span class=\"apple-converted-space\">&#160;</span>16</i>(Suppl 1), S399-S402.<span class=\"apple-converted-space\">&#160;</span><a rel=\"noopener\" target=\"_blank\" href=\"https://doi.org/10.4103/jpbs.jpbs_617_23\"><span style=\"color: #2659ab;\">https://doi.org/10.4103/jpbs.jpbs_617_23</span></a></span>\n<p style=\"margin-left: 36pt;text-indent: -36pt;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"color: #333333;\">Nejati, A., Moharari, R. S., Ashraf, H., Labaf, A., &amp; Golshani, K. (2011). Ketamine/Propofol versus Midazolam/Fentanyl for procedural sedation and analgesia in the emergency department: A randomized, prospective, Double\u2010Blind trial. <i>Academic Emergency Medicine,<span class=\"apple-converted-space\"> </span>18</i>(8), 800-806.<span class=\"apple-converted-space\">&#160;</span><a rel=\"noopener\" target=\"_blank\" href=\"https://doi.org/10.1111/j.1553-2712.2011.01133.x\"><span style=\"color: #2659ab;\">https://doi.org/10.1111/j.1553-2712.2011.01133.x</span></a></span>\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;Cheers,&#160;\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">Tenzing",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:57:55.705Z"
            }
        ]
    },
    {
        "Thread Title": "Question 6",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/110/View",
        "Question": "<p>Question 6: Describe the significant differences in clinical effect when opioids are given at sedative versus induction doses.</p>",
        "Responses": [
            {
                "Author": "Tenzing Choedar",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">The physiological and subsequent clinical effects of opioids is well studied. Opioids play a critical role in the management of perioperative care and are essential for effective pain control during and after surgery. Opioids bind primarily to mu receptors which are mainly found in the Central Nervous System (CNS) and since the nervous system significantly impacts the functioning of the whole body, the pharmacodynamic effects of mu opioid agonists are evident across various organ system (Cummings III &amp; Naguib, 2022; Egan, 2023). For the sake of this discussion, focus will be maintained solely on the acute phase of the clinical effect with sedative dosing versus induction dosing which can vary significantly. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Firstly, it is vital to understand that the therapeutic benefits of opioids as pain relievers and their potential to cause respiratory depression are inherently linked, making it difficult to separate their effectiveness from their harmful side effects. Depending on the specific clinical situation and treatment objectives, some of these broad effects may be regarded as either beneficial or harmful (Egan, 2023). Listed below are the highlights of opioids effect on the physiological system apart from pain suppression. These effects are dose-dependent, with higher dose having more exaggerated effects. &#160;</span>\n<p style=\"margin: 0cm 0cm 0cm 18pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 18pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Respiratory System: </span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Depress respiratory rate and can also affect tidal volume depending on the dosage via mu(\u03bc) receptor mediated hyperpolarization of the neurons in the respiratory control centre in the brainstem. At low doses, tidal volume may remain steady or rise slightly due to chemoreflex compensation, but it decreases at higher doses because of reduced phrenic motor neuron activity which innervates the diaphragm. </span>\n<ul style=\"list-style-type: circle;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Gradual opioid administration allows central chemoreceptors to adjust to rising CO2 levels, minimizing the risk of apnea, whereas rapid boluses can cause apnea before PaCO2 rises to stimulate compensatory increases in ventilation.</span></li>\n</ul>\n</li>\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Inhibits the hypercapnic and hypoxic ventilatory reflexes via hyperpolarization of the central and peripheral chemoreceptor neurons. This impairs the feedback response to the respiratory control centres leading to insufficient responses to hypercapnia and hypoxemia.</span></li>\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Inhibits upper airway protective reflexes (Bateman, Saunders, &amp; Levitt, 2023; Egan, 2023)</span></li>\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Can increase airway resistance due to its direct effect on bronchial smooth muscle and indirectly via histamine release (Cummings III &amp; Naguib, 2022) </span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><b><span style=\"font-size: 11.0pt;color: black;\">&#160;</span></b>\n<p style=\"margin: 0cm 0cm 0cm 18pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Central Nervous System:</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Dose dependent CNS depression ranging from drowsiness, sedation to sleep (At high enough doses, mu opioid agonists generate significant delta wave activity on an electroencephalogram (EEG), resembling the brain wave patterns typically seen during natural sleep.</span></li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Increases Intracranial Pressure (ICP) with decreases in cerebral blood flow and cerebral metabolic oxygen requirements despite maintenance of an unchanged Paco2. </span>\n<ul style=\"list-style-type: circle;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">This may be due to autoregulatory decreases in cerebral vascular resistance due to decrease in Mean Arterial Pressure (MAP). This rise in ICP can be avoided by maintaining adequate MAP. </span></li>\n</ul>\n</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Induces miosis via stimulation of the Edinger-Westphal nucleus of the oculomotor nerve but not seen with Meperidine, rather causes mydriasis (Cummings III &amp; Naguib, 2022; Egan, 2023)</span></li>\n</ul>\n<p style=\"margin: 0cm 0cm 0cm 72pt;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 18pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Cardiovascular System: </span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Systemic Vascular Resistance (SVR) \u2013 Can decrease SVR via vasodilation of the blood vessels by decreasing the activity of the vasomotor centers in the brainstem affecting preload and afterload. Has less direct effect on the blood vessels (Egan, 2023). </span>\n<ul style=\"list-style-type: circle;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Morphine contributes to more histamine release which can also decrease SVR, whereas Fentanyl derivatives do not cause the release of histamine. </span></li>\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Impairs compensatory sympathetic nervous system response leading to orthostatic hypotension and syncope.&#160; (Cummings III &amp; Naguib, 2022). </span></li>\n</ul>\n</li>\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Heart rate (HR) \u2013 Can decrease HR by directly increasing vagal nerve tone in the brainstem. Fentanyl has greater bradycardic effect than morphine however Meperidine can rather increase the HR due to its atropine like qualities.&#160; </span>\n<ul style=\"list-style-type: circle;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">In neonates, Fentanyl administration has to be carefully monitored to avoid bradycardia because cardiac output is mainly dependent on HR. (Cummings III &amp; Naguib, 2022; Egan, 2023).</span></li>\n</ul>\n</li>\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Ultimately, drop in blood pressure more pronounced in patients with higher sympathetic tone such as patients with shock, heart failure, hypertension and hypovolemia (Egan, 2023). </span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 18pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Musculoskeletal System: </span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Rapid large boluses of opioids particularly fentanyl and its derivatives can cause generalized muscle rigidity making bag and mask ventilation during induction of anesthesia difficult due to vocal cord rigidity and closure. </span>\n<ul style=\"list-style-type: circle;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">The inhibition of GABA release in the striatum, along with increased dopamine production, is likely responsible for the opioid-induced rise in skeletal muscle tone</span></li>\n</ul>\n</li>\n<li style=\"margin: 0cm 0cm 0cm 24px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Clonic skeletal muscle movements (myoclonus) can occur during opioid administration and can appear similar to grand mal seizures (Cummings III &amp; Naguib, 2022; Egan, 2023)</span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">GI</span>\n<ul style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">All opioids can induce nausea and vomiting in approximately 26% of patients (Arthur &amp; Hui 2018). This is due to stimulation of the chemoreceptor trigger zone in the area postrema on the floor of the fourth ventricle in the brain. </span>\n<ul style=\"list-style-type: circle;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Can be exacerbated by movement, more pronounced in day surgery patients.</span></li>\n</ul>\n</li>\n<li style=\"margin: 0cm 0cm 0cm 0px;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Can cause delayed gastric emptying and post operative ileus. Constipation is common with acute and chronic opioid use. </span></li>\n</ul>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Sedative dose effect: </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Opioids are a fundamental part of medications used during procedural sedation; however, they are seldom used alone but in conjunction with benzodiazepine. Sedative dosing for fentanyl as per Lexicomp Inc, 2024, are:</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">-0.5 to 1 mcg/kg every 2 minutes until desired level of sedation and analgesia achieved for adults and adolescents</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">-1 to 2 mcg/kg/dose; administer 3 minutes before the procedure; maximum dose: 50 mcg/dose; may repeat 1/2 original dose every 3 to 5 minutes if necessary; titrate to effect, for infants.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">The clinical effects of sedative opioid dosing can range from moderate analgesics control leading to heighten comfort, respiratory depression and drowsiness to sleep. Therefore, The American Society of Anesthesiologists (ASA) (2018), recommends strict monitoring of </span><span style=\"font-size: 11.0pt;color: black;\">Patient\u2019s Level of Consciousness, Ventilation (capnography) and Oxygenation, and </span><span style=\"font-size: 11.0pt;color: black;\">Hemodynamics (HR and BP). Furthermore, ASA (2018) recommends the use of supplemental oxygen as meta-analysis of multiple randomized controlled trial (RCT) showed association with reduced risk of hypoxemia in procedural sedation. Acarel, Yildirimturk, and Yapici (2021) found in their study with patients who underwent electrical cardioversion with the use of midazolam and fentanyl at standard doses provided adequate sedation without any adverse effects on hemodynamic. Fentanyl derivatives are known to cause minimal effect on the cardiovascular hemodynamic other than HR via direct effect on the vagal nerve tone in the brainstem. However, it is to note that combining benzodiazepine with fentanyl can sometime exacerbate respiratory depression and lower blood pressure with effects more pronounced in elderly population, high BMI and OSA (Cummings III &amp; Naguib, 2022; Egan, 2023). </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Induction dose effect:</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">When opioids are administered at **<span style=\"font-family: Calibri, sans-serif;font-weight: normal;\">induction doses</span>**<b>,</b> their clinical effects are significantly more pronounced compared to sedative doses. Opioids are rarely used as sole induction agents, rather as an adjuvant to other induction agents. The primary reason for the use of opioids for induction is to blunt the sympathetic responses to tracheal intubation via direct laryngoscopy as it inhibits upper airway protective reflexes (Cummings III &amp; Naguib, 2022; Egan, 2023). Fentanyl has been mainly used as a sole induction agent in cardiovascular surgery patients as it has minimal effects on patient\u2019s hemodynamics and sympathetic surge can have a negative impact in patients with coronary artery disease, heart failure etc. A great review article by Faine et al. (2024) looked at the effects of fentanyl dosing as a sole induction agent in cardiac surgery patients and the subsequent hemodynamic effects. They found that in one study moderate dose of fentanyl (10-25mcg/kg) produced 90% successful induction without significant changes in hemodynamics during the 10 minutes post intubation period. Similarly with another study looking at 50mcg/kg bolus dosing (high dose), loss of consciousness occurred within 45 seconds without significant hemodynamic changes during 5 minutes post intubation. Chest wall rigidity occurred in 27% in one study using only fentanyl as sole induction with high dose (300mcg-400mcg/min until unconscious). Overall, the review article concluded that generalization to today\u2019s practice is limited as studies were conducted 30 years ago and high doses of fentanyl are not used for induction in today\u2019s practice. Moreover, patients\u2019 awareness were not assessed after the use of paralytic agent and risk of prolonged respiratory depression remains post-surgery. Joo et al. (2004) found that using remifentanil (5mcg/kg) as a primary induction agent with midazolam (70mcg/kg) and glycopyrrolate (0.2mg) </span><span style=\"font-size: 11.0pt;\">offered a rapid, predictable loss of consciousness with no ability to recall, providing cardiac stability and effectively blunting the hemodynamic response to tracheal intubation. Bradycardia was prevented due to the use of glycopyrrolate. Due to its short duration of action, remifentanil may be a viable alternative to fentanyl for anesthesia induction in patients with heart disease, making it particularly useful in this high-risk group with decrease risk of post-operative respiratory depression. </span>\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\">&#160;\n<p style=\"margin-right: 0cm;margin-left: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">References: </span>\n<p style=\"margin-left: 36pt;text-indent: -36pt;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">Acarel, M., Yildirimturk, &#214;., &amp; Yapici, N. (2021). Comparison of hemodynamic and sedative effects of midazolam-fentanyl and midazolam-ketamine combinations used in cardioversion sedation.<span class=\"apple-converted-space\"><i>&#160;</i></span><i>Journal of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care Society, 27</i>(4), 266-71<i> </i>https://doi.org/10.5222/GKDAD.2021.46338</span>\n<p style=\"margin-left: 36pt;text-indent: -36pt;margin-right: 0cm;font-size: 12pt;font-family: &#39;Times New Roman&#39;, serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: #333333;\">Practice guidelines for moderate procedural sedation and analgesia 2018. (2018).<span class=\"apple-converted-space\">&#160;</span><i>Anesthesiology (Philadelphia),<span class=\"apple-converted-space\">&#160;</span>128</i>(3), 437-479.<span class=\"apple-converted-space\">&#160;</span>https://doi.org/10.1097/ALN.0000000000002043</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: #333333;\">Arthur, J., &amp; Hui, D. (2018). Safe opioid use: Management of opioid-related adverse effects and aberrant behaviors.<span class=\"apple-converted-space\"><i>&#160;</i></span><i>Hematology/oncology Clinics of North America,<span class=\"apple-converted-space\">&#160;</span>32</i>(3), 387-403 https://doi.org/10.1016/j.hoc.2018.01.003</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;\">Bateman, J. T., Saunders, S. E., &amp; Levitt, E. S. (2023). Understanding and countering opioid-induced respiratory depression. <i>British Journal of Pharmacology</i>, <i>180</i>(7), 813\u2013828. https://doi.org/10.1111/bph.15580</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;\">Cummings III, K. C., &amp; Naguib, M. A. (2022). Opioid agonists and antagonists. In P. Flood, J. P. Rathmell, &amp; R. D. Urman (Eds.), <i>Stoelting&#39;s pharmacology and physiology in Anesthetic Practice</i> (6th ed., pp. 206-245). Wolters Kluwer.</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Egan, T. D. (2023). Opioids. In M. C. Pardo (Ed.), <i>Miller\u2019s basics of anesthesia</i> (8th ed., pp. 107-124). Elsevier.</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">Faine, B. A., Carroll, E., Sharma, A., &amp; Mohr, N. (2024). Rapid sequence intubation, is it time to find an alternative induction agent? A narrative review. SAGE Publications. https://doi.org/10.1177/08971900231197501</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;color: #333333;\">Joo, H. S., Salasidis, G. C., Kataoka, M. T., Mazer, C. D., Naik, V. N., Chen, R. B., &amp; Levene, R. G. (2004). Comparison of bolus remifentanil versus bolus fentanyl for induction of anesthesia and tracheal intubation in patients with cardiac disease.<i>Journal of Cardiothoracic and Vascular Anesthesia,<span class=\"apple-converted-space\">&#160;</span>18</i>(3), 263-268.<span class=\"apple-converted-space\">&#160;</span>https://doi.org/10.1053/j.jvca.2004.03.003</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 11.0pt;\">UpToDate Inc. (2024). Fentanyl. Lexi-Drugs, <i>UpToDate Lexidrug</i>. Retrieved October 5, 2024, https://online-lexi-com.uhn.idm.oclc.org</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Calibri, sans-serif;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:00.668Z"
            },
            {
                "Author": "Adrian Harris",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Hi Tenzing! Thanks for sharing this super insightful look into the clinical effects of sedation vs induction dose opioids. Your information has given me a better appreciation of the dose effect of the various opioids, especially on hemodynamics, and some of the adverse of unwanted effects that come along with them. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">I was recently speaking to one of the AAs at my site about how a particular opioid is selected for a case.&#160; They mentioned that the reason for desired effect (what they need it for) and the duration of desired effect (how long the case is) can both play a large part in the decision process. When researching that, I came across some information that I can share with respect to the timing of effect, as that can also impact on the choice of opioid and its clinical effect.&#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">There is evidence that front-end kinetics of opioids, which is how they act right after bolus administration, can also impact on its clinical effect (1). Depending on the opioid choice, when given by bolus there may be a delay in clinical effect time before the expected response is seen, known as latency to peak effect (1).&#160; For example, if the desired effect of an induction dose opioid is the blunting of sympathetic response to an emergent intubation, then morphine as an example, may not be the optimal opioid of choice, as the latency to peak effect will be longer than a drug such a remifentanil or fentanyl (1). &#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Additionally, the back-end kinetics, which is the time to a clinically relevant concentration degradation or decay (1), can also play a role in the choice of opioids.&#160; If the desired clinical effect is a longer duration of analgesia with less dissipation of drug, then bolus dose remifentanil may not be the long-term drug of choice, for example during longer procedures (unless you want to keep providing bolus after bolus). &#160;However, if the desired clinical effect is maximal opioid effect but for much shorter case duration, there may be benefit from remifentanil infusion as an example.&#160; With that example, the time to context-sensitive half-time concentration will be much shorter, despite even a longer infusion-time, as compared to other opioid infusions (1).</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">The front-end and back-end kinetics of various opioids via bolus or infusion are illustrated in Figure 1 below.&#160; They are a helpful add-on to the already well-described clinical effects of sedation vs induction doses summary you&#39;ve provided.&#160;&#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Cheers, </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Adrian.&#160;</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><img style=\"width: 136pt;height: 234pt;visibility: visible;\" src=\"/d2l/le/7298/discussions/posts/4858/ViewAttachment?fileId=445463\"/>&#160;\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"0\" class=\"MsoTableGrid\" style=\"border-collapse: collapse;border: none;\">\n<tbody>\n<tr>\n<td valign=\"top\" style=\"width: 332.9pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 7.5pt;font-family: Calibri, sans-serif;\">Figure 1. Opioid pharmacokinetics. Bolus: Front-end and back-end time after injection vs % of peak concentration (top); infusion: front-end duration of infusion vs concentration (middle); infusion back-end infusion duration vs time to context-sensitive half-time (bottom) (1)</span>\n</td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;color: black;\">1. Egan TD. Opioids. In: Miller\u2019s basics of anesthesia. 8<sup>th</sup> ed. Philadelphia: Elsevier Inc; c2023. p. 125-142.</span>",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4858/ViewAttachment?fileId=445463",
                        "filename": "image_725406921728228622013.jpg"
                    }
                ],
                "Timestamp": "2024-12-07T22:58:00.669Z"
            },
            {
                "Author": "Meera Sathananthan",
                "Content": "Hi Tenzing and Adrian,\nThank you both for your insights. Adrian, your explanation on how timing affects patient outcomes, such as minimizing complications during induction, was very helpful!\nTenzing, your discussion on opioid effects provided an excellent foundation. Adrian, your points on latency to peak effect and context-sensitive half-time add valuable depth to opioid selection, especially in high-risk situations like cardiac arrest or major trauma which we frequently encounter at St. Michael&#39;s.\nAt St. Michael&#39;s, remifentanil is commonly used for induction and maintenance in the OR, particularly in patients with cardiac issues. Its rapid onset, short duration, and context-sensitive half-life make it ideal for procedures requiring quick anesthesia adjustments, helping blunt sympathetic responses during intubation like you mentioned Tenzing and maintain hemodynamic stability (1).\nRemifentanil&#39;s predictability and rapid recovery are beneficial for procedures like neurosurgery and cardiac surgeries, where precise sedation helps avoid complications like hemodynamic instability and improves recovery (2). Additionally, its minimal residual effects facilitate postoperative care, especially when prompt neurologic assessment is needed (2).\nOne downside of remifentanil to make note of is its potential to cause hyperalgesia, which is an increased sensitivity to pain after discontinuation. This can be managed with multimodal analgesia, such as using non-opioid analgesics like acetaminophen or NSAIDs to improve pain control and reduce opioid requirements (2). This is important to keep in mind when thinking of post-operative care. Remifentanil is rapidly metabolized, providing predictable sedation without the prolonged sedation or respiratory depression seen with morphine or fentanyl, which facilitates faster recovery and prompt neurologic assessments (1). Recently, I have even seen it implemented in our neurosurgical ICU to help a patient manage their pain and keep them calm while intubated, while still allowing nurses to perform neuro checks when necessary.\nRemifentanil also helps maintain hemodynamic stability, particularly in cardiac patients, by allowing precise anesthesia control and minimizing blood pressure or heart rate fluctuations (2). Its shorter latency to peak effect is beneficial during induction, particularly in critical situations requiring rapid reduction of the body&#39;s stress response (1).\nHopefully these additional tidbits about remifentanil are helpful! Thank you both again for the discussion :)\nSincerely,<br/>Meera\n**References**\n1. Egan TD, Newberry, C. Opioids. In: Pardo MC Jr, Miller RD, editors. Basics of anesthesia. 7th ed. Philadelphia (USA): Elsevier; 2018. p. 123-142.\n<br/>2. Cummings K 3rd, Naguib MA. Opioid agonists and antagonists. In: Flood P, Rathmell JP, Urman RD, editors. Stoelting&#39;s pharmacology and physiology in anesthetic practice. 6th ed. Wolters Kluwer; 2022. p. 217-250.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:00.670Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<p style=\"margin: 0cm 0cm 0.0001pt;line-height: 115%;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;line-height: 115%;color: black;font-family: Lato, sans-serif;\">Great discussion on opioids!</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: 115%;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: Lato, sans-serif;font-size: 19px;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Opioid is a special class of drug as it can be used at any level of the sedation continuum, from minimal sedation to general anesthesia.&#160; It is a great example to illustrate the dose-dependent clinical and side effects, as mentioned by Tenzing.&#160; Different doses of opioids can achieve a certain level of analgesia. However, their impact on the respiratory system, cardiovascular system, and degree of consciousness can vary greatly. Moreover, Adrian reminded us that the onset and duration of the effects also differ.</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: 115%;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: Lato, sans-serif;font-size: 19px;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: 115%;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;line-height: 115%;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">I want to take this opportunity to review the Ramsay Sedation Score, which we use to monitor the levels of sedation at the University Health Network.</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: 115%;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: Lato, sans-serif;font-size: 19px;\">&#160;</span>\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"0\" class=\"MsoNormalTable\" style=\"border-collapse: collapse;\">\n<tbody>\n<tr>\n<td valign=\"top\" style=\"width: 63.5pt;border: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Level</span>\n</td>\n<td valign=\"top\" style=\"width: 403.5pt;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Characteristics</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 63.5pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">1</span>\n</td>\n<td valign=\"top\" style=\"width: 403.5pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Awake, anxious, agitated, or restless</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 63.5pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">2</span>\n</td>\n<td valign=\"top\" style=\"width: 403.5pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Awake, cooperative, oriented, and tranquil</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 63.5pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">3</span>\n</td>\n<td valign=\"top\" style=\"width: 403.5pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Drowsy, with response to commands</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 63.5pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">4</span>\n</td>\n<td valign=\"top\" style=\"width: 403.5pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Asleep, brisk response to glabella tap or loud auditory stimulus</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 63.5pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">5</span>\n</td>\n<td valign=\"top\" style=\"width: 403.5pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Asleep, sluggish response to tactile stimulus</span>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 63.5pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">6</span>\n</td>\n<td valign=\"top\" style=\"width: 403.5pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">No response to firm nail-bed pressure or other noxious stimuli</span>\n</td>\n</tr>\n</tbody>\n</table>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: 115%;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;line-height: 115%;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">For sedation, at levels 2 \u2013 3, very low doses are used to maintain the respiratory drive.&#160; The patient is drowsy because there is a depression of consciousness, but the patient can still cooperate and follow commands.</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: 115%;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: Lato, sans-serif;font-size: 19px;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">In general anesthesia, level 6, the patient is unconscious with no response to noxious stimuli.&#160; There is a dose-dependent depression in ventilation through decreased respiratory rate and sensitivity to carbon dioxide.&#160; This causes an irregular breathing rhythm and potentially complete apnea. The cough reflex is inhibited, and airway obstruction can occur.&#160; </span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-family: Lato, sans-serif;font-size: 19px;\">&#160;</span>\n<p style=\"margin: 0cm 0cm 0.0001pt;line-height: normal;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: black;border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Tenzing pointed out that during the induction of general anesthesia, we give a small bolus of Fentanyl 1 \u2013 3 minutes before intubation to blunt circulatory responses evoked by direct laryngoscopy.&#160; We also give intermittent IV boluses to supplement inhaled anesthetics during maintenance, utilizing a balanced anesthesia approach.&#160; Large doses of Fentanyl can be used as the sole induction agent in cardiac surgeries to provide protective effects for the heart.&#160; They reduce the hemodynamic and stress response in patients by blunting the sympathetic nervous system response triggered by the vasodilation induced by other anesthetic agents.</span><span style=\"font-size: 11.0pt;color: black;\"> </span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:00.670Z"
            }
        ]
    },
    {
        "Thread Title": "Question 7",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/109/View",
        "Question": "<p>Question 7: Describe the significant differences in clinical effect when local anesthetics are given at local versus regional doses.</p>",
        "Responses": [
            {
                "Author": "Paula Watkis",
                "Content": "See attached document",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/5603/ViewAttachment?fileId=470488",
                        "filename": "Differences in clinical Effects of Local Anesthesia at LOCAL VS REGIONAL DOSE.docx"
                    }
                ],
                "Timestamp": "2024-12-07T22:58:04.699Z"
            },
            {
                "Author": "Ryan Smith",
                "Content": "Paula\nThanks for your summary of the differences of local anesthetic given at local versus regional dose ranges.&#160; As I have virtually no experience in this field apart from anecdote I found an interesting meta analysis worth sharing in trying to learn about this topic.\nA recent (2022) moderately high powered (n=3665) meta analysis of high (&gt;0.1%), low (&gt;0.08% to \u22640.1%) or ultra\u2010low (\u22640.08%)&#160;buvipicaine given via epidural for labour was conducted yielding interesting results. The ultra-low subgroup had statistically significantly higher incidence of vaginal delivery, improved motor score and no difference in c-section incidence and top-up needed. Overall the maternal and neonatal outcomes were similar or better in the ultra-low group.<sup>1</sup>\nGiven the small but present risk of local anesthetic toxicity, it begs the question as to the direction of peri-natal anesthetic care and drug strength choice for this particular patient group. Certainly avoiding the possible sequealae of higher dose local anesthetic administration is favourable and it will be interesting to watch over time if our practice changes with emerging data.\n<br/>-Ryan\nReference:\n1. Halliday L, Kinsella M, Shaw M, Cheyne J, Nelson SM, Kearns RJ. Comparison of ultra\u2010low, low and high concentration local anaesthetic for labour epidural analgesia: a systematic review and network meta\u2010analysis. Anaesthesia. 2022 Aug; 77(8): 910\u2013918.\n<br/><br/>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:04.700Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "Hi Paula,\nThanks for the overview of local and regional anesthesia. &#160;\nIt is interesting to note that local anesthetics can produce quite a different intensity of pain blockade, temperature sensation, and motor function. &#160;Nerve fibers have different sensitivities to local anesthetics because of different ion channel compositions or different arrangements of channels within the axon. &#160;We must consider all these factors when picking a local anesthetic and its dosage. &#160;\nAs you have mentioned, the motor function is usually spared with local doses, such as in a local infiltration. &#160;The dose of local anesthetics will anesthetize the nerve endings in a small area of tissue proximal to the site of the local anesthetic injection. &#160;This usage of local anesthetics is ideal in day surgery patients where ambulation is essential for discharge.\nWith regional doses, motor function will be profoundly blocked. This is valuable to patients who are contraindicated for general anesthesia. &#160;The required regional doses will depend on the type of regional block, the site of injection, and the local anesthetic used. &#160;For example, both spinal and epidural blocks can produce motor blockade from the waist down. &#160;A spinal block requires a relatively small dose because the local anesthetic is injected directly into the cerebrospinal fluid (CSF). &#160;In contrast, using the same local anesthetic, an epidural block will require a larger dose because it is not injected in CSF and needs to diffuse into the subarachnoid space through the dura. &#160;\nOne last point I want to highlight quickly is the sequence of the clinical blockade. &#160;Complete blockade of peripheral nerves usually progresses in the following order:\n1) &#160; &#160;Sympathetic block with peripheral vasodilation<br/>2) &#160; &#160;Loss of pain and temperature sensation<br/>3) &#160; &#160;Loss of proprioception<br/>4) &#160; &#160;Loss of touch and pressure sensation<br/>5) &#160; &#160;Motor paralysis\nThese are the markers we look for when testing block effectiveness.",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:04.700Z"
            }
        ]
    },
    {
        "Thread Title": "Question 8",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/108/View",
        "Question": "<p>Question 8: Describe the role of lipid resuscitation in the treatment of local anesthetic systemic toxicity. Provide the initial bolus dose and the maintenance dose.</p>",
        "Responses": [
            {
                "Author": "Janet Rozek",
                "Content": "<p style=\"text-indent: 36pt;line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">Local anesthetic systemic toxicity (LAST) is an adverse effect of local anesthetics. This complication occurs when there is an excess plasma concentration of the drug in the body. The plasma concentration of local anesthetics is defined by the rate of the drug in the systemic circulation relative to the redistribution to other tissue sites and the ability to clear the drug by metabolism. The most reported incidents of LAST are during epidural anesthesia and accidental direct intravascular injection of local anesthetic during peripheral nerve block anesthesia. (Maheshwari &amp; Nuguib 2018). Systemic toxicity of local anesthetics involves the central nervous system and the cardiovascular system. The signs and symptoms of LAST can vary from restlessness, vertigo, tinnitus, to slurred speech and muscle twitching to other significant effects with high plasma concentrations including systemic hypotension, seizures, apnea, cardiovascular depression and coma. Patients often report the delusion of imminent death (Maheshwari &amp; Nuguib 2018).\n<table cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\" style=\"border-collapse: collapse;border: none;\">\n<tbody>\n<tr style=\"height: 6.25pt;\">\n<td valign=\"top\" style=\"width: 184.05pt;border: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><b>Neurologic symptoms</b>\n</td>\n<td valign=\"top\" style=\"width: 283.45pt;border: solid windowtext 1.0pt;border-left: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\"><b>Cardiac symptoms</b>\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 184.05pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">Seizures\n</td>\n<td valign=\"top\" style=\"width: 283.45pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">Cardiovascular collapse\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 184.05pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">Altered mental status\n</td>\n<td valign=\"top\" style=\"width: 283.45pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">Hypotension\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 184.05pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">Tinnitus\n</td>\n<td valign=\"top\" style=\"width: 283.45pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">Arrythmia (Asystole, bradycardia, Ventricular arrythmias)\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 184.05pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">Metallic taste\n</td>\n<td valign=\"top\" style=\"width: 283.45pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n<tr>\n<td valign=\"top\" style=\"width: 184.05pt;border: solid windowtext 1.0pt;border-top: none;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">Perioral numbness\n</td>\n<td valign=\"top\" style=\"width: 283.45pt;border-top: none;border-left: none;border-bottom: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;padding: 0cm 5.4pt 0cm 5.4pt;\">\n<p style=\"margin: 0cm;line-height: normal;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n</td>\n</tr>\n</tbody>\n</table>\n<p style=\"line-height: normal;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"line-height: 115%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">Management of LAST:\n<ol style=\"margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Stop injection of local anesthetic at the fist indication of toxicity</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Call for help, get LAST treatment kit</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">If respiratory distress, apnea or loss of consciousness\n<ol style=\"list-style-type: lower-alpha;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Bag valve mask airway, deliver 100% oxygen, assist ventilation as needed</li>\n</ol>\n</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Ensure good IV access</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Is there is seizure activity administer\n<ol style=\"list-style-type: lower-alpha;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Midazolam IV 0.5 to 1mg increments</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Propofol IV 10 to 20 mg</li>\n</ol>\n</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Immediately administer lipid emulsion (20%)\n<ol style=\"list-style-type: lower-alpha;margin-bottom: 0cm;margin-top: 0px;\">\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Bolus 1.5mL/kg over 1 minute (approx. 100ml)</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Continuous infusion 0.25-0.5mL/kg/min until stable</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Can repeat bolus dose if symptoms continue</li>\n</ol>\n</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Monitor for further seizure activity</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 0cm 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Manage arrest as necessary</li>\n<li style=\"line-height: 115%;margin: 0cm 0cm 8pt 0px;font-size: 11pt;font-family: Aptos, sans-serif;\">Monitor in ICU for at least 12 hours</li>\n</ol>\n<p style=\"margin: 0cm 0cm 8pt 324pt;text-indent: 36pt;line-height: 115%;font-size: 11pt;font-family: Aptos, sans-serif;\">(Dority, 2015)\n<p style=\"text-indent: 36pt;line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">The mechanism of action of lipid emulsion is not entirely understood, but research supports the lipid sink theory which describes the lipid emulsion as a lipid depot where highly fat-soluble drugs are absorbed and cleared from the tissues and organs. The lipid molecules bind to the highly fat-soluble local anesthetic and significantly improve cardiovascular and neuro function of the patient. Below is an example of how lipid emulsion works in our bodies (Liu et al., 2021).\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><img alt=\"A diagram of a heart and brainDescription automatically generated\" height=\"257\" width=\"624\" src=\"/d2l/le/7298/discussions/posts/3980/ViewAttachment?fileId=432106\"/>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <a rel=\"noopener\" name=\"_Hlk178677292\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (Liu et al., 2021)</a>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: center;margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">References:\n<p style=\"margin: 0cm 0cm 8pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\">Dority, J.&#160;(2015). Neurologic Events. In D.M. Gaba &amp;&#160;A. Burden.<i> Crisis Management in </i>\n<p style=\"margin: 0cm 0cm 8pt 36pt;line-height: 107%;font-size: 11pt;font-family: Aptos, sans-serif;\"><i>Anesthesiology </i>(2<sup>nd</sup> ed., pp 243-249).&#160;United Kingdom:&#160;Elsevier Health Sciences.\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">Liu, Y., Zhang, J., Yu, P., Niu, J., &amp; Yu, S. (2021). Mechanisms and efficacy of intravenous\n<p style=\"margin: 0cm 0cm 8pt 72pt;line-height: 200%;font-size: 11pt;font-family: Aptos, sans-serif;\">lipid emulsion treatment for systemic toxicity from local anesthetics.&#160;<i>Frontiers in medicine</i>,&#160;<i>8</i>, 756866. https://doi.org/10.3389/fmed.2021.756866\n<p style=\"margin: 5pt 0cm 0cm;line-height: 200%;font-size: 12pt;font-family: Calibri, sans-serif;color: black;\"><a rel=\"noopener\" name=\"_Hlk178453916\"><span style=\"font-size: 11.0pt;line-height: 200%;font-family: Aptos, sans-serif;color: windowtext;\">Maheshwari,K &amp; Naguid,M. (2018).&#160;Local Anesthetics. In P. Flood, J. P. Rathmell, &amp; R. D. Urman </span></a>\n<p style=\"margin: 5pt 0cm 0cm 36pt;line-height: 200%;font-size: 12pt;font-family: Calibri, sans-serif;color: black;\"><span style=\"font-size: 11.0pt;line-height: 200%;font-family: Aptos, sans-serif;color: windowtext;\">(Eds.) <i>&#160;Stoelting\u2019s pharmacology and physiology in anesthetic practice</i>&#160;(5th ed., pp 282-309). Wolters Kluwer Health.</span>\n<p style=\"line-height: 200%;margin: 0cm 0cm 8pt;font-size: 11pt;font-family: Aptos, sans-serif;\">&#160;",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/3980/ViewAttachment?fileId=432106",
                        "filename": "image_45090847921727799860597.jpg"
                    }
                ],
                "Timestamp": "2024-12-07T22:58:09.664Z"
            },
            {
                "Author": "Kelly Gram",
                "Content": "Fantastic summary, thank you! And so relevant with regional anesthesia being so commonplace now. I was actually speaking with an anesthesiologist about this exact topic today and he was mentioning how shockingly fast the onset of the lipids are once the infusion is started. &#160;We keep the IV lipid emulsion in our block room so access to it is very fast, but he said his patients HR had dropped below 20, and before they could even begin compressions, the lipids had already begun to work and the side effects reversed very quickly as well.&#160; He also mentioned that in his experience, since the routine use of ultrasound with regional blocks, LAST is much less common, but all the more reason to be vigilant and aware of the symptoms.&#160;\nSince starting work in the block room, one of the AA&#39;s I&#39;ve been shadowing has given me a pneumonic to keep in mind if I&#39;m ever questioning LAST. I&#39;ll include it here incase it helps you guys :)\nSMACT&#160;&#160;<br/>Seizure<br/>Metallic taste<br/>Arrythmia<br/>Circumoral numbness (perioral numbness)<br/>Tinnitus",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:09.665Z"
            },
            {
                "Author": "Deena Kurilsky",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Thank you for your explanation Janet. It was very informative and highlights the urgent nature of treatment of local anesthetic systemic toxicity (LAST).<br/><br/>\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Regarding the use of local with peripheral nerve blocks. An important tip to remember when assisting with a peripheral nerve block that will help minimize the risk of accidental intravascular injection. Is to perform a negative aspiration test to confirm the needle is not in the blood vessel before injecting. Simple, yet very effective.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">Additionally, epinephrine can be added to the solution. The addition of epinephrine will cause vasoconstriction, this will help keep the drug in the intended area, help to prolong the anesthetic effect and reduce the rate of systemic absorption.\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 36pt;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;text-indent: -36pt;\">Toda, C., &amp; Naguib, M. A., (Eds.). (2022). Basic Principles of Pharmacology. In P. Flood, J. P. Rathmell (Eds.),&#160;<i>Stoelting\u2019s pharmacology &amp; physiology in anesthetic</i>&#160;practice (6<sup>th</sup>&#160;ed., pp 971-973). Wolters Kluwer\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: 400;text-align: start;\">",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:09.665Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Great contribution, everyone!</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Thanks, Janet, for providing the list of signs and symptoms so that we can recognize and treat LAST early. Kelly, the pneumonic is a nice touch! Pneumonic is so useful, and you will learn many more in the next semester. </span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">I want to add that the ester local anesthetics such as Procaine, Chloroprocaine, and Tetracaine cause fewer potential risks for LAST because of their rapid metabolism by plasma cholinesterase. &#160;They are less likely to gain significant concentration, which leads to toxicity. However, decreases in plasma cholinesterase quantity or activity will slow the elimination of these drugs. &#160;On the other hand, the amide local anesthetics such as Lidocaine, Bupivacaine, and Ropivacaine are metabolized slower by the liver and therefore, it is more likely to cumulate in the plasma and increase the risk of LAST. </span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Regarding the dosage of intralipid, according to the American Society of Regionals Anesthesia and Pain Medicine (ASRA) 2020 Guidelines, it depends on the patient\u2019s weight. In patients over 70 kg, it is recommended to bolus 100 mL IV over 2-3 minutes, followed by an infusion of 200-250 mL over 15-20 minutes. In patients under 70 kg, it is recommended to IV bolus 1.5 mL/kg over 2-3 minutes, followed by an infusion at 0.25 mL/kg/minute (1). </span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Like any other adverse event, the best treatment is prevention. Other than the good practice prevention techniques mentioned by Deena, it is also very important to be cognizant of the maximum allowable dosage for each local anesthetic plain and with Epinephrine.&#160;</span><br/><span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Here is a list of the maximum dose for the most commonly used local anesthetics:</span>\n<ul>\n<li style=\"font-size: 19px;font-family: Lato, sans-serif;\"><span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Lidocaine: 5 mg/kg plain; 7 mg/kg with epi</span></li>\n<li style=\"font-size: 19px;font-family: Lato, sans-serif;\"><span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Bupivacaine: 3 mg/kg</span></li>\n<li style=\"font-size: 19px;font-family: Lato, sans-serif;\"><span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Ropivacaine: 3 mg/kg</span></li>\n<li style=\"font-size: 19px;font-family: Lato, sans-serif;\"><span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Mepivacaine: 5 mg/kg plain; 7 mg/kg with epi</span></li>\n<li style=\"font-size: 19px;font-family: Lato, sans-serif;\"><span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Chloroprocaine: 12 mg/kg</span></li>\n</ul>\n<ol>\n<li style=\"font-size: 19px;font-family: Lato, sans-serif;\"><span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Neal JM, Neal EJ, Weinberg GL. American Society of Regional Anesthesia and Pain Medicine local anesthetic systemic toxicity checklist: 2020 version. Regional Anesthesia &amp; Pain Medicine. 2021;46(1):81-82. Available from:&#160;<a rel=\"noopener\" href=\"https://doi.org/10.1136/rapm-2020-101986\" style=\"letter-spacing: 0.02rem;\">https://doi.org/10.1136/rapm-2020-101986</a><span style=\"letter-spacing: 0.02rem;\">&#160;</span></span></li>\n</ol>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:09.665Z"
            },
            {
                "Author": "Paula Watkis",
                "Content": "This is a very informative summary from everyone. It is very important to at least put great emphasis on the prevention of LAST. I have noted that these have all been discussed already. My take away from the discussion and my readings. Lipid Emulsion should be on all resuscitation carts with the other emergency drugs. Once there is a suspicion of LAST, especially if patients are presenting with cardiac symptoms, sustained arrhythmias or neurological symptoms like seizures, lipid emulsion should be initiated immediately. As per&#160; the ASRA guidelines, an intravenous bolus dose of 20% lipid emulsion starts with a bolus of 1.5 mL/kg over 2 to 3 minutes (100 mL if greater than 70 kg) followed by a continuous infusion at 0.25 mL/kg/min for 30-60 minutes (this varies from text to text, some literature says 15 to 20 minutes). The bolus dose can be repeated once or twice if there is still cardiac instability and the rate increased to 0.5ml/kg/min. Lipid emulsion infusion should be continued for at least 15 minutes after hemodynamic stability is achieved. Lipid emulsion is quite effective from the onset, however, other supportive measures may need to be initiated or on standby. These include proper airway management, seizure control and cardiovascular support. It is also important to continue to monitor the patient very closely for another 2 hours for signs of recurrent toxicity, as local anesthetics can redistribute overtime.\nBerde, C.B. &amp; Koka, A. (2022). Millers Basics of Anesthesia. Elsevier. Local Anesthetics. (8th ed). Elsevier&#160;\nWarren, L. (September, 2024). Local anesthetic systemic toxicity. <a rel=\"noopener\" href=\"https://www.uptodate.com/contents/local-anesthetic-systemic-toxicity?search=Management%20of%20LAST%20with%20lipids&amp;source=search_result&amp;selectedTitle=7%7E150&amp;usage_type=default&amp;display_rank=6\">Local anesthetic systemic toxicity - UpToDate</a>&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:09.665Z"
            }
        ]
    },
    {
        "Thread Title": "Question 9",
        "Thread URL": "https://michbrite.michener.ca/d2l/le/7298/discussions/threads/107/View",
        "Question": "<p>Question 9: What is the role of nitrous oxide in general anesthesia? What does the current literature and practice suggest about its use?</p>",
        "Responses": [
            {
                "Author": "Janelyne Mandegarian",
                "Content": "<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Nitrous oxide (N<sub>2</sub>O) plays an important role in general anesthesia (GA) as it has multiple functions even though it is the least potent inhalation anesthetic. It works differently from the other volatiles anesthetics by being an NMDA \u2013 receptor antagonists, whereas the others potentiate GABA<sub>A</sub> receptors. Knuf and Maani (2023) state the anesthetic effects are produced through non-competitive NMDA inhibition in the central nervous system.\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">N<sub>2</sub>O and GABA modulators act synergistically to generate an amnesia and hypnosis effect (Cook &amp; Hemmings, 2023). Because of the high concentration of 104% to achieve MAC it is normally combined with other volatile anesthetics that are more potent and can not endure being the sole anesthetic agent which makes it a worthwhile adjunct in anesthesia. N<sub>2</sub>O is administered at about 60-70% of the gas mixture and affects the alveolar volume and uptake into the lungs. N<sub>2</sub>O diffuses out of the alveoli quickly, thus the remains of the inhalation agents in the alveoli are more concentrated, this is called concentration effect. Second gas effect as seen on Figure 1 (Cook &amp; Hemmings, 2023) improves the speed of onset of volatile gases. The onset of action is approximately 2 to 5 minutes and when combined can achieve general anesthesia and decreases the risk of awareness intraoperatively (Knuf &amp; Maani, 2023).\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><img alt=\"A diagram of a gas reactionDescription automatically generated with medium confidence\" hspace=\"12\" align=\"left\" height=\"256\" width=\"565\" src=\"/d2l/le/7298/discussions/posts/4458/ViewAttachment?fileId=444492\"/>&#160;\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Figure 1: <span style=\"font-size: 12.0pt;line-height: 115%;font-family: Aptos, sans-serif;\">When nitrous oxide is delivered at high concentrations it will diffuse the N<sub>2</sub>O out of the alveoli. Then, the decreasing alveolar volume will concentrate the remaining anesthetic gases, which is called the concentration effect and second gas effect. The effects of such will produce a high partial pressure which increases the rate of induction. </span>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Note. Adapted from <i>Miller\u2019s basics of anesthesia, </i>by Padro, 2023, p. 89. Copyright 2023 by Elsevier.\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Conversely, the same principle can also be used for emergence from anesthesia causing a \u201cwashout\u201d of the brain because it has a short elimination half time (Cook &amp; Hemmings, 2023). During emergence diffusion hypoxia can occur because of the low ventilation with air and the nitrous oxide. N<sub>2</sub>O transfers into the alveolus, diluting the oxygen concentration and impairs the transfer into the blood which causes the hypoxia (Brown &amp; Syned, 2016).\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">N<sub>2</sub>O has analgesics properties that are effective with treatment for severe and chronic pain. It can also weaken hyperalgesia from remifentanil (Flood et al, 2022). The analgesic effect is produced from endogenous opioids that stimulate opioid receptors which mimic morphine and produces anxiolytics effects through GABA activation. N<sub>2</sub>O is commonly seen with dental procedure, where is it known as \u201claughing gas\u201d because it leads to euphoria (Knuf &amp; Maani, 2023).\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">Nitrous oxide can be mixed 50% with oxygen to achieve these effects and can be very beneficial in the obstetrical ward but in accordance with American College of Obstetricians and Gynecologists (ACOG), N<sub>2</sub>O can cross the placenta but is swiftly eliminated from neonates when they take their first breathes. They also note it should not be combined with other sedatives, hypnotics and opioids for increased risk of maternal hypoxemia and mothers can resume breastfeeding after they have recovered from anesthesia because of its short elimination half life (Knuf &amp; Maani, 2023).\n<p style=\"text-indent: 0.5in;margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;N<sub>2</sub>O should be used with caution for surgeries with enclosed compartments generating gases. Whether conditions or surgeries, nitrous oxide can diffuse faster into gas filled cavities because of the high partial pressures. Patients with vitamin b12 deficiency can yield neuropathy and megaloblastic anemia due to the inhibition of methionine synthetase. Also, concern was raised for increased cardiovascular morbidity from possible increase of homocysteine levels (Cook &amp; Hemmings, 2023). &#160;&#160;&#160;\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 200%;font-size: 12pt;font-family: Aptos, sans-serif;\">Cook, D., Hemmings, H. (2023) Inhaled Anesthetics in Pardo, M. <i>Miller\u2019s basics of anesthesia</i> (8th ed.,96,97). Elsevier.\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 200%;font-size: 12pt;font-family: Aptos, sans-serif;\">Flood, P., Shafer, S. L., Ardin, S. B. (2022) in Flood, P., Rathmell, J. <i>Stoelting&#39;s pharmacology &amp; physiology in anesthetic practice</i> (6<sup>th</sup> ed., 373). Wolters Kluwer.\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 200%;font-size: 12pt;font-family: Aptos, sans-serif;\">Brown, S.M., Sneyd, J.R. (2016). Nitrous oxide in modern anaesthetic practice. <i>BJA Education</i> (16, 3, 87\u201391). <a rel=\"noopener\" href=\"https://doi.org/10.1093/bjaceaccp/mkv019\">https://doi.org/10.1093/bjaceaccp/mkv019</a>\n<p style=\"margin: 0in 0in 8pt 0.5in;text-indent: -0.5in;line-height: 200%;font-size: 12pt;font-family: Aptos, sans-serif;\">Knuf, K., Maani, C.V. Nitrous Oxide. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.&#160;Available from: <a rel=\"noopener\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK532922/\">https://www.ncbi.nlm.nih.gov/books/NBK532922/</a>\n<p style=\"margin: 0in 0in 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;",
                "Attachments": [
                    {
                        "url": "https://michbrite.michener.ca/d2l/le/7298/discussions/posts/4458/ViewAttachment?fileId=444492",
                        "filename": "image_32967727421728009488325.png"
                    }
                ],
                "Timestamp": "2024-12-07T22:58:13.659Z"
            },
            {
                "Author": "Teresa Nguyen",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Hi Janelyne,</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Thank you for your answer. I appreciate your incorporation of the \u201csecond gas effect\u201d and the explanation. To add on, another critical point that is applicable in patient care is that when a patient is emerging from anesthesia, they may experience diffusion hypoxia, as you mentioned. According to Knuf and Maani (2023), once nitrous oxide administration is stopped, the patient should receive 100% oxygen to combat the adverse effects of diffusion hypoxia. </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">In regards to exercising caution with nitrous oxide, examples of surgeries/procedures that involve enclosed compartments are contraindicated: closed-loop bowel obstruction, pneumocephalus, pneumothorax and middle ear surgery (Pardo, Miller, &amp; Stoelting, 2023).</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">In your post, you mentioned that nitrous oxide has analgesic properties, therefore making it an effective treatment for severe and chronic pain. Can you clarify and further explain how nitrous oxide is related to endogenous opioids (as you mentioned that the analgesic effect from nitrous oxide is produced from endogenous opioids)? </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Furthermore, my inquiry question for you is that if nitrous oxide is related to opioid receptors, is nitrous oxide equally effective for treating acute pain as it is with chronic pain? How about if you were to consider that the patient with chronic pain had a medical history of taking oral opioids? Chronic use of opioids leads to tolerance and limits clinical use (Morgan &amp; Christie, 2011). </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">References</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;\">Knuf, K., &amp; Maani, C. (2023). Nitrous oxide. In <i>Bookshelf.</i> </span>\n<p style=\"text-indent: 36pt;margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;color: black;\">https://www.ncbi.nlm.nih.gov/books/NBK532922/</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">Morgan, M., &amp; Christie, M. (2011). Analysis of opioid efficacy, tolerance, addition, and </span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;padding-left: 40px;\"><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">dependence from </span><span style=\"font-size: 11.0pt;font-family: Calibri, sans-serif;\">cell culture to human<i>. British Journal of Pharmacology, 164</i>(4), 1322-1334. https://doi:<span style=\"color: rgb(0, 0, 0);\">&#160;<a rel=\"noopener\" target=\"_blank\" href=\"https://doi.org/10.1111%2Fj.1476-5381.2011.01335.x\" style=\"color: rgb(0, 0, 0);\">10.1111/j.1476-5381.2011.01335.x</a></span></span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-size: 11.0pt;\">Pardo, M., Miller, R. D., &amp; Stoelting, R. K. (2023). <i>Miller\u2019s Basics of Anesthesia</i>. Elsevier. </span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:13.660Z"
            },
            {
                "Author": "Junia Isaac",
                "Content": "<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">Hi Janelyne and Teresa, Thank you both for your thorough insights into nitrous oxide\u2019s (N<sub>2</sub>O) role in general anesthesia, especially with the explanation of the second gas effect and diffusion hypoxia. I\u2019d like to expand on the conversation by discussing a few additional aspects of nitrous oxide. Janelyne highlighted the analgesic properties of nitrous oxide via endogenous opioid stimulation, I found it interesting that nitrous oxide\u2019s analgesic effect may also involve the activation of noradrenergic pathways, specifically in the periaqueductal gray area of the brain (Fujinaga &amp; Maze, 2002). This dual mechanism of action, through both opioidergic and noradrenergic systems, suggests that nitrous oxide could offer broader applications in managing different types of pain. Teresa\u2019s question about its efficacy in treating acute versus chronic pain is quite relevant here. Could the involvement of these pathways suggest that nitrous oxide may be more effective in certain acute pain settings compared to chronic pain, particularly for opioid-tolerant patients? Another emerging discussion is the neurotoxicity associated with prolonged or repeated exposure to N<sub>2</sub>O, especially in the pediatric and elderly populations. Evidence from Davidson and Sun (2018) suggests that prolonged or repeated exposure to nitrous oxide in pediatric populations may result in neuronal apoptosis and long-term cognitive deficits (Davidson et al., 2016). This is particularly concerning for vulnerable groups, which raises the question of whether nitrous oxide should be used more conservatively in these populations. Lastly, building on the idea of balancing benefits with risks, Teresa mentioned surgeries involving enclosed compartments where nitrous oxide is contraindicated. Interestingly, there\u2019s also literature suggesting that N<sub>2</sub>O could exacerbate air embolisms due to its rapid diffusion into air-filled spaces (Junghans et al., 2000; Munson &amp; Merrick, 1966). Could this be a reason why nitrous oxide use is reduced in certain high-risk surgeries? With all these factors in mind (dual mechanisms of analgesia, neurotoxicity, and surgical contraindications), do you think we\u2019ll see a decline in nitrous oxide use in the coming years, or does its unique set of benefits still justify its regular use in clinical practice?&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">References\n<p class=\"MsoNormal\" style=\"margin: 0cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Davidson, A. J., Disma, N., de Graaff, J. C., Withington, D. E., Dorris, L., Bell, G., Stargatt, R., Bellinger, D. C., Schuster, T., Arnup, S. J., Hardy, P., Hunt, R. W., Takagi, M. J., Giribaldi, G., Hartmann, P. L., Salvo, I., Morton, N. S., von Ungern Sternberg, B. S., Locatelli, B. G., Wilton, N., \u2026 GAS consortium. (2016). Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial.&#160;<i>Lancet (London, England)</i>,&#160;<i>387</i>(10015), 239\u2013250.&#160;<a rel=\"noopener\" href=\"https://doi-org.uhn.idm.oclc.org/10.1016/S0140-6736(15)00608-X\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi-org.uhn.idm.oclc.org/10.1016/S0140-6736(15)00608-X</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Davidson, A. J., &amp; Sun, L. S. (2018). Clinical Evidence for Any Effect of Anesthesia on the Developing Brain.&#160;<i>Anesthesiology</i>,&#160;<i>128</i>(4), 840\u2013853.&#160;<a rel=\"noopener\" href=\"https://doi-org.uhn.idm.oclc.org/10.1097/ALN.0000000000001972\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi-org.uhn.idm.oclc.org/10.1097/ALN.0000000000001972</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Fujinaga, M., &amp; Maze, M. (2002). Neurobiology of nitrous oxide-induced antinociceptive effects.&#160;<i>Molecular neurobiology</i>,&#160;<i>25</i>(2), 167\u2013189.&#160;<a rel=\"noopener\" href=\"https://doi-org.uhn.idm.oclc.org/10.1385/MN:25:2:167\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi-org.uhn.idm.oclc.org/10.1385/MN:25:2:167</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Junghans, T., B&#246;hm, B., &amp; Meyer, E. (2000). Influence of nitrous oxide anesthesia on venous gas embolism with carbon dioxide and helium during pneumoperitoneum.&#160;<i>Surgical endoscopy</i>,&#160;<i>14</i>(12), 1167\u20131170.&#160;<a rel=\"noopener\" href=\"https://doi-org.uhn.idm.oclc.org/10.1007/s004640000227\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi-org.uhn.idm.oclc.org/10.1007/s004640000227</a>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">&#160;\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0cm 1cm;font-size: medium;font-family: Aptos, sans-serif;color: rgb(0, 0, 0);font-style: normal;font-weight: normal;text-align: start;text-indent: -1cm;\">Munson, E. S., &amp; Merrick, H. C. (1966). Effect of nitrous oxide on venous air embolism.&#160;<i>Anesthesiology</i>,&#160;<i>27</i>(6), 783\u2013787.&#160;<a rel=\"noopener\" href=\"https://doi-org.uhn.idm.oclc.org/10.1097/00000542-196611000-00010\" style=\"color: rgb(150, 96, 125);text-decoration: underline;\">https://doi-org.uhn.idm.oclc.org/10.1097/00000542-196611000-00010</a>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:13.660Z"
            },
            {
                "Author": "Mary Johnsy Joseph",
                "Content": "<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hi Janelyn, it is very informative, you explained in detail the important role of </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">nitrous oxide (N<sub>2</sub>O)&#160;in general anesthesia. N<sub>2</sub>O is an anesthetic and analgesic&#160;gas, it acts on </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">multiple supraspinal and spinal targets and has utility in a wide range of clinical situations </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">(Hosseinian et. al, 2018)</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160; &#160;&#160;Hosseinian et. al., (2018) stated that N<sub>2</sub>O is one of the earliest anesthetics in use. It has </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">retained its role as a versatile agent with anesthetic, analgesic, and sedative roles owing to </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">its efficacy and relative safety. N<sub>2</sub>O is a viable alternative to more invasive procedures for </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">labor analgesia. </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Knuf and Maani (2023) explained that compared to other anesthetic agents, nitrous oxide </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">causes minimal effects on respiration and hemodynamics. It leads to decreased tidal volume and </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">increased respiratory rate but minimizes overall minute ventilation. Nitrous oxide leads to direct </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">myocardial depression, but nitrous oxide&#39;s sympathetic stimulation reduces this effect, and the net </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">effect is minimal. Unlike other volatile anesthetics, nitrous oxide has no muscle relaxation </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">properties. </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160; &#160;Hi Teresa, I had the same question that how nitrous oxide is related to endogenous opioids. I </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">found it interesting that the analgesic effects occur by releasing endogenous opioids that act on </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">opioid receptors: its analgesic actions are like morphine (Knuf &amp; Maani, 2023). The anxiolytic </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">effects are through GABA-A activation. Nitrous oxide has a central sympathetic stimulating </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">activity that supports blood pressure, systemic vascular resistance, and cardiac output (Knuf &amp; </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Maani, 2023).</span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Hi Junia, to clarify about the contraindications, I found that the blood: gas partition </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">coefficient of nitrous oxide is 30 times greater than that of nitrogen. Because of this, N<sub>2</sub>O will </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">enter gas-filled spaces more than thirty times faster than nitrogen. intrapleural gas volumes </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">doubled within 10 min and tripled in 30\u201345 min. In contrast, intrapleural and intestinal gas </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">volumes remained constant or decreased with halothane and oxygen administration.&#160;Therefore, </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">pneumothorax, bowel obstruction and pneumopericardium are considered contraindications to </span>\n<p style=\"margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">N<sub>2</sub>O (Lew, et. al., 2018).</span>\n<p style=\"text-align: center;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">References</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;Knuf, K., &amp; Maani, V. C.</span><b><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: black;\"> </span></b><span style=\"font-family: &#39;Times New Roman&#39;, serif;color: black;\">(2023). </span><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Nitrous<b> </b>Oxide. In <i>StatPearls.</i> StatPearls Publishing.</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; https://www.ncbi.nlm.nih.gov/books/NBK532922/</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;Lew, V., McKay, E., &amp; Maze, M. (2018). Past, present, and future of nitrous oxide. In <i>British </i></span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><i><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Medical Bulletin. </span></i><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"><a rel=\"noopener\" href=\"https://doi.org/10.1093/bmb/ldx050\">https://doi.org/10.1093/bmb/ldx050</a> 125(1), 119</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Zafirova, Z., Sheehan, C., &amp; Hosseinian, L. (2018). Update on nitrous oxide and its use in </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; anesthesia practice, Best Practice &amp; Research Clinical Anaesthesiology. In <i>ScienceDirect</i>. </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Elsevier Publishing. </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>&#160;&#160;&#160;&#160;<span style=\"font-family: &#39;Times New Roman&#39;, serif;\"><a rel=\"noopener\" href=\"https://www.sciencedirect.com/science/article/abs/pii/S1521689618300508\">https://www.sciencedirect.com/science/article/abs/pii/S1521689618300508</a> </span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 32(2), 113-123</span>\n<p style=\"text-align: justify;margin: 0cm 0cm 8pt;line-height: 115%;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:13.660Z"
            },
            {
                "Author": "Kurt Protacio",
                "Content": "<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Hey Janelyne,</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Thank you for your thorough research on helping us understand the use of nitrous oxide in general anesthesia. I really appreciate everyone\u2019s responses thus far, and would like to add on another reason why nitrous oxide can be beneficial in today\u2019s practice.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">In addition to what Mary highlighted, nitrous oxide is a choice many anesthesiologists will consider for a general anesthesia case as it is a viable, inexpensive, versatile agent with anesthetic, analgesic, and sedative properties. In 2014, a study was published, highlighting the overall effect of using nitrous oxide for general anesthesia in patients with perioperative cardiovascular risk (dubbed ENIGMA-II trial). After one year, they concluded from their sample size of nearly 6000 patients that had non-cardiac surgery, there was no increase in mortality, cardiovascular complications such as myocardial infarction, and even surgical-site infections compared to patients with cardiovascular history (Myles et al., 2014). This was a huge step forward in the decision to use nitrous oxide more often, however, most literature tends to disagree with the use of nitrous oxide on cardiovascular patients undergoing cardiac surgery as, Janelyne and the rest have pointed out, nitrous oxide can produce a decrease in myocardial contractility, decreasing overall cardiac output, and increases the systemic vascular resistance. This can lead to further cardiovascular complications such as heart failure. Therefore, the use of nitrous oxide, based on the literature, should be avoided in patients with congential heart disease (CHD) where pulmonary arterial pressure tends to be higher than the normal population, and coronary bypass graft surgery (CABG), where monitoring hemodynamics can be troublesome and can require strategic monitoring using emergency drugs (Neidecker, 2001). Therefore, although inexpensive, we have discussed on the previous threads of the use of nitrous oxide as a multimodal anesthetic, and should remember that it has a negative inotropic effect due to its direct effect on the heart.</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">References</span>\n<p style=\"margin: 0cm;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\"></span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Myles, P. S., Leslie, K., Chan, M. T. V., Forbes, A., Peyton, P. J., Paech, M. J., Beattie, W. S., Sessler, D. I., Devereaux, P. J., Silbert, B., Schricker, T., &amp; Wallace, S. (2014). The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.&#160;<i>The Lancet</i>,&#160;<i>384</i>(9952), 1446\u20131454. https://doi.org/10.1016/s0140-6736(14)60893-x</span>\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\">&#160;\n<p style=\"margin: 0cm 0cm 0cm 36pt;text-indent: -36pt;font-size: 12pt;font-family: Aptos, sans-serif;\"><span style=\"font-family: &#39;Times New Roman&#39;, serif;\">Neidecker, J. (2001). Nitrous oxide: use in cardiovascular risk patients.&#160;<i>Best Practice &amp; Research Clinical Anaesthesiology</i>,&#160;<i>15</i>(3), 429\u2013435. https://doi.org/10.1053/bean.2001.0178</span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:13.660Z"
            },
            {
                "Author": "Phoebe Lam",
                "Content": "<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Thanks, everyone, for sharing your perspective on the usage of nitrous oxide.</span><br/><span style=\"font-size: 19px;font-family: Lato, sans-serif;\"></span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">The role and practice of nitrous oxide have been debatable for many years. &#160;The appeal of nitrous oxide is its analgesic properties and its use in dental clinics and labour and delivery. &#160;Nitronox and Entonox are popular brands with a 50/50 oxygen-nitrous oxide mixture.&#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">In contrast, some anesthesiologists argue against nitrous oxide due to its side effects, such as diffusion hypoxia and rapid diffusion into closed air spaces, causing increased pressure and volume, as mentioned above. Other than the closed air spaces that have been suggested, nitrous oxide can diffuse into endotracheal tube cuffs and increase the pressure against tracheal mucosa, causing unnecessary potential airway damage. Also, because nitrous oxide deactivates vitamin B12, which is necessary for DNA synthesis, we should use it with caution in pregnant patients during the first two trimesters of pregnancy and those with a deficiency in vitamin B12. &#160;</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">Furthermore, it is important to note that nitrous oxide is a potent greenhouse gas that contributes to global warming. Muret et al. (2019) examined its environmental impact and commented that nitrous oxide has about 300 times higher global warming potential than carbon dioxide. Using 50% nitrous oxide at a fresh gas flow of 1 L/min has an equivalent greenhouse potential as driving an average-sized car for 120 km.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">With its long list of adverse effects mentioned in our discussion and the fact that many other drugs work just as well or better for the maintenance of anesthesia, nitrous oxide has lost its popularity in general anesthesia. &#160;This is evident by the removal of the emergency tank of nitrous oxide at the back of anesthesia gas machines in most operating rooms nowadays.</span>\n<span style=\"font-size: 19px;font-family: Lato, sans-serif;\">References</span>\n<p style=\"margin: 0cm 0cm 0.0001pt 14.2pt;text-indent: -14.2pt;line-height: 12.65pt;background: white;font-size: 12pt;font-family: Calibri, sans-serif;\"><span style=\"font-size: 19px;color: rgb(17, 17, 17);border: 1pt none windowtext;padding: 0cm;font-family: Lato, sans-serif;\">Muret, J., Fernandes, T. D., Gerlach, H., Imberger, G., J&#246;rnvall, H., Lawson, C., McGain, F., Mortimer, F., Pauchard, J.-C., Pierce, T., Shinde, S., Swinton, F., &amp; Williams, L. (2019). Environmental impacts of nitrous oxide: No laughing matter! Comment on Br J Anaesth 2019; 122: 587\u2013604.&#160;<i>British Journal of Anaesthesia</i>,&#160;<i>123</i>(4), e481\u2013e482. <a rel=\"noopener\" href=\"https://doi.org/10.1016/j.bja.2019.06.013\">https://doi.org/10.1016/j.bja.2019.06.013</a> </span>",
                "Attachments": [],
                "Timestamp": "2024-12-07T22:58:13.661Z"
            }
        ]
    }
]